Diabetes & Metabolism Journal

Review

Pharmacotherapy
Sodium-Glucose Cotransporter 2 Inhibitors as Emerging Anticancer Agents: Yun Kyung Cho, Chang Hee Jung; Diabetes Metab J. 2026;50(1):1-18. Published online January 1, 2026; DOI: https://doi.org/10.4093/dmj.2025.0964

2,112 View
246 Download

Abstract PDF PubReader ePub: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are established treatments for type 2 diabetes mellitus, heart failure, and chronic kidney disease, with well-documented metabolic and cardiorenal benefits. Emerging evidence indicates that these agents may also exert anticancer effects through mechanisms independent of glucose lowering. Preclinical studies have demonstrated functional SGLT2 expression in tumors such as prostate, pancreatic, breast, colorectal, and bone cancers. Inhibition of SGLT2 decreases tumor glucose uptake, disrupts mitochondrial respiration with subsequent adenosine monophosphate-activated protein kinase activation, and induces endoplasmic reticulum stress and autophagy. Immunomodulatory effects, including programmed death-ligand 1 (PD-L1) degradation and stimulator of interferon genes (STING)–interferon regulatory factor 3 (IRF3)–interferon-β (IFN-β) pathway activation, further illustrate their pleiotropic effects. Observational cohort studies, particularly from nationwide Korean databases, report reduced risks of pancreatic and prostate cancer among new users of SGLT2 inhibitors. In contrast, randomized controlled trials and meta-analyses focused on cardiovascular outcomes demonstrate neutral effects on overall cancer risk, providing reassurance regarding safety. Early translational studies suggest that combining SGLT2 inhibitors with chemotherapy is feasible and tolerable. In this review, we summarize the biological rationale and mechanistic insights underlying the anticancer effects of SGLT2 inhibitors, highlight preclinical and clinical evidence across different cancer types, and discuss challenges and future directions for their integration into oncology.

Original Articles

Pharmacotherapy
New Users of Sodium-Glucose Cotransporter 2 Inhibitors Are at Low Risk of Prostate Cancer: A Nationwide Cohort Study: Yun Kyung Cho, Sehee Kim, Myung Jin Kim, Woo Je Lee, Ye-Jee Kim, Chang Hee Jung; Diabetes Metab J. 2026;50(1):90-100. Published online July 22, 2025; DOI: https://doi.org/10.4093/dmj.2024.0693

2,431 View
61 Download
1 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Preclinical studies have reported anticancer properties of sodium-glucose cotransporter 2 inhibitors (SGLT2is). We aimed to elucidate the association between the use of SGLT2is and the risk of prostate cancer among male patients with type 2 diabetes mellitus (T2DM).
Methods
An active-comparator, new-user cohort design using a nationwide database between September 2014 and June 2020 was conducted on 45,601 new SGLT2i users and 205,395 new users of other glucose-lowering medications (oGLMs). In the following 1:1 propensity score matched (PSM) analysis, 35,371 SGLT2i users matched with an equivalent number of oGLM users were assessed. The hazard ratios (HRs) and 95% confidence intervals (CIs) for prostate cancer were calculated.
Results
Among the cohort, prostate cancer was diagnosed in 210 out of 45,601 SGLT2i users, corresponding to a cumulative incidence of 1.0%, in contrast to 1,880 cases among 205,395 users of oGLMs, with a cumulative incidence of 1.5%. The use of SGLT2is was significantly correlated with a reduced risk of prostate cancer based on a multivariable-adjusted HR of 0.83 (95% CI, 0.71 to 0.98). PSM analysis affirmed 18% reduction in prostate cancer risk associated with SGLT2i use (HR, 0.82; 95% CI, 0.67 to 0.99). Subgroup analyses revealed that body mass index (BMI) significantly influenced the effect of SGLT2i on prostate cancer risk, with a more pronounced reduction in the subgroup with a BMI <25 kg/m² (P=0.037).
Conclusion
The use of SGLT2is in Korean male patients with T2DM is associated with a lower risk of prostate cancer.

Citations

Citations to this article as recorded by

Sodium-Glucose Cotransporter 2 Inhibitors as Emerging Anticancer Agents
Yun Kyung Cho, Chang Hee Jung
Diabetes & Metabolism Journal.2026; 50(1): 1. CrossRef

Metabolic Risk/Epidemiology
Effects of Pancreatitis and Type 2 Diabetes Mellitus on the Development of Pancreatic Cancer: A Nationwide Nested Case-Control Study: Young-eun Kim, Min Heui Yu, Chung Mo Nam, Eun Seok Kang; Diabetes Metab J. 2025;49(2):252-263. Published online March 1, 2025; DOI: https://doi.org/10.4093/dmj.2024.0277

5,854 View
256 Download
2 Web of Science
2 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Despite diabetes mellitus (DM) and pancreatitis being known risk factors for pancreatic cancer, patients with these conditions are not included in pancreatic cancer screening due to the low incidence of pancreatic cancer in these populations. This study aimed to determine the high-risk subgroup of patients with diabetes and pancreatitis that would benefit from pancreatic cancer screening.
Methods
A nested case-control study was conducted using data from the National Health Information Database of the Korean National Health Insurance Service. Patients were categorized into the following groups: type 2 diabetes mellitus only (T2DM-only), pancreatitis-only (PAN-only), T2DM followed by pancreatitis (T2DM-PAN), post-pancreatitis diabetes mellitus (PPDM), and no diabetes and no pancreatitis (NDNP). Conditional logistic regression was used to determine significant associations of each group with pancreatic cancer development risk.
Results
The risk of pancreatic cancer was significantly higher in the T2DM-PAN (adjusted odds ratio [AOR], 4.96; 95% confidence interval [CI], 4.48 to 5.49) and PPDM (AOR, 4.71; 95% CI, 4.12 to 5.37) groups than in the NDNP group. Compared to patients in the NDNP group, those with PPDM using insulin had a 17-fold increased risk (AOR, 16.72; 95% CI, 9.50 to 29.43), and individuals with PPDM who had diabetes for less than 3 years had a more than 8-fold increased risk of pancreatic cancer (AOR, 8.83; 95% CI, 5.99 to 13.01).
Conclusion
In patients with post-pancreatitis diabetes, insulin use or shorter duration of diabetes was associated with a higher risk of pancreatic cancer, suggesting that patients in these subgroups may require close monitoring for pancreatic cancer development.

Citations

Citations to this article as recorded by

Effects of Pancreatitis and Type 2 Diabetes Mellitus on the Development of Pancreatic Cancer: A Nationwide Nested Case-Control Study (Diabetes Metab J 2025;49:252-63)
Young-eun Kim, Min Heui Yu, Chung Mo Nam, Eun Seok Kang
Diabetes & Metabolism Journal.2025; 49(3): 522. CrossRef
Pancreatitis, Type 2 Diabetes Mellitus, and Pancreatic Cancer (Diabetes Metab J 2025;49:252-63)
Shih-Wei Lai, Kuan-Fu Liao
Diabetes & Metabolism Journal.2025; 49(3): 518. CrossRef

Pharmacotherapy
Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus: Mijin Kim, Seung Chan Kim, Jinmi Kim, Bo Hyun Kim; Diabetes Metab J. 2025;49(1):49-59. Published online October 24, 2024; DOI: https://doi.org/10.4093/dmj.2024.0105

8,072 View
386 Download
8 Web of Science
15 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for the treatment of type 2 diabetes mellitus (T2DM) given their extra-pancreatic effects. However, there are concerns about carcinogenesis in the pancreas and thyroid gland. We aimed to evaluate the site-specific incidence of cancer in patients with T2DM-treated GLP-1 RAs using a nationwide cohort.
Methods
This study included data obtained from the Korean National Health Insurance Service (between 2004 and 2021). The primary outcome was newly diagnosed cancer, and the median follow-up duration for all participants was 8 years.
Results
After propensity score matching, 7,827 participants were analyzed; 2,609 individuals each were included in the GLP-1 RA, diabetes mellitus (DM) control, and non-DM control groups. The incidence rate ratio (IRR) of subsequent cancer in patients with T2DM was 1.73, which was higher than that of individuals without DM, and it increased in both men and women. Analysis of patients with T2DM showed no increased cancer risk associated with the use of GLP-1 RA, and similar results were observed in both men and women. The IRRs of pancreatic cancer (0.74), thyroid cancer (1.32), and medullary thyroid cancer (0.34) did not significantly increase in the GLP-1 RA group compared with those in the DM control group.
Conclusion
There was a 73% higher risk of cancer in patients with T2DM compared with the general population. However, among patients with T2DM, there was no association between the use of GLP-1 RAs and new-onset cancers, including pancreatic and medullary thyroid cancers.

Citations

Citations to this article as recorded by

Implications of Glucagon-like Peptide-1 Receptor Agonists on Thyroid Function and Thyroid Nodules: A Drug Target Mendelian Randomization and Cohort Study
Zhijun Zhang, Jingyun Yang, Ling Gao
Endocrine Practice.2026; 32(1): 60. CrossRef
Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use
Tina Vilsbøll, Michael Stellfeld, Vanita R. Aroda, Sune Dandanell, Jens‐Peter David, Ceyda T. P. Kristiansen, Søren Rasmussen, Fiona L. Roberts, Laszlo Hegedüs
Diabetes, Obesity and Metabolism.2026; 28(2): 1499. CrossRef
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
Setor K. Kunutsor, Samuel Seidu
Drugs.2026; 86(1): 11. CrossRef
Glucagon-like Peptide-1 Receptor Agonist Use and Pancreatic Cancer Risk in Patients with Chronic Pancreatitis
Sarina Ailawadi, Jennifer E. Murphy, Michael H. Storandt, Amit Mahipal
Cancers.2026; 18(2): 179. CrossRef
GLP‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials
Giovanni Antonio Silverii, Christian Marinelli, Costanza Bettarini, Gloria Giovanna Del Vescovo, Matteo Monami, Edoardo Mannucci
Diabetes, Obesity and Metabolism.2025; 27(8): 4454. CrossRef
Evaluating Thyroid Cancer Risk in Glucagon-like Peptide-1 Analog Users With Thyroid Nodules
Sanjana Balachandra, Rohma Syed, Zhixing Song, Julia Kasmirski, Andrea Gillis, Jessica Fazendin, Brenessa Lindeman, Herbert Chen
Journal of Surgical Research.2025; 312: 104. CrossRef
Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
Jung A Kim, Hye Jin Yoo
Diabetes & Metabolism Journal.2025; 49(4): 525. CrossRef
Association between Cancer and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review of Retrospective Cohort Studies
Hyun Jin Park, Si Yoon Lee
Research in Clinical Pharmacy.2025; 3(1): 28. CrossRef
GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study
Omar Faour, Moheb Boktor, Hanford Yau, Mustafa Kinaan, Ishak A Mansi
American Journal of Medicine Open.2025; 14: 100114. CrossRef
Semaglutide and weight management in the Arab countries: Focus on the United Arab Emirates
Sabina Semiz
Health Sciences Review.2025; 17: 100244. CrossRef
GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research
Estefania Valencia-Rincón, Rajani Rai, Vishal Chandra, Elizabeth A. Wellberg
Journal of Clinical Investigation.2025;[Epub] CrossRef
GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways
Daniela Lucente, Stefania Bellino, Anna La Salvia
Genes.2025; 16(11): 1352. CrossRef
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer
Stefano Iuliano, Maria Mirabelli, Stefania Giuliano, Antonio Brunetti
Current Opinion in Oncology.2025;[Epub] CrossRef
Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents
Sherry Yun Wang, Ryan Stofer, Hao Wang, Gregory A. Brent, Lu Shi, Yu Cai, Moom Roosan, Tannaz Moin
Diabetes & Metabolism Journal.2025; 49(6): 1331. CrossRef
Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer
Emma Watts, Jonathan Wadsley, Neil Sharma, Kristien Boelaert
Clinical Endocrinology.2025;[Epub] CrossRef

Review

Metabolic Risk/Epidemiology
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome: Scott L. Friedman; Diabetes Metab J. 2024;48(2):161-169. Published online January 26, 2024; DOI: https://doi.org/10.4093/dmj.2023.0240

11,585 View
514 Download
23 Web of Science
24 Crossref

Abstract PDF PubReader ePub

Metabolic dysfunction-associated steatotic (fatty) liver disease (MASLD), previously termed non-alcoholic fatty liver disease, is a worldwide epidemic that can lead to hepatic inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The disease is typically a component of the metabolic syndrome that accompanies obesity, and is often overlooked because the liver manifestations are clinically silent until late-stage disease is present (i.e., cirrhosis). Moreover, Asian populations, including Koreans, have a higher fraction of patients who are lean, yet their illness has the same prognosis or worse than those who are obese. Nonetheless, ongoing injury can lead to hepatic inflammation and ballooning of hepatocytes as classic features. Over time, fibrosis develops following activation of hepatic stellate cells, the liver’s main fibrogenic cell type. The disease is usually more advanced in patients with type 2 diabetes mellitus, indicating that all diabetic patients should be screened for liver disease. Although there has been substantial progress in clarifying pathways of injury and fibrosis, there no approved therapies yet, but current research seeks to uncover the pathways driving hepatic inflammation and fibrosis, in hopes of identifying new therapeutic targets. Emerging molecular methods, especially single cell sequencing technologies, are revolutionizing our ability to clarify mechanisms underlying MASLD-associated fibrosis and HCC.

Citations

Citations to this article as recorded by

Use of Artificial Intelligence-Assisted Histopathology for Evaluation of Sex-Specific Progression and Regression of Hepatocellular Carcinoma Related to Metabolic Dysfunction-Associated Fatty Liver Disease
Ke Yin, Yuyun Song, Ran Fei, Xu Cong, Baiyi Liu, Zilong Wang, Xin Ai, Minjun Liao, Yayun Ren, Kutbuddin Akbary, Wei Wang, Qiang Yang, Xiao Teng, Nan Wu, Huiying Rao, Xiaoxiao Wang, Feng Liu
Diagnostics.2026; 16(2): 234. CrossRef
The Effect of GLP-1 Agonists on Patients with Metabolic-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
Denisia Adelina Tornea, Christian Goldis, Alexandru Isaic, Alexandru Catalin Motofelea, Alexandra Christa Sima, Tudor Ciocarlie, Andreea Crintea, Razvan Gheorghe Diaconescu, Nadica Motofelea, Adrian Goldis
Pharmaceutics.2026; 18(1): 86. CrossRef
Metabolic Syndrome in Focus: Emerging Causes, New Diagnostic Approaches and Criteria, and Long-Term Health Consequences
Michalina Loson-Kawalec, Piotr Sawina, Anna Kowalczyk, Estera Pazek, Dorota Szydłowska, Julia Pawlowska, Dawid Boczkowski, Aleksandra Wielochowska, Dawid Szymanski, Mateusz Podkanowicz, Maciej Majchrzak, Tomasz Dolata, Weronika Majchrowicz, Patrycja Dadyn
Cureus.2026;[Epub] CrossRef
Liver Fibrosis and the Risks of Impaired Cognition and Dementia: Mechanisms, Evidence, and Clinical Implications
Mohamad Jamalinia, Ralf Weiskirchen, Amedeo Lonardo
Medical Sciences.2026; 14(1): 44. CrossRef
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj Klinaku, Federico Pialorsi, Valentina Tollemeto, Maria Zurlo, Antonio Seneci, Paolo Magni
Food Frontiers.2025; 6(2): 670. CrossRef
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment
Eleni Michalopoulou, John Thymis, Stamatios Lampsas, George Pavlidis, Konstantinos Katogiannis, Dimitrios Vlachomitros, Eleni Katsanaki, Gavriella Kostelli, Sotirios Pililis, Loukia Pliouta, Aikaterini Kountouri, Ioannis S. Papanikolaou, Vaia Lambadiari,
Journal of Clinical Medicine.2025; 14(2): 428. CrossRef
Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
Li-Hui Zhang, Su-Tong Liu, Qing Zhao, Xiao-Yan Liu, Tong Liu, Qiang Zhang, Ming-Hao Liu, Wen-Xia Zhao
World Journal of Hepatology.2025;[Epub] CrossRef
Efficacy of measuring natural killer-activating receptor ligands to predict the pathogenesis of metabolic dysfunction-associated steatotic liver disease
Jun Arai, Akinori Okumura, Satoshi Kimoto, Kazumasa Sakamoto, Tomoya Kitada, Rena Kitano, Tadahisa Inoue, Sayaka Nishimura, Noriko Inden, Yukiko Muraki, Naoya Kato, Kiyoaki Ito
Hepatology International.2025; 19(4): 836. CrossRef
Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
Yeon Jin Roh, Hyeonki Kim, Dong Wook Choi
Diabetes & Metabolism Journal.2025; 49(3): 368. CrossRef
Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease
Joonyub Lee, Won Gun Choi, Marie Rhee, Seung-Hwan Lee
Diabetes & Metabolism Journal.2025; 49(3): 348. CrossRef
Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysis
Hongkun Yin, Xusheng Zhang, Qi Wang
Discover Oncology.2025;[Epub] CrossRef
Elucidating the mechanistic interplay of AMPK and Nrf2 in MASLD: A focus on dietary phytochemical modulation of lipid and redox homeostasis
Cindy H.J. Yu, H.P. Vasantha Rupasinghe
Biochemical and Biophysical Research Communications.2025; 777: 152300. CrossRef
Notch signaling in metabolic diseases: A key regulator and potential target
Zhaoqing Xi, Junxia Zhang, Mingwei Bao
Biochemical and Biophysical Research Communications.2025; 781: 152492. CrossRef
Role of ChREBP–PPARα–FGF21 Axis in Metabolic Dysfunction of MASLD
Karina Mireya Palacios Girón, Zamira Helena Hernandez Nazara, Montserrat Maldonado-González, Erika Martínez-López, Martha P. Sánchez Muñoz, Carlos Alfredo Bautista López, Ma. Soledad Aldana Aguiñaga, Jose Alfredo Dominguez-Rosales, Belinda Vargas-Guerrero
International Journal of Molecular Sciences.2025; 26(23): 11425. CrossRef
Activating the Osteoblastic USP26 Pathway Alleviates Multi‐Organ Fibrosis by Decreasing Insulin Resistance
Jiyuan Tang, Wenkai Ye, Liang He, Zhou Dan, Leilei Chang, Zijie You, Yuanyue Jiang, Guoqing Tang, Lianfu Deng, Changwei Li
Advanced Science.2025;[Epub] CrossRef
Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning Techniques
Sergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, Ana M. Torres, Natalia Martínez-García, Pilar Blasco, Miguel Torralba, Jorge Mateo
Metabolites.2024; 14(6): 305. CrossRef
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Na Young Lee, Myeung Gi Choi, Eui Jin Lee, Ja Hyun Koo
Archives of Pharmacal Research.2024; 47(6): 558. CrossRef
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo
Journal of Personalized Medicine.2024; 14(8): 798. CrossRef
AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response
Feng Liu, Yameng Sun, Dean Tai, Yayun Ren, Elaine L. K. Chng, Aileen Wee, Pierre Bedossa, Rui Huang, Jian Wang, Lai Wei, Hong You, Huiying Rao
Diagnostics.2024; 14(16): 1837. CrossRef
Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
Harrison T. Muturi, Hilda E. Ghadieh, Suman Asalla, Sumona G. Lester, Getachew D. Belew, Sobia Zaidi, Raziyeh Abdolahipour, Abhishek P. Shrestha, Agnes O. Portuphy, Hannah L. Stankus, Raghd Abu Helal, Stefaan Verhulst, Sergio Duarte, Ali Zarrinpar, Leo A.
Molecular Metabolism.2024; 88: 102010. CrossRef
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review
Xingting Xue, Hongbing Zhou, Jiaxing Gao, Xinghua Li, Jia Wang, Wanfu Bai, Yingchun Bai, Liya Fan, Hong Chang, Songli Shi
Heliyon.2024; 10(19): e38339. CrossRef
Beneficial Effects of Tyrosol and Oleocanthal from Extra Virgin Olive Oil on Liver Health: Insights into Their Mechanisms of Action
Daniela Gabbia
Biology.2024; 13(10): 760. CrossRef
Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells
Kavita Prasad, Dipankar Bhattacharya, Shams Gamal Eldin Shams, Kimberly Izarraras, Tia Hart, Brent Mayfield, Maryjka B. Blaszczyk, Zhongren Zhou, Utpal B. Pajvani, Scott L. Friedman, Moshmi Bhattacharya
Cells.2024; 13(19): 1651. CrossRef
Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders
Michal Selc, Radka Macova, Andrea Babelova
Drug Design, Development and Therapy.2024; Volume 18: 4629. CrossRef

Original Article

Metabolic Risk/Epidemiology
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis: Shu Yi Wang, Wei Sen Zhang, Chao Qiang Jiang, Ya Li Jin, Tong Zhu, Feng Zhu, Lin Xu; Diabetes Metab J. 2024;48(1):134-145. Published online January 3, 2024; DOI: https://doi.org/10.4093/dmj.2022.0383

7,089 View
230 Download
6 Web of Science
5 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Abnormal glucose metabolism is a risk factor for colorectal cancer (CRC). However, association of glycosylated hemoglobin (HbA1c) with CRC risk remains under-reported. We examined the association between glycemic indicators (HbA1c, fasting plasma glucose, fasting insulin, 2-hour glucose, 2-hour insulin, and homeostasis model of risk assessment-insulin resistance index) and CRC risk using prospective analysis and meta-analysis.
Methods
Participants (n=1,915) from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy were included. CRC events were identified through record linkage. Cox regression was used to assess the associations of glycemic indicators with CRC risk. A meta-analysis was performed to investigate the association between HbA1c and CRC risk.
Results
During an average of 12.9 years follow-up (standard deviation, 2.8), 42 incident CRC cases occurred. After adjusting for potential confounders, the hazard ratio (95% confidence interval [CI]) of CRC for per % increment in HbA1c was 1.28 (95% CI, 1.01 to 1.63) in overall population, 1.51 (95% CI, 1.13 to 2.02) in women and 1.06 (95% CI, 0.68 to 1.68) in men. No significant association of other measures of glycemic indicators and baseline diabetes with CRC risk was found. Meta-analyses of 523,857 participants including our results showed that per % increment of HbA1c was associated with 13% higher risk of CRC, with the pooled risk ratio being 1.13 (95% CI, 1.01 to 1.27). Subgroupanalyses found stronger associations in women, colon cancer, Asians, and case-control studies.
Conclusion
Higher HbA1c was a significant predictor of CRC in the general population. Our findings shed light on the pathology of glucose metabolism and CRC, which warrants more in-depth investigation.

Citations

Citations to this article as recorded by

Association between accelerated biological aging and colorectal cancer: a cross-sectional study
Sai Wang, Keyu Wang, Xiu Wang
Frontiers in Medicine.2025;[Epub] CrossRef
Increased colorectal cancer risk in prediabetes: A meta-analysis
Na Wang, Tian-Yi Zhao, Xiao Ma
World Journal of Diabetes.2025;[Epub] CrossRef
Caracterización del perfil epidemiológico depacientes con cáncer colorrectal en Chile en el año2019 según base de datos GRD
Felipe Ignacio Santos Santos , Camila Andrea Guajardo Cantillanez , Esteban Rodolfo Acevedo Araya, Camila Jose Carrasco Bravo, Camilo Patricio Cáceres Espinoza, Javiera Andrea Sandoval Pino
Revista ANACEM.2025;[Epub] CrossRef
Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Journal of Korean Medical Science.2024;[Epub] CrossRef
Associations between blood glucose and early- and late-onset colorectal cancer: evidence from two prospective cohorts and Mendelian randomization analyses
Chenyu Luo, Jiahui Luo, Yuhan Zhang, Bin Lu, Na Li, Yueyang Zhou, Shuohua Chen, Shouling Wu, Qingsong Zhang, Min Dai, Hongda Chen
Journal of the National Cancer Center.2024; 4(3): 241. CrossRef

Reviews

Pathophysiology
Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice: Yun Kyung Cho, Chang Hee Jung; Diabetes Metab J. 2023;47(6):757-766. Published online July 24, 2023; DOI: https://doi.org/10.4093/dmj.2023.0072

16,106 View
739 Download
29 Web of Science
36 Crossref

Abstract PDF PubReader ePub

With the increasing use of immune-checkpoint inhibitors (ICIs), such as anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and anti-programmed cell death-1 (PD-1), for the treatment of malignancies, cases of ICI-induced type 1 diabetes mellitus (ICI-T1DM) have been reported globally. This review focuses on the features and pathogenesis of this disease. T1DM is an immune-related adverse event that occurs following the administration of anti-PD-1 or anti-programmed death ligand-1 (PDL1) alone or in combination with anti-CTLA-4. More than half of the reported cases presented as abrupt-onset diabetic ketoacidosis. The primary mechanism of ICI-T1DM is T-cell stimulation, which results from the loss of interaction between PD-1 and PD-L1 in pancreatic islet. The similarities and differences between ICI-T1DM and classical T1DM may provide insights into this disease entity. ICI-T1DM is a rare but often life-threatening medical emergency that healthcare professionals and patients need to be aware of. Early detection of and screening for this disease is imperative. At present, the only known treatment for ICI-T1DM is insulin injection. Further research into the mechanisms and risk factors associated with ICI-T1DM development may contribute to a better understanding of this disease entity and the identification of possible preventive strategies.

Citations

Citations to this article as recorded by

Adult-onset type 1 diabetes: early detection, differential diagnosis, and emerging disease-modifying therapies
Robert Wagner, Martin Füchtenbusch, Michael Hummel, Martin Miszon, Andreas Pfützner, Susanne Reger-Tan, Tobias Wiesner
Diabetes Research and Clinical Practice.2026; 231: 113047. CrossRef
Risk Factors and Survival Outcomes of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus: A Retrospective Cohort Study
Sang-hyeok Go, Yun Kyung Cho, Eun Hee Koh
Diabetes & Metabolism Journal.2026; 50(1): 115. CrossRef
Sintilimab-related fulminant autoimmune diabetes mellitus manifesting as diabetic ketoacidosis and rare insulin resistance: A case report and literature review
Junhui Zhang, Yuping Zhang, Hongmei Li, Fang Deng, Liling Ma, Wenjing Yang, Hong Yang, Huiqing Yu, Bing Chen, Jiongyu Hu
Endocrine Journal.2026; 73(1): 93. CrossRef
Sodium-Glucose Cotransporter 2 Inhibitors as Emerging Anticancer Agents
Yun Kyung Cho, Chang Hee Jung
Diabetes & Metabolism Journal.2026; 50(1): 1. CrossRef
Fulminant type 1 diabetes mellitus induced by tislelizumab in a patient with lung adenocarcinoma: a case report
Yuanzhen Feng, Xiankang Cheng, Jiao Liu, Jun Qi, Limin Han
Journal of Medical Case Reports.2026;[Epub] CrossRef
Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome in patients with cancer: A multicentre study
Rabia K. Shahid, Qasem Haider, Sunil Yadav, Duc Le, Shahid Ahmed
Clinical Medicine.2025; 25(1): 100262. CrossRef
Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association
Fumika Kamitani, Yuichi Nishioka, Miyuki Koizumi, Hiroki Nakajima, Yukako Kurematsu, Sadanori Okada, Shinichiro Kubo, Tomoya Myojin, Tatsuya Noda, Tomoaki Imamura, Yutaka Takahashi
Journal of Diabetes Investigation.2025; 16(2): 334. CrossRef
Management of Immunotherapy-Induced Type 1 Diabetes
Veronica Brady
Critical Care Nursing Clinics of North America.2025; 37(1): 93. CrossRef
Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection
Raluca-Ileana Pătru, Miruna Ghigeanu, Maria-Alexandra Barbu, Andreea Iuliana Ionescu, Antone-Iordache Ionuț-Lucian
Reports.2025; 8(1): 31. CrossRef
Immune Checkpoint Inhibitor-Induced Pancreatic Injury (ICI-PI) in Adult Cancer Patients: A Systematic Review and Meta-Analysis
Cha Len Lee, Israt Jahan Riya, Ifrat Jahan Piya, Thiago Pimentel Muniz, Marcus Otho Butler, Samuel David Saibil
Cancers.2025; 17(7): 1080. CrossRef
Cemiplimab and diabetic ketoacidosis: a case report of a rare endocrinopathy associated with immune checkpoint inhibitors
Anna Arecco, Cristian Petolicchio, Alessandro Pastorino, Enrica Teresa Tanda, Lara Vera, Mara Boschetti, Francesco Cocchiara, Davide Carlo Maggi, Diego Ferone, Federico Gatto
Frontiers in Endocrinology.2025;[Epub] CrossRef
Efficacy and adverse events of immune checkpoint inhibitors: evidence from non-small cell lung cancer and gastric cancer in Korea and Japan
Mc Neil Valencia, Zeeshan Abbas, Seung Won Lee
Precision and Future Medicine.2025; 9(1): 15. CrossRef
Durvalumab‑induced type 1 diabetes mellitus in lung adenocarcinoma: A case report and literature review
Huijing Dong, Shengfu Li, Yanmei Peng, Xu Zhang, Jiabin Zheng, Chongxiang Xue, Yumin Zheng, Yixuan Yu, Xingyu Lu, Zixin Hu, Huijuan Cui
Oncology Letters.2025; 29(6): 1. CrossRef
Pembrolizumab-Induced Hypothyroidism and Diabetes Mellitus: A Rare Case Presentation Post-Treatment
Jeevan Perera, Shubham Bhanot
Cureus.2025;[Epub] CrossRef
Risk Factors Associated with the Development of Immune-Checkpoint Inhibitor Diabetes Mellitus: An Integrative Review
Vivian Crowder, Veronica Brady
Life.2025; 15(7): 1063. CrossRef
Prenatal pembrolizumab exposure as the potential link among recurrent necrotizing enterocolitis, neonatal diabetes mellitus and exocrine pancreatic insufficiency: a case report
Pasquale Castaldo, Luigi Altimari, Maria Grazia Capretti, Giulio Maltoni, Andrea Scozzarella, Vittoria Paoletti, Luigi Corvaglia, Arianna Aceti
Italian Journal of Pediatrics.2025;[Epub] CrossRef
Development of type 1 diabetes mellitus after nivolumab dose escalation: A case report
Sayaka Mabuchi, Naoko Adachi, Atsushi Nagasawa, Satoshi Nabika
Medicine.2025; 104(29): e43356. CrossRef
Checkpoint Inhibitor-Associated Diabetes Mellitus Following Rapid Pancreatic Metastasis Resolution: Implications for Endocrine Toxicities in Immunotherapy
Sinead Cadogan, Sadhbh Doherty, Deirdre Kelly, Nigel Glynn
AACE Endocrinology and Diabetes.2025; 12(4): 339. CrossRef
Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus in a Patient With Melanoma: A Case Report
Mati Shavit
Cureus.2025;[Epub] CrossRef
Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes
Xuan Zhou, Andrii Iakovliev, Stuart McGurnaghan, Buddhiprabha Erabadda, Caroline Hayward, Paul M. McKeigue, Athina Spiliopoulou, Helen M. Colhoun
Diabetes.2025; 74(10): 1873. CrossRef
Natural coumarins as anti-diabetic agents: Mechanisms, therapeutic potential, and amelioration of diabetic complications
Shahnaaz Khatoon, Raabia Naaz, Umam Khan, Fayeqa Qayyum, Shakir Ahamad, Mohammad Saquib, Mohd Kamil Hussain
Phytomedicine.2025; 148: 157339. CrossRef
Atezolizumab-Induced Thyroiditis and Immune Checkpoint Inhibitor (ICI)-Type 1 Diabetes Mellitus: Diagnostic and Therapeutic Challenges in ICI-Associated Endocrinopathies
Rafal Al-Rubaye, Sabha Nadeem, Ahmed Abdulkader Zaki Ali Soliman
Cureus.2025;[Epub] CrossRef
Interconnected Mechanistic Pathways, Molecular Biomarkers, and Therapeutic Approach of Oral Cancer in Patients with Diabetes Mellitus
Viviana Elian, Violeta Popovici, Mihnea Ioan Nicolescu, Alexandra Maria Nicolescu, Sorina Maria Aurelian, Emma Adriana Ozon
Current Issues in Molecular Biology.2025; 47(11): 929. CrossRef
Tislelizumab-induced fulminant type 1 diabetes mellitus (FT1D): A case report and literature review
Xipeng Zhou, Peng Jiang, Mingxiang Chen, Jiashun Chen
Medicine.2025; 104(47): e46310. CrossRef
Immune Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus: An Indian Case Series
Medha N Rao, Aditi Chopra, Aditya G Hegde, Adarsh K S, Gunna Sriharsha
Cureus.2025;[Epub] CrossRef
Beyond Tumor Immunity: The Disruption of Endocrine and Infectious Homeostasis by Immune Checkpoint Inhibitors
Ema Schönberger, Luka Švitek, Barbara Grubišić, Tara Cvijić Perić, Romana Marušić, Nika Vlahović Vlašić, Tomislav Kizivat, Silvija Canecki Varžić, Lorna Stemberger Marić, Ines Bilić Ćurčić
International Journal of Molecular Sciences.2025; 26(23): 11619. CrossRef
Immune Checkpoint Restoration as a Therapeutic Strategy to Halt Diabetes-Driven Atherosclerosis
Dwaipayan Saha, Preyangsee Dutta, Abhijit Chakraborty
Biology.2025; 14(12): 1731. CrossRef
Research Advances of Immune Checkpoint Inhibitors Related Endocrine Adverse Events
晶晶王
Advances in Clinical Medicine.2024; 14(02): 2706. CrossRef
Immune checkpoint inhibitor‑associated diabetes mellitus in patients with HCC: Report of three cases and literature review
Gaocheng Wang, Jingjing Wang, Shuilin Dong, Zhanguo Zhang, Wanguang Zhang, Jianping Zhao
Experimental and Therapeutic Medicine.2024;[Epub] CrossRef
Type 1 diabetes: immune pathology and novel therapeutic approaches
Eleanor M. Ling, Joana R. N. Lemos, Khemraj Hirani, Matthias von Herrath
Diabetology International.2024; 15(4): 761. CrossRef
Pathophysiology, diagnosis, and management of immune checkpoint inhibitor-induced diabetes mellitus
Eleni-Rafaela Kani, Eleftheria Karaviti, Dimitra Karaviti, Eleni Gerontiti, Ioanna A. Paschou, Katerina Saltiki, Katerina Stefanaki, Theodora Psaltopoulou, Stavroula A. Paschou
Endocrine.2024; 87(3): 875. CrossRef
Use pembrolizumab may cause acute and severe adverse reactions: a case report and review
Linna Ouyang, Huixing Liu, Zhixiang Tang, Rui Wu, Yujie Zhong, Haibin Chen
International Journal of Surgery Oncology.2024; 9(3): 40. CrossRef
Pembrolizumab-Induced Insulin-Dependent Diabetes Mellitus in a Patient With Triple-Negative Breast Cancer: A Rare Immune-Related Adverse Event
Mirac Burak Tak, Zaid Munir, Ahmet Aydin
Cureus.2024;[Epub] CrossRef
Diabetes and the associated complications: The role of antioxidants in diabetes therapy and care
Lowell Dilworth, Dewayne Stennett, Aldeam Facey, Felix Omoruyi, Shada Mohansingh, Felix O. Omoruyi
Biomedicine & Pharmacotherapy.2024; 181: 117641. CrossRef
Fulminant type 1 diabetes mellitus: a neglected but high-risk adverse event associated with immune checkpoint inhibitors
Kelin Meng, Shengling Fu, Yaochen Huang, Wei Chen, Wenbin Zou
Expert Opinion on Drug Safety.2024; : 1. CrossRef
Fulminant Type 1 Diabetes Mellitus Leading to Diabetic Ketoacidosis and Mesenteric Ischemia With Necrosis Following Pembrolizumab Administration: A Case Report
Mayu Ueki, Takeshi Fukuda, Kenta Oue, Takuma Wada, Toshiyuki Sumi
Cureus.2024;[Epub] CrossRef

Metabolic risk/Epidemiology
Obesity, Diabetes, and Increased Cancer Progression: Dae-Seok Kim, Philipp E. Scherer; Diabetes Metab J. 2021;45(6):799-812. Published online November 22, 2021; DOI: https://doi.org/10.4093/dmj.2021.0077

31,092 View
1,038 Download
204 Web of Science
210 Crossref

Graphical Abstract Abstract PDF PubReader ePub

Rates of obesity and diabetes have increased significantly over the past decades and the prevalence is expected to continue to rise further in the coming years. Many observations suggest that obesity and diabetes are associated with an increased risk of developing several types of cancers, including liver, pancreatic, endometrial, colorectal, and post-menopausal breast cancer. The path towards developing obesity and diabetes is affected by multiple factors, including adipokines, inflammatory cytokines, growth hormones, insulin resistance, and hyperlipidemia. The metabolic abnormalities associated with changes in the levels of these factors in obesity and diabetes have the potential to significantly contribute to the development and progression of cancer through the regulation of distinct signaling pathways. Here, we highlight the cellular and molecular pathways that constitute the links between obesity, diabetes, cancer risk and mortality. This includes a description of the existing evidence supporting the obesity-driven morphological and functional alternations of cancer cells and adipocytes through complex interactions within the tumor microenvironment.

Citations

Citations to this article as recorded by

Clinical significance of cytoplasmic discrete dots (AC-18) patterns in HEp-2 cell indirect Immunofluorescence: insights from a Taiwanese multicenter study
Chao-Yang Hsiao, Li-Jen Su, Kuang-Hui Yu, Tien-Ming Chan
Clinica Chimica Acta.2026; 578: 120521. CrossRef
Hyperglycemia accelerated the metastasis of triple-negative breast cancer via promoting TNFα/Gli-1 axis in endothelial cells
Xiyu Mei, Chuang Ke, Ziyun Gao, Fan Yang, Zhenlin Huang, Bin Lu, Lili Ji
Biochimica et Biophysica Acta (BBA) - General Subjects.2026; 1870(1): 130875. CrossRef
The impact of metformin use on survival outcomes in colorectal cancer: A systematic review and meta-analysis
Mohammad Rahmanian, Iman Elahi Vahed, Mohammad Shirali, Nima Barazandeh, Mehraban Amirhosseini, Mahdi Bamdad, Mohammadreza Mesri, Amirmohammad Jabbarpour, Farbod Khosravi, Niloufar Shabani, Soudeh Ghafouri-Fard
Cancer Treatment and Research Communications.2026; 46: 101073. CrossRef
Weighing the impact of bariatric surgery: A meta-analysis of long-term outcomes of Roux-en-Y gastric bypass and sleeve gastrectomy
Marcus H. Cunningham, Grace C. Bloomfield, Mike Y. Chen, Amanda C. Foshag, Dan E. Azagury, Yewande R. Alimi, Nicholas J. Prindeze
Surgery.2026; 190: 109934. CrossRef
Network and Gene Set Enrichment Analysis of Adipokine Drivers of Prostate Cancer; Unravelling the Mechanistic Link Between Excess Adiposity and Prostate Cancer Risk
Zachary Dovey, Elena Tomas Bort, Jeffrey I. Mechanick
Cancer Medicine.2026;[Epub] CrossRef
Global burden of cancers attributable to high fasting plasma glucose from 1990 to 2021 and projections until 2031
Xianglin Zhu, Lang Wang, Hao Liang, Jie Zhang, Shijun Zhao, Cheng Zhao, Dehai Wang, Yinlu Ding
Diabetology & Metabolic Syndrome.2026;[Epub] CrossRef
Influence of diabetes mellitus and anti-diabetic drugs on pathophysiology and prognosis for primary prostate cancer
Mikhail Kazachok, Aleksander Ślusarczyk, Łukasz Zapała, Tomasz Piecha, Piotr Radziszewski, Piotr Zapała
International Urology and Nephrology.2026;[Epub] CrossRef
New Users of Sodium-Glucose Cotransporter 2 Inhibitors Are at Low Risk of Prostate Cancer: A Nationwide Cohort Study
Yun Kyung Cho, Sehee Kim, Myung Jin Kim, Woo Je Lee, Ye-Jee Kim, Chang Hee Jung
Diabetes & Metabolism Journal.2026; 50(1): 90. CrossRef
The atherogenic index of plasma and triglyceride-glucose index as promising predictors of overall and disease-free survival in postoperative breast cancer patients
Zhimin Chen, Minhui Luo, Longdan Liu, Mingwen Cheng, Honglan Gao, Shuangshuang Ma
Frontiers in Endocrinology.2026;[Epub] CrossRef
Integrative immunogenomic profiling identifies CALU as a brown adipocyte–linked modulator of progression and treatment response in pancreatic cancer
Fang Wu, Xufan Cai, Zhenyuan Qian, Guangyuan Song, Xiao Zhang, Tao Ding, Weilang Xu, WeiLin Wang
Discover Oncology.2026;[Epub] CrossRef
Protein kinase D: Integrating cancer and metabolic disorders
A. Shemy, B. Sanchez, H. Mizuno, J. Van Lint, A. Voet
Molecular Aspects of Medicine.2026; 108: 101446. CrossRef
Changes in physical activity and diabetes risk after cancer diagnosis: a nationwide cohort study
Wonyoung Jung, In Young Cho, Jinhyung Jung, Mi Hee Cho, Hye Yeon Koo, Yong-Moon Mark Park, Jong-Ha Baek, Kyungdo Han, Dong Wook Shin
Journal of Cancer Survivorship.2025; 19(6): 1924. CrossRef
Analysis of the relationship between resistin with prognosis, cell migration, and p38 and ERK1/2 activation in breast cancer
Reyna L. Cuachirria-Espinoza, Alin García-Miranda, Rafael Hernández-Barragán, Dania A. Nava-Tapia, Monserrat Olea-Flores, Napoleón Navarro-Tito
Biochimie.2025; 229: 19. CrossRef
Research status of anti-obesogenic functional foods: mechanism of endocrine-disrupting chemicals and glucocorticoid receptor pathway
Ji-Hyun Im, Geon Oh, Xiaolu Fu, June Seok Lim, Sun-Il Choi, Ok-Hwan Lee
Food Science and Biotechnology.2025; 34(4): 829. CrossRef
Association of the Immunity Genes with Type 1 Diabetes Mellitus
Youssef Khaiz, Najib Al Idrissi, Mohammed Bakkali, Samir Ahid
Current Diabetes Reviews.2025;[Epub] CrossRef
Chitooligosaccharide-epigallocatechin gallate conjugate ameliorates lipid accumulation and promotes browning of white adipose tissue in high fat diet fed rats
Kanokrada Tonphu, Sirikul Mueangaun, Natcha Lerkdumnernkit, Jirakhamon Sengking, Jiraporn Tocharus, Soottawat Benjakul, Ajay Mittal, Chainarong Tocharus
Chemico-Biological Interactions.2025; 406: 111316. CrossRef
The growing range of complications of diabetes mellitus
Peter S. Hamblin, Anthony W. Russell, Stella Talic, Sophia Zoungas
Trends in Endocrinology & Metabolism.2025; 36(10): 943. CrossRef
Cancer et prise en charge nutritionnelle du surpoids et de l’obésité : évaluation de pratique
Léo Pernaton, Dominique Cellier, Romain Buono, Antoine Pierre, Marine Sauzet, Jean-Yves Blay, Olivia Pérol, Béatrice Fervers
Bulletin du Cancer.2025; 112(5): 478. CrossRef
IGFBP2 Promotes Proliferation and Glycolysis of Endometrial Cancer by Regulating PKM2/HIF‐1α Axis
Yuxi Jin, Meng Qi, Lulu Si, Xiaojing Shi, Mingbo Cai, Hanlin Fu, Yana Liu, Ruixia Guo
Cancer Science.2025; 116(3): 656. CrossRef
Genetic association of lipid-lowering drug target genes with pancreatic cancer: a Mendelian randomization study
Bohan Su, Zhiyao Fan, Jiexi Wu, Hanxiang Zhan
Scientific Reports.2025;[Epub] CrossRef
Gene mutation in diabetic patients with lung adenocarcinoma: a real-world retrospective cohort study
Lei Yang, Yang Hong, TingTing Zeng, HongMei Yue, DePeng Jiang
Frontiers in Medicine.2025;[Epub] CrossRef
Impact of obesity on iron metabolism and the effect of intravenous iron supplementation in obese patients with absolute iron deficiency
Laura Tarancon-Diez, Marianela Iriarte-Gahete, Pilar Sanchez-Mingo, Mª Ángeles Muñoz-Fernandez, Maria Luisa Navarro-Gomez, Yolanda M. Pacheco, Manuel Leal
Scientific Reports.2025;[Epub] CrossRef
Rapid and efficient detection of acetone using C20-based nanostructures: A novel non-invasive strategy for diabetes assay through DFT/TD-DFT calculations
Ahmad Khaleel AlOmari
Diamond and Related Materials.2025; 154: 112137. CrossRef
Identify key genes and biological processes participated in obesity-related cancer based on studying 12 cancers
Lijuan Zhu, Cuicui Zhao
The International Journal of Biochemistry & Cell Biology.2025; 182-183: 106764. CrossRef
Association between triglyceride‑glucose index as a marker of insulin resistance and the risk of malignant melanoma: A retrospective study
Jiukang Sun, Zhihang Han, Chuanjun Song
Oncology Letters.2025;[Epub] CrossRef
A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer—State-of-the-Art Review and Future Perspectives
Klaudia Kołakowska, Joanna Kiśluk, Jacek Nikliński
International Journal of Molecular Sciences.2025; 26(5): 1857. CrossRef
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries
Luigi Demarchis, Sabrina Chiloiro, Antonella Giampietro, Laura De Marinis, Antonio Bianchi, Maria Fleseriu, Alfredo Pontecorvi
Reviews in Endocrine and Metabolic Disorders.2025; 26(4): 525. CrossRef
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank
Zelong Wu, Jiayu Yang, Zuyi Ma, Yubin Chen, Mingqian Han, Qianlong Wu, Baohua Hou, Shanzhou Huang, Chuanzhao Zhang
Journal of Gastroenterology.2025; 60(6): 794. CrossRef
A review on the molecular mechanisms and pharmacology of andrographolide from Andrographis paniculata (Burm.f.) Nees in the management of the interplay between type 2 diabetes and breast cancer
Salik Abdullah, Pritam Chatterjee
Phytomedicine Plus.2025; 5(2): 100772. CrossRef
Factors affecting the postoperative survival rate of obese Asian patients with endometrial cancer
Huiqiao Gao, Qi Lu, Jianxin Zhang
Journal of Obstetrics and Gynaecology.2025;[Epub] CrossRef
Celastrol targets CKB-mediated futile creatine cycle in human brown adipocytes thermogenesis
Jingyi Ni, Baicheng Wang, Xinyue Liu, Rui Yin, Jinlin Tang, Siyu Hua, Xiaoxiao Zhang, Yangyang Wu, Shihu Zhang, Chenbo Ji
Metabolism Open.2025; 26: 100359. CrossRef
Sirtuins as therapeutic targets in diabetes
Kajetan Kielbowski, Aleksandra Wiktoria Bratborska, Estera Bakinowska, Andrzej Pawlik
Expert Opinion on Therapeutic Targets.2025; 29(3): 117. CrossRef
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy
Elena Crecca, Gianfranco Di Giuseppe, Claudia Camplone, Virginia Vigiano Benedetti, Ombretta Melaiu, Teresa Mezza, Chiara Cencioni, Francesco Spallotta
Pharmacology & Therapeutics.2025; 270: 108847. CrossRef
Cancer risk subsequent to cardiovascular disease: a prospective population-based study and meta-analysis
Chi Shu, Huiqiao Han, Hong Li, Linru Wei, Hong Wu, Changtao Li, Xuan Xie, Bin Zhang, Zhexuan Li, Xin Chen, Jichun Zhao, Yanhong Zhou, Yazhou He, Chuan Xu
BMC Medicine.2025;[Epub] CrossRef
The hidden pathway: biological aging as a mediator between diabetes and breast cancer risk: a Mendelian randomized study
Yipang Zhao, Jingzhi Zhang, Dong Chen, Sixuan Xing, Shuhan Zhang, Qing Zhang
Discover Oncology.2025;[Epub] CrossRef
The application of mendelian randomization in cancer research: a bibliometric analysis
Zhongtao Bai, Genlong Zhang
Discover Oncology.2025;[Epub] CrossRef
New Obesity Treatment Agent: β-Caryophyllene
Peiyi He, Linquan Zang, Shuguang Zhu
Current Drug Therapy.2025; 20(3): 379. CrossRef
The serum levels of leptin and adiponectin in endometrial carcinoma and their association with histopathological factors
Aarthi S. Jayraj, Sunesh Kumar, Daya Nand Sharma, Rajesh Khadgawat, Lalit Kumar, Vanamail Perumal, Jyoti Meena, Seema Singhal
Journal of Cancer Research and Therapeutics.2025; 21(1): 98. CrossRef
The role of nutrition in cancer prevention: the effect of dietary patterns, bioactive compounds, and metabolic pathways on cancer development
Sebastián Chapela, Julieta Locatelli, Facundo Saettone, Carla Antonella Forte, Pasqualina Memoli, Gabriela Cucalon, Florencia Ceriani, Gerardo Sarno, Luigi Coppola, Evelyn Frias-Toral
Food and Agricultural Immunology.2025;[Epub] CrossRef
MATHEMATICAL MODEL AS A METHOD OF EVALUATING THE ACTIVATION OF ONCOGENESIS IN PATIENTS WITH TYPE 2 DIABETES
Tamara S. Vatseba, Liubov K. Sokolova, Volodymyr M. Pushkarev, Mariana O. Vatseba, Vasyl Ye. Neiko, Valentyna V. Dzvonkovska
Clinical and Preventive Medicine.2025; (2): 68. CrossRef
Building a Hand-Curated ceRNET for Endometrial Cancer, Striving for Clinical as Well as Medicolegal Soundness: A Systematic Review
Roberto Piergentili, Stefano Sechi, Lina De Paola, Simona Zaami, Enrico Marinelli
Non-Coding RNA.2025; 11(3): 34. CrossRef
Obesity–cancer axis crosstalk: Molecular insights and therapeutic approaches
Ahmed Rakib, Md Abdullah Al Mamun, Mousumi Mandal, Priti Sinha, Udai P. Singh
Acta Pharmaceutica Sinica B.2025; 15(6): 2930. CrossRef
Adipokines and Adipose Tissue: The Role and Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients with Diabetes or Heart Failure
Michalina Mazurkiewicz, Patryk Bodnar, Dominika Blachut, Tomasz Chwalba, Wiktor Wagner, Eliza Barczyk, Ewa Romuk, Wojciech Jacheć, Celina Wojciechowska
Biomedicines.2025; 13(5): 1098. CrossRef
Changes Connected to Early Chronic Pancreatitis and Early Pancreatic Cancer in Endoscopic Ultrasonography (EUS): Clinical Implications
Natalia Pawelec, Łukasz Durko, Ewa Małecka-Wojciesko
Cancers.2025; 17(11): 1891. CrossRef
Normal Weight Obesity Overview and Update: A narrative review
Antonino De Lorenzo, Paola Gualtieri, Giulia Frank, Roselisa Palma, Rossella Cianci, Leonardo Romano, Lucilla Ciancarella, Glauco Raffaelli, Laura Di Renzo
Current Obesity Reports.2025;[Epub] CrossRef
Inhibition of serotonin-Htr2b signaling in skeletal muscle mitigates obesity-induced insulin resistance
Suhyeon Park, Hyeongseok Kim, Soyeon Shin, Yeongmin Kim, Yunwon Kang, Hye-Na Cha, So-Young Park, Sangkyu Park, Chang-Myung Oh
Experimental & Molecular Medicine.2025; 57(6): 1177. CrossRef
Polygenic Risk and Nutrient Intake Interactions on Obesity Outcomes: A Systematic Review and Meta‐Analysis of Observational Studies
Guiomar Masip, Hannah Yang Han, Tongzhu Meng, Daiva E. Nielsen
Obesity Reviews.2025;[Epub] CrossRef
Mechanisms underlying obesity-malignancy connection: a systematic narrative review
Ayesha Sultana, Sobia Rana
Journal of Physiology and Biochemistry.2025; 81(2): 403. CrossRef
Impact of body mass index in patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors
Qishen Wang, Fang Liu, Chixiang Liu, Haoyu Lu, Zhen Huang, Xiaolong Gong, Quanwei Chen, Na Li, Chunxue Wu, Hao Zhang, Jianjun Han
Oncologie.2025; 27(4): 603. CrossRef
Impact of body mass index on recurrent stroke in stroke survivors: An updated systematic review and meta-analysis
Sheng Lun Wei, Kuan Lin Chiu
Obesity Research & Clinical Practice.2025; 19(3): 202. CrossRef
The epidemiology, etiology, and future prophylactic options for cancers in Mainland China
Hongsen Chen, Jie Xu, Wenbin Liu, Xi Chen, Ping Li, Guangwen Cao
Frontiers in Oncology.2025;[Epub] CrossRef
Meta-analysis and network pharmacology study of Xiaoke Pill in the treatment of type 2 diabetes mellitus
Xue Zhao, Yi Zhang, Pengling Ge
European Journal of Integrative Medicine.2025; 77: 102502. CrossRef
The Impact of BMI on the Incidence and Severity of Radiation Dermatitis on Patients Undergoing External Beam Radiotherapy: A Case Study
Felistus Mawisire, Sindiso Nleya, Lidion Sibanda, Polite Mukwada, George Rugare Chingarande
South African Radiographer.2025; 63(1): 13. CrossRef
Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements
Iman Mohammad Said Jallod, Ammar Khalo Abbas, Faheemah Ismael Yaqoob, Abdul-Aziz Ahmed Aziz
Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(11): 14637. CrossRef
The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021
Jinli Liu, Tingling Xu, Yanan Wang, Fanpu Ji, Lei Zhang
Global Health Research and Policy.2025;[Epub] CrossRef
Effect of physical exercise on adiponectin levels in humans: a systematic review
Dany Pramuno Putra, Junian Cahyanto Wibawa, Melya Rossa, Ahmad Riyono
Fizjoterapia Polska.2025; 25(2): 436. CrossRef
The association between weight-waist-adjustment index and serum folate in US adults: NHANES 2013 to 2018
Zilin Zhou, Qi Zhao
Medicine.2025; 104(19): e42313. CrossRef
Gut Microbiota Dysbiosis and Its Impact on Type 2 Diabetes: From Pathogenesis to Therapeutic Strategies
Yonghua Yu, Yilan Ding, Shuangyuan Wang, Lei Jiang
Metabolites.2025; 15(6): 397. CrossRef
Adipose Tissue-Derived Mediators in Multiple Myeloma: Linking Obesity to Bone Disease via Inflammatory Pathways
Alexandra-Ştefania Stroe-Ionescu, Alina Daniela Tǎnase, Ionela Rotaru, Janina-Georgiana Goanțǎ, Ana Maria Pǎtraşcu, Mihail Virgil Boldeanu, Mohamed-Zakaria Assani, Isabela Siloși, Lidia Boldeanu, Daniela-Teodora Maria
International Journal of Molecular Sciences.2025; 26(12): 5618. CrossRef
Association of the Appendicular Skeletal Muscle Mass-to-Visceral Fat Area Ratio with Cause-Specific Mortality in Diabetes
Shuwu Wei, Jiale Zhang, Huijuan Zheng, Weimin Jiang, Jie Yang, Yaoxian Wang, Weihong Chen, Weiwei Sun
Calcified Tissue International.2025;[Epub] CrossRef
The multifaceted impact of circadian disruption on cancer risk: a systematic review of insights and economic implications
Vicente Javier Clemente-Suarez, Eduardo Navarro-Jiménez, Juan Camilo Benitez-Agudelo, Ana Isabel Beltrán-Velasco, Pedro Belinchón-deMiguel, Domingo Jesús Ramos-Campo, Carlota Valeria Villanueva-Tobaldo, Alexandra Martín-Rodríguez, Jose Francisco Tornero-A
Journal of the National Cancer Center.2025; 5(5): 524. CrossRef
Obesity and cervical intraepithelial neoplasia: regulation of mitochondrial energy metabolism via the Kisspeptin/GPR54 signaling pathway
Jiajia Pan, Yuanyuan Chen, Yan Ye, Peipei Li, Feifei Ni, Haizhen He
Cancer & Metabolism.2025;[Epub] CrossRef
Obesity and breast cancer: exploring the nexus of chronic inflammation, metabolic dysregulation, and nutritional strategies
Claudia Reytor-González, Daniel Simancas-Racines, Náthaly Mercedes Román-Galeano, Martín Campuzano-Donoso, Angelo Michele Carella, Raynier Zambrano-Villacres, Teresa Marinelli, Luigi Coppola, Marco Marchetti, Martina Galasso, Ludovica Verde, Gerardo Sarno
Food and Agricultural Immunology.2025;[Epub] CrossRef
A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2
Monica M. Mita, Alain C. Mita, Bradley J. Carver, James M. Shanahan, Benjamin A. Mayes, Pierre J. Dufour, David Browning, Alfred Anderson-Villaluz, John S. Petersen, David J. Turnquist, Peter Cornelius
Cancer Research Communications.2025; 5(6): 1008. CrossRef
Body mass index and breast cancer risk among postmenopausal women with and without cardiometabolic diseases: Findings from two prospective cohort studies in Europe
Emma Fontvieille, Anna Jansana, Laia Peruchet‐Noray, Reynalda Córdova, Quan Gan, Sabina Rinaldi, Laure Dossus, Yahya Mahamat‐Saleh, Marc J. Gunter, Alicia Heath, Dagfinn Aune, Elif Inan‐Eroglu, Matthias B. Schulze, Niels Bock, Christina C. Dahm, Carlota C
Cancer.2025;[Epub] CrossRef
Association between life’s essential 8 and colorectal cancer: A population-based study
Xiaohan Ma, Xiaofei Zhang, Fasheng Wu, Sheng Chen, Jing Peng, Xuan Lan, Xinyue Zhang, Encun Hou
Medicine.2025; 104(27): e43261. CrossRef
Sarcopenia and Its Impact on Sexual Health: A Systematic Review
Giuseppe Defeudis, Rossella Mazzilli, Olivia Di Vincenzo, Marianna Minnetti, Eleonora Poggiogalle, Daniele Gianfrilli, Andrea M. Isidori, Lorenzo M. Donini, Silvia Migliaccio
Diabetes/Metabolism Research and Reviews.2025;[Epub] CrossRef
The relationship between increased levels of microbiota-derived lipopolysaccharide in obesity and the pathophysiology of neurodegenerative diseases
Mahtab Mehboodi, Milad PourMohammadAli Namdari, Zeynab Abdollahi, Zahra Mobarezi, Maedeh Kiani, Forozan Chamani, Hadis Khanbabaie, Saman Rabiei, Mohammad Hasan Maleki, Hamidreza Sanati, Golshid Javdani Shahedin, Elham Isaei
Microbial Pathogenesis.2025; 207: 107905. CrossRef
Subcellular organelle-mediated precise delivery of nanomedicines: Advances and applications in cancer therapy
Wenli Dang, Tongcan Cui, Guorui Jiao, Jiawei Li, Zhidong Liu
Journal of Drug Delivery Science and Technology.2025; 112: 107261. CrossRef
Cancer prevention and interception with antidiabetic and anti-obesity drugs: Current and future perspectives
Adriana Albini, Anna Rita Cantelmo, Lorenzo Mortara, Douglas M. Noonan, Giovanni Corso
Seminars in Cancer Biology.2025; 115: 40. CrossRef
Targeting the molecular crosstalk between diabetes and lung cancer for therapeutic intervention
Alireza Azani, Nahal Aghajamal Avval, Mohammad Saeed Soleimani Meigoli, Mahshid Imankhan, Pouya Asgari, Gholamreza Ebrahimisaraj, Reza Morovatshoar, Ahmad Mir Hosseini, Seyedeh Tarlan Mirzohreh, Masoumeh Nouri, Hossein Azari Bostanabad, Qumars Behfar, Fah
Discover Oncology.2025;[Epub] CrossRef
Comparative safety of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients receiving anti-neoplastic therapies for cancer: An inverse probability treatment weighting analysis
Jiaxuan Lyu, Katherine Specht, Jacqueline A. Seiglie, Tianqi Ouyang, Kavita Mistry, Harish Seethapathy, Leyre Zubiri, Si Yuan Khor, Paul E. Hanna, Andrew Cao, Daiana Moreno, Sherley M. Mejia, Shruti Gupta, Meghan E. Sise
Cancer Letters.2025; 632: 217958. CrossRef
Influence of microbiota composition on the pathogenesis of type 2 diabetes: Physiological aspects
Nataliya V. Zharova, Filipp D. Mikhailidi, Darya A. Kabanova, Alena Y. Tatarintseva, Olga L. Polyakova, Yury O. Zharikov, Nikolai A. Zharov, Sergey N. Ryagin, André Pontes-Silva, Tatiana S. Zharikova
Molecular Aspects of Medicine.2025; 106: 101410. CrossRef
Diabetes Mellitus and Lung Cancer Screening Outcomes in the National Lung Screening Trial
Robert P. Young, Ralph C. Ward, Raewyn J. Scott, Gerard A. Silvestri
Annals of the American Thoracic Society.2025; 22(9): 1409. CrossRef
Tirzepatide retention in iWAT with mesoporous polydopamine encapsulation enhances weight loss through leptin receptor signaling
Lin Mi, Tan Li, Xiaoxin Xiang, Yimin Zhou, Na Xiong, Yanyu Chen, Jiaoting Chen, Sijia Shang, Shumeng Chen, Wai W. Cheung, Zecong Xiao, Yanming Chen, Jiahai Wang, Jun Peng, Xintao Shuai, Guojun Shi
Journal of Advanced Research.2025;[Epub] CrossRef
Objective Assessment of Physical Activity in Breast Cancer Survivors: Associations With Adiposity and Metabolic Parameters of Glucose and Insulin—Insights From NHANES
Jose J. Cao‐Alvira, Emilia F. Luciano, Moira Sauane, Columba de la Parra
Cancer Reports.2025;[Epub] CrossRef
A LITERATURE REVIEW ON THE ROLE OF ADIPOCYTOKINES IN BREAST CANCER AND METABOLIC SYNDROME
DEEPTHI ENUMULA, YASHASWI GUNTUPALLI, VANITHA RANI NAGASUBRAMANIAN, PRATHAP REDDY BASANI, BHAWNA DEV, SHYAM SUNDER ANCHURI, SHABNA ROUPAL
Asian Journal of Pharmaceutical and Clinical Research.2025; : 4. CrossRef
Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study
Testimony Ipaye, Jonathan Goldney, Thomas J. Wilkinson, Francesco Zaccardi, Thomas Yates, Melanie J. Davies, Karen Brown, Dimitris Papamargaritis
Diabetes, Obesity and Metabolism.2025; 27(12): 6914. CrossRef
Insulin signalling-associated cell fate promotes neoplastic invasiveness in non-functioning pituitary gonadotroph adenoma via cis-regulatory elements activation
Hongwei Liu, Zhouyang Pan, Qi Yang, Luohuan Dai, Wei Zhang, Yihao Zhang, Hongyi Liu, Yueshuo Li, Kexuan Zhong, Jia Gu, Kang Peng, Nian Jiang, Siyi Wanggou, Xuejun Li
British Journal of Cancer.2025; 133(10): 1454. CrossRef
Ret finger protein deficiency attenuates adipogenesis in male mice with high fat diet-induced obesity
Yun-Gyeong Lee, Anna Jeong, Yongwoon Lim, Sera Shin, Hosouk Joung, Hye Jung Cho, Su-Jin Lee, Hwang Chan Yu, Hyung-Seok Kim, Kwang-Il Nam, Gwang Hyeon Eom, Byung-Hyun Park, So-Young Park, Duk-Hwa Kwon, Hyun Kook
Experimental & Molecular Medicine.2025; 57(9): 2052. CrossRef
Obesity as a Multifactorial Chronic Disease: Molecular Mechanisms, Systemic Impact, and Emerging Digital Interventions
Ewelina Młynarska, Kinga Bojdo, Anna Bulicz, Hanna Frankenstein, Magdalena Gąsior, Natalia Kustosik, Jacek Rysz, Beata Franczyk
Current Issues in Molecular Biology.2025; 47(10): 787. CrossRef
Should we exclude hemato-oncological patients from obesity treatment with semaglutide? – A case report
Julia Dobrowolska, Katarzyna Kozak, Agnieszka Morawa, Laura Peisert, Kamil Wdowiak, Jerzy Chudek
Annales Academiae Medicae Silesiensis.2025; 79: 316. CrossRef
Exploring irisin levels in patients with endometrial atypical hyperplasia and carcinoma: a comparative analysis
Tevfik Berk Bildacı, Can Ata, Ufuk Atlıhan, Huseyin Aytug Avsar, Selcuk Erkılınc
BMC Cancer.2025;[Epub] CrossRef
Frequency and structure of endocrine diseases in patients with endometrial cancer
A.Ye. Kryzhanivska, I.B. Dyakiv
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 21(6): 626. CrossRef
Fatty acid-heterocyclic hybrids from green algae as novel therapeutic prospects for diabetes management
Aryanti R. Bamahry, Abdul Mubdi Ardiansyar, Asrini Safitri, Derren David Christian Homenta Rampengan, Rony Abdi Syahputra, Nurpudji Astuti Taslim, Antonello Santini, Sergio Vencio, Fahrul Nurkolis
Discover Food.2025;[Epub] CrossRef
Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk
Zheng Ma, Song Wang, Shanglong Liu, Wenchang Yang, Jilin Hu, Lianghong Lv, Qian Yu, Yun Lu
Frontiers in Immunology.2025;[Epub] CrossRef
Effects of tailored exercise on glycemic and nutritional outcomes in diabetic patients with colorectal cancer and on chemotherapy
Lin Yang, Xian-Ping Liu, Xiao-Meng Deng
World Journal of Diabetes.2025;[Epub] CrossRef
Cross-talk between cancer and diabetes: Exploring shared molecular pathways in cellular metabolism and signaling
Zhangzhi Tang, Nuo Xu, Pin Lyu, Hui Zhao, Wenjie Zheng
Molecular Aspects of Medicine.2025; 106: 101420. CrossRef
Bio‐Inspired Pancreas With Microfluidic Multi‐Component Hydrogel Microfibers for Exploring Pancreatic Exocrine and Endocrine Interactions
Zhikun Huan, Zhiqiang Luo, Jingbo Li, Yunru Yu, Ling Li
Aggregate.2025;[Epub] CrossRef
Comparative trends in pancreatic cancer burden and risk factors in the USA and China (1990–2021): insights from GBD analysis
Chengzhou Pa, Shijun Shen, Shuxian Song, Kuan Li, Gang Chen
BMC Gastroenterology.2025;[Epub] CrossRef
LEP and FOXO1 genes, as a proposed tumor suppressor autophagic cell death related genes, can be targeted by antidiabetic therapy in nondiabetic breast cancer patients
Gizem Ayna Duran, Yağmur Kiraz, Deniz Baykara
Discover Oncology.2025;[Epub] CrossRef
The Relationship Between Obesity and Pregnancy
Hadeel Tahseen Al-hashimi, Ghufran Mohammed Sadee Merie
Pharaonic Journal of Science.2025; 1(2): 219. CrossRef
Inverse Association Between METS-IR and Lung Cancer Risk: The Role of BMI in a Nationwide Korean Cohort
Bo-Kyung Shine, In Hwa Jeong, Minkook Son, Bongjo Kim, Sang Yi Moon, Jong Yoon Lee, Hye Ryeon Kim, Seok Jae Huh
Cancers.2025; 17(23): 3727. CrossRef
Membrane remodeling, ion channels, Ca2+ signaling, and stress pathways as molecular links between type 2 diabetes and cancer
Gonzalo Ferreira, Luisina Chavarría, Agustín DeMarco, Franco Bernech, Romina Cardozo, Axel Santander, Lucía Domínguez, Nicolás Mujica, Luis Sobrevia, Garth L. Nicolson
Molecular Aspects of Medicine.2025; 106: 101426. CrossRef
Current Knowledge of Obesity‐Related Vascular Injury
Jing Liu, Di Yang
Obesity Reviews.2025;[Epub] CrossRef
Prevalence and Pattern of Distribution of Obesity and Diabetes in the Population of Tripura: A Monitoring Survey-Based Report from a Regional Cancer Centre, India
Sharadia Majumder, Partha Sarathi Pal, Gautam Majumdar, Ankita Debnath, Sukanta Nath
International Journal of Science and Healthcare Research.2025; : 107. CrossRef
Comprehensive analysis of autophagy- and glycolysis-related differentially expressed genes involved in chronic inflammation in obese patients.
Simin Yang, Rexidanmu Hudabai, Xinwei Su
Investigación Clínica.2025; 66(4): 390. CrossRef
Effects of T2DM on postoperative outcome of patients with colorectal cancer: a study on the relationship between blood glucose control and survival rate
Kangzhong Wu
American Journal of Cancer Research.2024; 14(4): 1892. CrossRef
Triglyceride‐glucose index (TyG index) and endometrial carcinoma risk: A retrospective cohort study
Haimeng Shi, Feifei Guo, Kang Zheng, Rong Li, Huaijun Zhou
International Journal of Gynecology & Obstetrics.2024; 164(1): 298. CrossRef
Association between total cholesterol levels and all-cause mortality among newly diagnosed patients with cancer
Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
Scientific Reports.2024;[Epub] CrossRef
The Role of Adipokines in Tumor Progression and Its Association with Obesity
Jae Won Kim, Jun Hyeok Kim, Yoon Jae Lee
Biomedicines.2024; 12(1): 97. CrossRef
Triglyceride-glucose index is a risk factor for breast cancer in China: a cross-sectional study
Jinghua Zhang, Binbin Yin, Ya Xi, Yongying Bai
Lipids in Health and Disease.2024;[Epub] CrossRef
Insulin Resistance: The Increased Risk of Cancers
Leszek Szablewski
Current Oncology.2024; 31(2): 998. CrossRef
Epigenetic modifications in obesity‐associated diseases
Yiqian Long, Chao Mao, Shuang Liu, Yongguang Tao, Desheng Xiao
MedComm.2024;[Epub] CrossRef
The Juncture of Diabetes, Cancer, and Observational Population-based Studies: Novel Insights From Canadian Provincial Health Records
Terra Arnason, Kerry Mansell
Canadian Journal of Diabetes.2024; 48(3): 145. CrossRef
The impact of chemotherapy on adipose tissue remodeling: The molecular players involved in this tissue wasting
Samuel Barbosa, Mafalda Barbosa Pedrosa, Rita Ferreira, Daniel Moreira-Gonçalves, Lúcio Lara Santos
Biochimie.2024; 223: 1. CrossRef
Epidemiological and transcriptome data identify shared gene signatures and immune cell infiltration in type 2 diabetes and non-small cell lung cancer
Qian Yuan, Long Li, Liu-shun Wang, Shi-gui Xing
Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
THE INFLUENCE OF DIABETES-ASSOCIATED FACTORS OF ONCOGENESIS ON THE RISK OF BREAST AND ENDOMETRIAL CANCER AND ON THE SURVIVAL OF WOMEN WITH THIS CANCER
Tamara S. Vatseba, Liubov K. Sokolova, Vasyl Ye. Neyko, Valentyna V. Dzvonkovska, Oksana V. Muravlova, Volodymyr V. Derpak
Clinical and Preventive Medicine.2024; (2): 99. CrossRef
Associations between diabetes and cancer: A 10-year national population-based retrospective cohort study
Heléna Safadi, Ágnes Balogh, Judit Lám, Attila Nagy, Éva Belicza
Diabetes Research and Clinical Practice.2024; 211: 111665. CrossRef
Colorectal Cancer: Epidemiology, Risk Factors, and Prevention
Gholamreza Roshandel, Fatemeh Ghasemi-Kebria, Reza Malekzadeh
Cancers.2024; 16(8): 1530. CrossRef
Metabolic Alteration Bridging the Prediabetic State and Colorectal Cancer
Antonino Colloca, Isabella Donisi, Camilla Anastasio, Maria Luisa Balestrieri, Nunzia D’Onofrio
Cells.2024; 13(8): 663. CrossRef
Stratification and prognostic evaluation of breast cancer subtypes defined by obesity-associated genes
Dongjuan Chen, Zilu Xie, Jun Yang, Ting Zhang, Qiliang Xiong, Chen Yi, Shaofeng Jiang
Discover Oncology.2024;[Epub] CrossRef
Feasible mechanisms and therapeutic potential of food probiotics to mitigate diabetes‐associated cancers: A comprehensive review and in silico validation
Annadurai Vinothkanna, Xiang Shi‐Liang, Durairaj Karthick Rajan, Ragothaman Prathiviraj, Soundarapandian Sekar, Shubing Zhang, Bo Wang, Zhu Liu, Ai‐Qun Jia
Food Frontiers.2024; 5(4): 1476. CrossRef
Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells
Xuefen Lin, Jianfeng Zheng, Xintong Cai, Li Liu, Shan Jiang, Qinying Liu, Yang Sun
BMC Cancer.2024;[Epub] CrossRef
Diabetes and Cancer: A Twisted Bond
Mihai Cosmin Stan, Doru Paul
Oncology Reviews.2024;[Epub] CrossRef
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Shahad Sabaawi Ibrahim, Raghad Sabaawi Ibrahim, Batoul Arabi, Aranka Brockmueller, Mehdi Shakibaei, Dietrich Büsselberg
Cancer and Metastasis Reviews.2024; 43(4): 1297. CrossRef
Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey
Wenjie Li, Peixin Dong, Wei Wang
Acta Diabetologica.2024; 61(11): 1403. CrossRef
A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML
He-Zhou Guo, Rui-Xue Feng, Yan-Jie Zhang, Ye-Hua Yu, Wei Lu, Jia-Jia Liu, Shao-Xin Yang, Chong Zhao, Zhao-Li Zhang, Shan-He Yu, Hui Jin, Si-Xuan Qian, Jian-Yong Li, Jiang Zhu, Jun Shi
Cell Reports Medicine.2024; 5(6): 101592. CrossRef
Targeting SIRT3 signaling alleviates lung carcinoma progression by reducing hyperinsulinemia in postmenopausal obese mice: Protective intervention of betaxanthin
Bobo Li, Jie Liu, Yuhui Sun, Mengmeng Song, Xiaoming Zhao, Yulan Sun
Journal of Functional Foods.2024; 119: 106313. CrossRef
Global prevalence of obesity and overweight among medical students: a systematic review and meta-analysis
Arman Shafiee, Zahra Nakhaee, Razman Arabzadeh Bahri, Mohammad Javad Amini, Amirhossein Salehi, Kyana Jafarabady, Niloofar Seighali, Pegah Rashidian, Hanieh Fathi, Fatemeh Esmaeilpur Abianeh, Samira Parvizi Omran, Mahmood Bakhtiyari, Amirhesam Alirezaei
BMC Public Health.2024;[Epub] CrossRef
Association of body composition indicators with colorectal cancer: a hospital-based case-control study
Qiujin Chen, Kai Li, Yang Liu, Xiaozhai Yu, Fengrong Ou
Journal of Cancer Research and Clinical Oncology.2024;[Epub] CrossRef
CD161 + CD127 + CD8 + T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
Jingjing Qu, Yuekang Li, Binggen Wu, Qian Shen, Lijun Chen, Wenjia Sun, Bo Wang, Lixiong Ying, Li Wu, Hong Zhou, Jianya Zhou, Jianying Zhou
OncoImmunology.2024;[Epub] CrossRef
The dichloromethane fraction from Calotropis gigantea (L.) dryand. Stem bark extract prevents liver cancer in SDT rats with insulin-independent diabetes mellitus
Thaiyawat Haewphet, Supawadee Parhira, Pattaraporn Chaisupasakul, Apirath Wangteeraprasert, Ittipon Phoungpetchara, Dumrongsak Pekthong, Worasak Kaewkong, Zhi-Hong Jiang, Li-Ping Bai, Julintorn Somran, Piyarat Srisawang
Journal of Ethnopharmacology.2024; 334: 118516. CrossRef
Associations between Diabetes Mellitus and Selected Cancers
Monika Pliszka, Leszek Szablewski
International Journal of Molecular Sciences.2024; 25(13): 7476. CrossRef
Combination of handgrip strength and high-sensitivity modified Glasgow prognostic score predicts survival outcomes in patients with colon cancer
Yifan Shi, Yuting Sun, Xiaoming Shen, Zenghui Yang, Binghua Xu, Chuanqing Bao
Frontiers in Nutrition.2024;[Epub] CrossRef
DIABETES MELLITUS TIPO 2 E OBESIDADE, PRÓGONOS DE NEOPLASIAS?
Victor Becchi, Luísa Emanoela Bandolin Goinski, Ana Letícia Loesch Wojcik, Patrícia Costa Mincoff Barbanti
Revista Contemporânea.2024; 4(7): e5071. CrossRef
Research Progress on the Association between Obesity and Prostate Cancer
Hang Xu, Yingshuang Tang, Xiaorui Zhang, Xian Zhang, Along Kang
annals of urologic oncology.2024;[Epub] CrossRef
Associations Between Dietary Intake of Tomato and Lycopene with All-Cause and Cancer-Specific Mortality in US Adults with Diabetes: Results From a Cohort Study
Yuqian Liu, Heyin Liu, Jinde Liu, Wen Liu, Yang Yang, Yiming Liu
Nutrition and Cancer.2024; 76(10): 974. CrossRef
Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer
Chaojun Zhu, Yihong Lai, Chengdong Liu, Lan Teng, Yuxin Zhu, Xinyu Lin, Xinyi Fu, Qiuhua Lai, Side Liu, Xiaohan Zhou, Yuxin Fang
Frontiers in Pharmacology.2024;[Epub] CrossRef
Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment
Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn
Cancers.2024; 16(15): 2652. CrossRef
The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside
Xiaofei Shen, Hongling Yang, Yang Yang, Xianjun Zhu, Qingxiang Sun
MedComm.2024;[Epub] CrossRef
Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
Yan Zhang, Shibo Wei, Eun-Ju Jin, Yunju Jo, Chang-Myung Oh, Gyu-Un Bae, Jong-Sun Kang, Dongryeol Ryu
Diabetes & Metabolism Journal.2024; 48(4): 487. CrossRef
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian-Bogdan Tigu, Raluca Munteanu, Cristian-Silviu Moldovan, David Kegyes, Anca Onaciu, Diana Gulei, Gabriel Ghiaur, Hermann Einsele, Carlo M. Croce
Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef
Clinical characteristics and complication risks in data‐driven clusters among Chinese community diabetes populations
Binqi Li, Zizhong Yang, Yang Liu, Xin Zhou, Weiqing Wang, Zhengnan Gao, Li Yan, Guijun Qin, Xulei Tang, Qin Wan, Lulu Chen, Zuojie Luo, Guang Ning, Weijun Gu, Yiming Mu
Journal of Diabetes.2024;[Epub] CrossRef
Optical imaging for brown or beige adipose tissue
Jiamin Liu, Linjie Ni, Minmin Peng, Yiying Liang, Chan Lu, Hanying Zheng, Zicheng Huang, Jinde Zhang, Ronghe Chen
VIEW.2024;[Epub] CrossRef
Associations between SII, SIRI, and cardiovascular disease in obese individuals: a nationwide cross-sectional analysis
Zhou Liu, Longxuan Zheng
Frontiers in Cardiovascular Medicine.2024;[Epub] CrossRef
Evaluating coronary arteries and predicting MACEs using CCTA in lung cancer patients receiving chemotherapy or chemoradiotherapy
Yuhang Xie, Hesong Shen, Qian Xu, Chunrong Tu, Rui Yang, Tao Liu, Hao Tang, Zhiming Miao, Jiuquan Zhang
Radiotherapy and Oncology.2024; 200: 110498. CrossRef
Risk factor analysis and nomogram development for predicting 28-day mortality in elderly ICU patients with sepsis and type 2 diabetes mellitus
Haopeng Li, Yaru Zu, Qinghua Wang, Tong Zi, Xin Qin, Yan Zhao, Wei Jiang, Xin’an Wang, Chengdang Xu, Xi Chen, Gang Wu
European Journal of Inflammation.2024;[Epub] CrossRef
Relationship of body mass index and kidney outcomes in patients with primary glomerulonephritis: A systematic review and meta-analysis
Qinling Liu, Tianhua Yao, Yan Chen, Fei Xiao, Yazhou Wu, Huanzi Dai
Medicine.2024; 103(41): e39621. CrossRef
The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer
Wenzhe Li, Da Ke, Yi Xu, Ya Wang, Qian Wang, Jie Tan, Hongyan Wu, Xianglin Cheng
Frontiers in Immunology.2024;[Epub] CrossRef
Histologic Characterization of Tumor-Adjacent Mammary Adipose Tissue in Normal-Weight and Overweight/Obese Patients with Triple-Negative Breast Cancer
Marietta Wolf, Christoph Brochhausen, Vignesh Ramakrishnan, Sabine Iberl, Jonas Roth, Stephan Seitz, Ralph Burkhardt, Sonja C. Stadler
Cancers.2024; 16(20): 3515. CrossRef
Glucose impacts onto the reciprocal reprogramming between mammary adipocytes and cancer cells
Maria Rosaria Ambrosio, Michiel Adriaens, Kasper Derks, Teresa Migliaccio, Valerio Costa, Domenico Liguoro, Simona Cataldi, Vittoria D’Esposito, Giovanni Maneli, Rita Bassolino, Simone Di Paola, Marinella Pirozzi, Fabrizio Schonauer, Francesco D’Andrea, F
Scientific Reports.2024;[Epub] CrossRef
Research Progress of Sodium-Glucose Co-Transporter Protein-2 Inhibitors in Lung Cancer
晓倩林
Advances in Clinical Medicine.2024; 14(10): 1375. CrossRef
Hyperactive browning and hypermetabolism: potentially dangerous element in critical illness
Lu Huang, Lili Zhu, Zhenxiong Zhao, Shenglu Jiang
Frontiers in Endocrinology.2024;[Epub] CrossRef
Genetically Proxied Therapeutic Effect of Lipid-Lowering Drugs Use, Breast Cancer, and Endometrial Cancer’s Risk: A Drug Target-Based Mendelian Randomization Study
Chunxiao Dang, Xiaofeng Wang, Pengfei Liu, Jinxing Liu, Xiao Yu
International Journal of Women's Health.2024; Volume 16: 2033. CrossRef
The Role of Frailty and Myosteatosis in Predicting All-Cause Mortality in Older Adults with Cancer
Efthymios Papadopoulos, Andy Kin On Wong, Sharon Hiu Ching Law, Sarah Costa, Angela M. Cheung, Dmitry Rozenberg, Shabbir M. H. Alibhai
Current Oncology.2024; 31(12): 7852. CrossRef
The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment
Hao Lyu, Jinghua Kong, Jiasi Chen, Rui Zhang, Shuai Xiao, Dong Guo, Qi Zhang, Xing-Zhen Chen, Jingfeng Tang, Cefan Zhou
International Journal of Molecular Sciences.2024; 25(24): 13334. CrossRef
Phytochemical composition and antidiabetic, anti-obesity, antioxidant, and cytotoxic activities of Carthamus tinctorius seed oil
Nidal Jaradat, Mohammed Hawash, Mustafa Ghanim, Malik Alqub, Maha Rabayaa, Majdi Dwikat, Linda Issa, Fatima Hussein, Lana Asadi, Larin Yassin, Heba Rabee, Asil Gamhur
Scientific Reports.2024;[Epub] CrossRef
Ultra‐processed food consumption and the risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Guo‐Chao Zhong, Qian Zhu, Dong Cai, Jie‐Jun Hu, Xin Dai, Jian‐Ping Gong, Wei‐Ping Sun
International Journal of Cancer.2023; 152(5): 835. CrossRef
Advances in “adiponcosis”: Insights in the inner mechanisms at the base of adipose and tumour tissues interplay
Cristina Pagano, Erika di Zazzo, Giorgio Avilia, Beatrice Savarese, Giovanna Navarra, Maria Chiara Proto, Donatella Fiore, Monica Rienzo, Patrizia Gazzerro, Chiara Laezza, Maurizio Bifulco
International Journal of Cancer.2023; 152(12): 2464. CrossRef
Metabolites as signalling molecules
Steven Andrew Baker, Jared Rutter
Nature Reviews Molecular Cell Biology.2023; 24(5): 355. CrossRef
Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer
Biao Zhang, Qihang Yuan, Bolin Zhang, Shuang Li, Zhizhou Wang, Hangyu Liu, Fanyue Meng, Xu Chen, Dong Shang
Frontiers in Endocrinology.2023;[Epub] CrossRef
Concentration of Selected Adipokines and Factors Regulating Carbohydrate Metabolism in Patients with Head and Neck Cancer in Respect to Their Body Mass Index
Jarosław Nuszkiewicz, Jolanta Czuczejko, Wiktor Dróżdż, Alina Woźniak, Bogdan Małkowski, Karolina Szewczyk-Golec
International Journal of Molecular Sciences.2023; 24(4): 3283. CrossRef
Hormonal Gut–Brain Signaling for the Treatment of Obesity
Eun Roh, Kyung Mook Choi
International Journal of Molecular Sciences.2023; 24(4): 3384. CrossRef
A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining
Huaqing Huang, Xintong Cai, Jiexiang Lin, Qiaoling Wu, Kailin Zhang, Yibin Lin, Bin Liu, Jie Lin
Computers in Biology and Medicine.2023; 155: 106632. CrossRef
Green Antimicrobials as Therapeutic Agents for Diabetic Foot Ulcers
Ines D. Teixeira, Eugenia Carvalho, Ermelindo C. Leal
Antibiotics.2023; 12(3): 467. CrossRef
Impact of abdominal obesity on the risk of glioma development in patients with diabetes: A nationwide population-based cohort study in Korea
Hyunji Sang, Yun Kyung Cho, Kyungdo Han, Eun Hee Koh, Sandar Tin Tin
PLOS ONE.2023; 18(3): e0283023. CrossRef
Relationship Between Physical Exercise and Cognitive Impairment Among Older Adults with Type 2 Diabetes: Chain Mediating Roles of Sleep Quality and Depression
Han Zhang, Yefan Zhang, Sen Sheng, Yang Xing, Zhongchen Mou, Yanqiu Zhang, Zhixue Shi, Zhenjie Yu, Qianqian Gao, Weiqin Cai, Qi Jing
Psychology Research and Behavior Management.2023; Volume 16: 817. CrossRef
The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer
Rosa Divella, Graziella Marino, Stefania Infusino, Laura Lanotte, Gaia Gadaleta-Caldarola, Gennaro Gadaleta-Caldarola
Nutrients.2023; 15(7): 1667. CrossRef
Distribution of ABO blood groups and Rh factor in benign and malign thyroid nodules
Muzaffer Serdar DENİZ
Journal of Health Sciences and Medicine.2023; 6(2): 462. CrossRef
The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
Sebastian Stępień, Paweł Olczyk, Joanna Gola, Katarzyna Komosińska-Vassev, Aleksandra Mielczarek-Palacz
Cells.2023; 12(8): 1118. CrossRef
Coronary Revascularization in Patients With Cancer
Bala Pushparaji, Teodora Donisan, Dinu Valentin Balanescu, Jong Kun Park, Dominique J. Monlezun, Abdelrahman Ali, Ibrahim Halil Inanc, Jaime Caballero, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cezar Iliescu
Current Treatment Options in Cardiovascular Medicine.2023; 25(6): 143. CrossRef
Hepatocellular carcinoma in a large cohort of type 2 diabetes patients
Carlo B. Giorda, Roberta Picariello, Barbara Tartaglino, Elisa Nada, Giuseppe Costa, Roberta Manti, Luca Monge, Roberto Gnavi
Diabetes Research and Clinical Practice.2023; 200: 110684. CrossRef
Prediction of Hypoglycemia in Diabetic Patients During Colonoscopy Preparation
Xiaohua Lu, Lingqiao Xie, Wane Zhao, Chuangbiao Zhang, Xixi Luo, Yan Zhou
Experimental and Clinical Endocrinology & Diabetes.2023; 131(05): 274. CrossRef
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity
Min Jeong Park, Kyung Mook Choi
Metabolism.2023; 144: 155577. CrossRef
PIK3CA mutation in endometriotic epithelial cells promotes viperin-dependent inflammatory response to insulin
Mike R. Wilson, Shannon Harkins, Jake J. Reske, Rebecca A. Siwicki, Marie Adams, Victoria L. Bae-Jump, Jose M. Teixeira, Ronald L. Chandler
Reproductive Biology and Endocrinology.2023;[Epub] CrossRef
The Function of MondoA and ChREBP Nutrient—Sensing Factors in Metabolic Disease
Byungyong Ahn
International Journal of Molecular Sciences.2023; 24(10): 8811. CrossRef
Mechanism of Cephalophyllum cephalus Intervention in Diabetes Based on Network Pharmacology and Molecular Docking Technology
志梁范
Hans Journal of Medicinal Chemistry.2023; 11(02): 81. CrossRef
Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
Xingchen Li, Xiao Yang, Yuan Cheng, Yangyang Dong, Jingyuan Wang, Jianliu Wang
Journal of Gynecologic Oncology.2023;[Epub] CrossRef
Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness
Ting-Yu Chang, Kuo-Cheng Lan, Chia-Hung Wu, Meei-Ling Sheu, Rong-Sen Yang, Shing-Hwa Liu
Archives of Toxicology.2023; 97(8): 2231. CrossRef
The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?
Małgorzata Kozłowska, Agnieszka Śliwińska
International Journal of Molecular Sciences.2023; 24(12): 10252. CrossRef
Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions
Leonardo de Andrade Mesquita, Laura Fink Wayerbacher, Gilberto Schwartsmann, Fernando Gerchman
Archives of Endocrinology and Metabolism.2023;[Epub] CrossRef
Distinct Lipid Phenotype of Cancer-Associated Fibroblasts (CAFs) Isolated From Overweight/Obese Endometrial Cancer Patients as Assessed Using Raman Spectroscopy
Tze Hua Yeu, Intan Sofia Omar, S.F. Abdul Sani, Dharini Pathmanathan, Boon Tong Goh, Nithyialakshmi Ravindran, Ik Hui Teo, Yogeeta Gunasagran, Noor Azmi Mat Adenan, Ivy Chung, Amira Hajirah Abd Jamil
Applied Spectroscopy.2023; 77(7): 723. CrossRef
Global, Regional, and National Epidemiology of Diabetes in Children From 1990 to 2019
Kexin Zhang, Chengxia Kan, Fang Han, Jingwen Zhang, Chuanhua Ding, Zhentao Guo, Na Huang, Yang Zhang, Ningning Hou, Xiaodong Sun
JAMA Pediatrics.2023; 177(8): 837. CrossRef
The effects of physical exercise therapy on weight control: its regulation of adipocyte physiology and metabolic capacity
Hyun Jung Park, Sung Ja Rhie, Insop Shim
Journal of Exercise Rehabilitation.2023; 19(3): 141. CrossRef
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells
Marianna Talia, Francesca Cirillo, Asia Spinelli, Azzurra Zicarelli, Domenica Scordamaglia, Lucia Muglia, Salvatore De Rosis, Damiano Cosimo Rigiracciolo, Gianfranco Filippelli, Ida Daniela Perrotta, Mariano Davoli, Rosanna De Rosa, Rachele Macirella, Elv
Journal of Experimental & Clinical Cancer Research.2023;[Epub] CrossRef
Signal detection in real‐world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having
Elad Sharon, Megan Othus, Zoe Eloise Quandt
Cancer.2023; 129(18): 2769. CrossRef
Ultra-Processed Food Consumption and Obesity in Korean Adults
Jee-Seon Shim, Kyoung Hwa Ha, Dae Jung Kim, Hyeon Chang Kim
Diabetes & Metabolism Journal.2023; 47(4): 547. CrossRef
Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer
Vanda Marques, Fabiola Arella, Marta B. Afonso, André A. Santos, Cecília M.P. Rodrigues
Clinical Science.2023; 137(15): 1095. CrossRef
Diabetes and two kinds of primary tumors in a patient with thalassemia: a case report and literature review
Xiaoyan Yu, Yi Peng, Tingting Nie, Wenjia Sun, Yajuan Zhou
Frontiers in Oncology.2023;[Epub] CrossRef
Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: A longitudinal nationwide population-based study
Eyun Song, Soon Young Hwang, Min Jeong Park, Ahreum Jang, Kyeong Jin Kim, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
Metabolism.2023; 148: 155678. CrossRef
Obesity and Colorectal Cancer
Jundeok Lee, Su Young Kim
The Korean Journal of Gastroenterology.2023; 82(2): 63. CrossRef
Cognitive Behavioural Therapies for Weight-Loss in Adults: A Scoping Review Protocol
Laura María Compañ-Gabucio, Diana Mancheño-Bañón, Laura Torres-Collado, Jesús Vioque, Manuela García-de-la-Hera
Healthcare.2023; 11(18): 2473. CrossRef
Saxagliptin, a selective dipeptidyl peptidase-4 inhibitor, alleviates somatic cell aneugenicity and clastogenicity in diabetic mice
Sabry M. Attia, Sheikh F. Ahmad, Ahmed Nadeem, Mohamed S.M. Attia, Mushtaq A. Ansari, Abdelkader E. Ashour, Norah A. Albekairi, Mohammed A. Al-Hamamah, Ali A. Alshamrani, Saleh A. Bakheet
Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2023; 892: 503707. CrossRef
Mechanisms of Linggui Zhugan Decoction in the Treatment of Obesity Based on Network Pharmacology
Chunmei Liu, Li Zhang, Yubin Yang
Science of Advanced Materials.2023; 15(9): 1265. CrossRef
Beyond Body Size: Adiponectin as a Key Player in Obesity-Driven Cancers
Maurizio Capuozzo, Venere Celotto, Loris Landi, Francesco Ferrara, Francesco Sabbatino, Francesco Perri, Marco Cascella, Vincenza Granata, Mariachiara Santorsola, Alessandro Ottaiano
Nutrition and Cancer.2023; 75(10): 1848. CrossRef
Impact of sarcopenic obesity on post-hepatectomy bile leakage for hepatocellular carcinoma
Hikaru Hayashi, Akira Shimizu, Koji Kubota, Tsuyoshi Notake, Hitoshi Masuo, Takahiro Yoshizawa, Kiyotaka Hosoda, Hiroki Sakai, Koya Yasukawa, Yuji Soejima, Ezio Lanza
PLOS ONE.2023; 18(10): e0286353. CrossRef
Colorectal Cancer: From Risk Factors to Oncogenesis
Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Alexandru Laurentiu Chiotoroiu, Camelia Diaconu
Medicina.2023; 59(9): 1646. CrossRef
The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
Barbara Mensah Sankofi, Estefania Valencia-Rincón, Malika Sekhri, Adriana L. Ponton-Almodovar, Jamie J. Bernard, Elizabeth A. Wellberg
Frontiers in Endocrinology.2023;[Epub] CrossRef
Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis
Tingting Kong, Yunpeng Gu, Lei Sun, Run Zhou, Jie Li, Junping Shi
Endocrine Journal.2023; 70(10): 959. CrossRef
Impact of Caloric Restriction in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Prospective Case Control Study
Isabella Castellano, Francesco Gallo, Paola Durelli, Taira Monge, Maurizio Fadda, Jasna Metovic, Paola Cassoni, Fulvio Borella, Carlo Raucci, Monica Menischetti, Alessandra Beano, Giuseppe Migliaretti, Concetta Finocchiaro
Nutrients.2023; 15(21): 4677. CrossRef
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
Na Cui, Wensen Zhang, Fazhi Su, Zhihong Zhang, Biao Li, Donghui Peng, Yanping Sun, Yuanning Zeng, Bingyou Yang, Haixue Kuang, Qiuhong Wang
Frontiers in Pharmacology.2023;[Epub] CrossRef
Is MG53 a potential therapeutic target for cancer?
Yunyu Du, Tieying Li, Muqing Yi
Frontiers in Endocrinology.2023;[Epub] CrossRef
Blood Biomarkers Panels for Screening of Colorectal Cancer and Adenoma on a Machine Learning-Assisted Detection Platform
Hui Wang, Zhiwei Zhou, Haijun Li, Weiguang Xiang, Yilin Lan, Xiaowen Dou, Xiuming Zhang
Cancer Control.2023;[Epub] CrossRef
Post-treatment serum triglyceride: An effective biomarker for body fat mass and overall survival in esophageal squamous cell cancer patients treated with chemoradiotherapy
Jiahua Lyu, Ningjing Yang, Wang Guan, Ling Xiao, Xinyu Nie, Long Liang, Hansong Bai, Churong Li, Hao Kuang, Xiao Wang, Tao Li
Frontiers in Nutrition.2022;[Epub] CrossRef
Research Progress of MicroRNA-122 in Obesity and Type 2 Diabetes
路路潘
Advances in Clinical Medicine.2022; 12(06): 5706. CrossRef
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Ethan Lazarus, Harold Edward Bays
Obesity Pillars.2022; 3: 100026. CrossRef
Obesity Fact Sheet in Korea, 2021: Trends in Obesity Prevalence and Obesity-Related Comorbidity Incidence Stratified by Age from 2009 to 2019
Ye Seul Yang, Byoung-Duck Han, Kyungdo Han, Jin-Hyung Jung, Jang Won Son
Journal of Obesity & Metabolic Syndrome.2022; 31(2): 169. CrossRef
Fried food consumption and the risk of pancreatic cancer: A large prospective multicenter study
Guo-Chao Zhong, Qian Zhu, Jian-Ping Gong, Dong Cai, Jie-Jun Hu, Xin Dai, Jun-Hua Gong
Frontiers in Nutrition.2022;[Epub] CrossRef
Intermittent Fasting Is Associated With a Decreased Risk of Age-Related Macular Degeneration
Eun Young Choi, Min Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Minyoung Lee
American Journal of Ophthalmology.2022; 243: 1. CrossRef
Metformin Mitigated Obesity-Driven Cancer Aggressiveness in Tumor-Bearing Mice
Chun-Jung Chen, Chih-Cheng Wu, Cheng-Yi Chang, Jian-Ri Li, Yen-Chuan Ou, Wen-Ying Chen, Su-Lan Liao, Jiaan-Der Wang
International Journal of Molecular Sciences.2022; 23(16): 9134. CrossRef
Visceral fat area and body fat percentage measured by bioelectrical impedance analysis correlate with glycometabolism
Shuying Li, Shaoping Li, Jie Ding, Weihong Zhou
BMC Endocrine Disorders.2022;[Epub] CrossRef
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer
Roberto Buonaiuto, Fabiana Napolitano, Sara Parola, Pietro De Placido, Valeria Forestieri, Giovanna Pecoraro, Alberto Servetto, Luigi Formisano, Pietro Formisano, Mario Giuliano, Grazia Arpino, Sabino De Placido, Carmine De Angelis
Biomolecules.2022; 12(10): 1394. CrossRef
Adipokines as Regulators of Autophagy in Obesity-Linked Cancer
Alin García-Miranda, Alejandra Garcia-Hernandez, Eduardo Castañeda-Saucedo, Napoleon Navarro-Tito, Paola Maycotte
Cells.2022; 11(20): 3230. CrossRef
Roles of hydroxyeicosatetraenoic acids in diabetes (HETEs and diabetes)
Linyue Dong, Heyao Wang, Kaixian Chen, Yiming Li
Biomedicine & Pharmacotherapy.2022; 156: 113981. CrossRef
Changes in the Fecal Metabolome Accompany an Increase in Aberrant Crypt Foci in the Colon of C57BL/6 Mice Fed with a High-Fat Diet
Huawei Zeng, Bryan D. Safratowich, Wen-Hsing Cheng, Andrew D. Magnuson, Matthew J. Picklo
Biomedicines.2022; 10(11): 2891. CrossRef
Targeting Adiponectin in Breast Cancer
Rawan Nehme, Mona Diab-Assaf, Caroline Decombat, Laetitia Delort, Florence Caldefie-Chezet
Biomedicines.2022; 10(11): 2958. CrossRef
Multidisciplinary Progress in Obesity Research
Xiaoqing Lu, Yuxin Jin, Dexin Li, Jingxin Zhang, Jingyan Han, Yin Li
Genes.2022; 13(10): 1772. CrossRef
The association between serum copper and obesity and all-cause mortality: the NHANES 2011–2016
Hongrong Wu, Qingqi Li, Kaifang Zhang, Jianfeng Zhao
Environmental Science and Pollution Research.2022; 30(11): 31395. CrossRef
The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities
Christina S. Ennis, Pablo Llevenes, Yuhan Qiu, Ruben Dries, Gerald V. Denis
Frontiers in Endocrinology.2022;[Epub] CrossRef

Pathophysiology
Hyperinsulinemia in Obesity, Inflammation, and Cancer: Anni M.Y. Zhang, Elizabeth A. Wellberg, Janel L. Kopp, James D. Johnson; Diabetes Metab J. 2021;45(3):285-311. Published online March 29, 2021; DOI: https://doi.org/10.4093/dmj.2020.0250; Correction in: Diabetes Metab J 2021;45(4):622

49,536 View
1,205 Download
204 Web of Science
208 Crossref

Graphical Abstract Abstract PDF PubReader ePub

The relative insufficiency of insulin secretion and/or insulin action causes diabetes. However, obesity and type 2 diabetes mellitus can be associated with an absolute increase in circulating insulin, a state known as hyperinsulinemia. Studies are beginning to elucidate the cause-effect relationships between hyperinsulinemia and numerous consequences of metabolic dysfunctions. Here, we review recent evidence demonstrating that hyperinsulinemia may play a role in inflammation, aging and development of cancers. In this review, we will focus on the consequences and mechanisms of excess insulin production and action, placing recent findings that have challenged dogma in the context of the existing body of literature. Where relevant, we elaborate on the role of specific signal transduction components in the actions of insulin and consequences of chronic hyperinsulinemia. By discussing the involvement of hyperinsulinemia in various metabolic and other chronic diseases, we may identify more effective therapeutics or lifestyle interventions for preventing or treating obesity, diabetes and cancer. We also seek to identify pertinent questions that are ripe for future investigation.

Citations

Citations to this article as recorded by

Revisiting the Warburg-Based “Sugar Feeds Cancer” Hypothesis: A Critical Appraisal of Epidemiological, Experimental and Mechanistic Evidence
Karim Khaled, Hala Jardaly, Byeongsang Oh
Onco.2026; 6(1): 5. CrossRef
Obesity and GEP-NEN: what’s new?
M. Boschetti, I. Hasballa, I. Patelli, G. Piras, M. Albertelli
Seminars in Cancer Biology.2026; 118: 74. CrossRef
Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition
Faria Athar, Sarah Gregory, Emma J Houston, Nicole M Templeman
The Journal of Clinical Endocrinology & Metabolism.2026;[Epub] CrossRef
PDX1 phosphorylation at S61 by mTORC1 links nutrient signaling to β cell function and metabolic disease
Jialin Fan, Xin Zhang, Jinling Zhang, Tinghan Zhao, Stephen K. Burley, X.F. Steven Zheng
Cell Reports.2026; 45(1): 116811. CrossRef
Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy
Isabella D. Cooper, Lucy Petagine, Adrian Soto-Mota, Tomás Duraj, Thomas N. Seyfried, Derek C. Lee, Naja Cooper, Yvoni Kyriakidou
Frontiers in Nutrition.2026;[Epub] CrossRef
Impact of metabolic risk factors on colorectal cancer burden in China: a comprehensive analysis of trends from 1990 to 2021
Zhouwei Zhan, Hanchen Zheng, Chuying Chen, Jiami Yu, Lina Zheng, Chunkang Yang, Zengqing Guo, Bijuan Chen
Frontiers in Nutrition.2026;[Epub] CrossRef
Assessing insulin resistance: the triglyceride-glucose index as a predictor of survival in nasopharyngeal carcinoma
Xin Hua, Fei Xu, Xu-Xin Lin, Yong-Miao Lin, Zhi-Qing Long, Si-Fen Wang, Fang-Fang Duan, Chao Zhang, Xin Huang, Wen Xia, Wen-Chao Li, Ao-Qiang Chen, De-Huan Xie, Sha-Sha Du
Frontiers in Physiology.2026;[Epub] CrossRef
Maternal Immune Activation Disrupts Autophagy and Glucose Homeostasis: Experimental Evidence for the Protective Effects of N‐Acetylcysteine on Maternal and Offspring Outcomes in a Rat Model
Ebru Afşar, Mehmet Öz, Erkan Özkan, Işıl Eranıl
Journal of Applied Toxicology.2026;[Epub] CrossRef
Exploring the genetic link between type 2 diabetes and its complications and esophageal malignancy: A Mendelian randomization study
Mingzhi Lin, Chongrui Li, Bin Li, Zhongting Li, Yiming Hui, Haitian Li, Yuzhen Chen, Zhizhong Zheng
Medicine.2026; 105(3): e47202. CrossRef
A randomized controlled trial in healthy participants to compare the insulinogenic effects of whey protein and pea protein co-ingested with glucose
Pariyarath Sangeetha Thondre, Elysia Young, Sam Pledger, Sarah Kefyalew, Isabel Hatami, Caroline Perreau, Laetitia Guérin Deremaux, Catherine Lefranc-Millot, Jonathan Tammam, Prakash Palaniswamy
PLOS One.2026; 21(1): e0340386. CrossRef
Association Between Asthma and the Risk of Type 2 Diabetes Mellitus: Results From NHANES 2009–2016 Data
Jinyue Meng, Decheng Lu, Jianli Huang, Li Liu, Cen Huang, Jinqun Ye, Xuemei Huang, Daniela Merlotti
International Journal of Endocrinology.2026;[Epub] CrossRef
Carbohydrate quality indices and lung cancer risk: a case–control study from Iran
Milad Mohammadzadeh, Fatemeh Abdi, Melika Mamaghanian, Amin Paydareh, Alireza Bahrami, Zahra Sheikhi, Ehsan Hejazi
European Journal of Cancer Prevention.2025; 34(4): 357. CrossRef
Association between different patterns of obesity and the short-term outcomes of gastric cancer surgery
Guoqing Shi, Tianyu Gao, Peng Du, Jiwu Guo, Yan Dong, Jie Mao
European Journal of Cancer Prevention.2025; 34(5): 436. CrossRef
Association between triglyceride-glucose index and endometriosis: results from a cross-sectional study and Mendelian randomization study
Ting Xu, Yuan Zhuang, Huabin Cao, Jingqi Yang
Frontiers in Endocrinology.2025;[Epub] CrossRef
The Interplay Between Obesity and Aging in Breast Cancer and Regulatory Function of MicroRNAs in This Pathway
Nima Mahdei Nasir Mahalleh, Mina Hemmati, Arezou Biyabani, Fatemeh Pirouz
DNA and Cell Biology.2025; 44(2): 55. CrossRef
Dysregulation of Metabolic Peptides in the Gut–Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration
Camille Green, Vandana Zaman, Kayce Blumenstock, Narendra L. Banik, Azizul Haque
Biomedicines.2025; 13(1): 132. CrossRef
Obesity and orthodontic treatment: A scoping review
Dimitrios Michelogiannakis, Nadia Abou Kheir, Paul Emile Rossouw, Elli Anna Kotsailidi
Seminars in Orthodontics.2025; 31(4): 564. CrossRef
Global, regional, and national burden of pancreatic cancer from 1990 to 2021, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021
Tianyu Li, Chen Lin, Weibin Wang
BMC Cancer.2025;[Epub] CrossRef
Exploring the Association Between Dietary Fruit Intake and Endometriosis: A Systematic Review and Meta-Analysis
Pegah Rashidian, Ehsan Amini-Salehi, Shaghayegh Karami, Camran Nezhat, Farr Nezhat
Journal of Clinical Medicine.2025; 14(4): 1246. CrossRef
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
Aditi Singh, Sucharita Shadangi, Pulkit Kr. Gupta, Soumendra Rana
Comprehensive Physiology.2025;[Epub] CrossRef
Changes in pancreatic levodopa uptake in patients with obesity and new-onset type 2 diabetes: an 18F-FDOPA PET-CT study
Yeongkeun Kwon, Hanseok Yoon, Jane Ha, Hyeon-seong Lee, Kisoo Pahk, Hyunwoo Kwon, Sungeun Kim, Sungsoo Park
Frontiers in Endocrinology.2025;[Epub] CrossRef
Physical activity, genetic susceptibility, and risk of colorectal cancer in type 2 diabetes: a large population-based cohort study
Yanjun Wu, Meijun Meng, Yufeng Liu, Ruijie Zeng, Jing Feng, Qizhou Lian, Yuying Ma, Lijun Zhang, Wentao Huang, Felix W. Leung, Chongyang Duan, Weihong Sha, Hao Chen
Deutsches Ärzteblatt international.2025;[Epub] CrossRef
High-Fat Diet and Altered Radiation Response
Jiraporn Kantapan, Takanori Katsube, Bing Wang
Biology.2025; 14(4): 324. CrossRef
Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
Mohammad Muzaffar Mir, Mohammed Jeelani, Muffarah Hamid Alharthi, Syeda Fatima Rizvi, Shahzada Khalid Sohail, Javed Iqbal Wani, Zia Ul Sabah, Waad Fuad BinAfif, Partha Nandi, Abdullah M. Alshahrani, Jaber Alfaifi, Adnan Jehangir, Rashid Mir
International Journal of Molecular Sciences.2025; 26(6): 2770. CrossRef
Insights on metabolic connections and interplay between cancer and diabetes: role of multi-target drugs
Angeline Julius, Suresh Malakondaiah, Raghu Babu Pothireddy
Discover Medicine.2025;[Epub] CrossRef
IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions
Wenyuan He, Neruja Loganathan, Denise D Belsham
Endocrinology.2025;[Epub] CrossRef
Obesity and Cancer: Excess Body Fat as a Risk Factor in Carcinogenesis; Consequences Across Human Body Systems and Significance for Associated Medical Specialties
Nicholas A. Kerna, Taylor M. Nicely, Uwakmfonabasi A. Umoudoh, Adina Boulos, Ogonna P. Arisi, Chibuike Eze, Breanna M. Jomsky, Dabeluchi C. Ngwu, Hilary M. Holets
European Journal of Medical and Health Research.2025; 3(2): 122. CrossRef
Role of insulinemic and inflammatory dietary patterns on gut microbial composition and circulating biomarkers of metabolic health among older American men
Sushma Nepal, Ni Shi, Rebecca Hoyd, Daniel J. Spakowicz, Eric Orwoll, James M. Shikany, Nicola Napoli, Fred K. Tabung
Gut Microbes.2025;[Epub] CrossRef
Association between triglyceride-glucose related indicators, genetic risk, and incident breast cancer among postmenopausal women in UK Biobank
Zhen Li, Zengle Zhao, Tongchao Zhang, Xiaorong Yang, Hao Chen, Xiaolin Yin, Hao Bai, Xinjie Liu, Tongmin Chang, Yuan Zhang, Ming Lu
BMC Cancer.2025;[Epub] CrossRef
Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation
Maurizio Giuseppe Abrignani, Fabiana Lucà, Vincenzo Abrignani, Mariacarmela Nucara, Daniele Grosseto, Chiara Lestuzzi, Marinella Mistrangelo, Bruno Passaretti, Carmelo Massimiliano Rao, Iris Parrini
Journal of Clinical Medicine.2025; 14(9): 3083. CrossRef
MATHEMATICAL MODEL AS A METHOD OF EVALUATING THE ACTIVATION OF ONCOGENESIS IN PATIENTS WITH TYPE 2 DIABETES
Tamara S. Vatseba, Liubov K. Sokolova, Volodymyr M. Pushkarev, Mariana O. Vatseba, Vasyl Ye. Neiko, Valentyna V. Dzvonkovska
Clinical and Preventive Medicine.2025; (2): 68. CrossRef
Blood metabolic biomarkers and colorectal cancer risk: results from large prospective cohort and Mendelian randomisation analyses
Fangcheng Yuan, Guochong Jia, Wanqing Wen, Shuai Xu, Valerie Gunchick, Kui Deng, Jirong Long, Danxia Yu, Xiao-Ou Shu, Wei Zheng
British Journal of Cancer.2025; 133(1): 94. CrossRef
Integrated effect of naturopathy and yoga-based interventions on euglycemic hyperinsulinemia among grade 2 obesity: a non-randomized controlled trial
Vaishali Mathapati, K. J. Sujatha, Prashanth Shetty
Traditional Medicine and Modern Medicine.2025; 08: 45. CrossRef
Diagnostic performance of the triglyceride-glucose index in predicting occurrence of cancer: a meta-analysis
I-Wen Chen, Wei-Ting Wang, Jheng-Yan Wu, Chia-Hung Yu, Ying-Jen Chang, Kuo-Chuan Hung
Frontiers in Oncology.2025;[Epub] CrossRef
Insights into the molecular and genetic role of obesity in breast cancer pathogenesis
Sandeep Mallya, Varsha Gangadhar, Sophia Evangeline Aldrin, Meghana Acharya, Shama Prasada Kabekkodu, Kiran Kumar Kolathur, Sanjiban Chakrabarty
Cancer Biology & Therapy.2025;[Epub] CrossRef
Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies
Jie Yang, Chengming Wen, Hongkai Guo, Yahui Chai, Guodong Sun, Huijuan Cheng
Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Long-term trends in the burden of cancer attributable to high body mass index in China from 1990 to 2021
Zhouwei Zhan, Yi Zeng, Shaohua Xu, Hongju Chen, Rui Huang, Wei Lin, Jiami Yu, Xiaojie Wang, Chunkang Yang, Zengqing Guo, Bijuan Chen
Frontiers in Nutrition.2025;[Epub] CrossRef
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Guoqing Li, Yuxuan Wan, Alan Jiao, Ke Jiang, Gaoyuan Cui, Jinxin Tang, Simin Yu, Zhengang Hu, Songfeng Zhao, Zhenjie Yi, Lifu Long, Yang Yang, Xuehao Cui, Chunrun Qu
Med Research.2025; 1(1): 62. CrossRef
Insulin resistance in cancer risk and prognosis
Emmanuel Jacobo-Tovar, Andrea Medel-Sánchez, Cosette Durán-Castillo, Rodolfo Guardado-Mendoza
Seminars in Cancer Biology.2025; 114: 73. CrossRef
Obesity and endometrial cancer: biological mechanisms, nutritional strategies, and clinical perspectives
Daniel Simancas-Racines, Martín Campuzano-Donoso, Náthaly Mercedes Román-Galeano, Raynier Zambrano-Villacres, Pasqualina Memoli, Ludovica Verde, Claudia Reytor-González, Luigi Carbone
Food and Agricultural Immunology.2025;[Epub] CrossRef
The interplay of depressive symptoms, adiposity, and metabolic markers in young adults
Dewald Naudé, Wayne Smith, Esmé Jansen van Vuren
Psychoneuroendocrinology.2025; 179: 107521. CrossRef
Dietary Manipulation on Gut Microbiome in Patients with Diabetes and Colorectal cancer
Natural H. S Chu
Current Nutrition Reports.2025;[Epub] CrossRef
Fructose metabolism and its roles in metabolic diseases, inflammatory diseases, and cancer
Zhenhong Li, Xinzou Fan, Fan Gao, Shengguang Pan, Xiao Ma, Hao Cheng, Hiroko Nakatsukasa, Wei Zhang, Dunfang Zhang
Molecular Biomedicine.2025;[Epub] CrossRef
Childhood obesity and insulin resistance is correlated with gut microbiome serum protein: an integrated metagenomic and proteomic analysis
Lujie Liu, Meng Li, Yujie Qin, Yuesheng Liu, Min Li, Biyao Lian, Ruilong Guo, Yanfeng Xiao, Chunyan Yin
Scientific Reports.2025;[Epub] CrossRef
Adipose-Derived Stem Cells at the Crossroads of Obesity and Cancer
Ahmad Reza Panahi Meymandi, Abbas Ghaderi
Stem Cell Reviews and Reports.2025; 21(7): 1901. CrossRef
Rapid Development of Breast Mass With Recurrent Episodes of Hypoglycemia Should Raise Suspicion of Breast Cancer With Insulinoma: A Case Report
Tingting Liu, Lin Deng, Ruohan Su, Lin Ni, Zhiwei Wang, Wanqiu Xiong, Bing Wang, Sheng Huang
Cancer Reports.2025;[Epub] CrossRef
Obesity and breast cancer: exploring the nexus of chronic inflammation, metabolic dysregulation, and nutritional strategies
Claudia Reytor-González, Daniel Simancas-Racines, Náthaly Mercedes Román-Galeano, Martín Campuzano-Donoso, Angelo Michele Carella, Raynier Zambrano-Villacres, Teresa Marinelli, Luigi Coppola, Marco Marchetti, Martina Galasso, Ludovica Verde, Gerardo Sarno
Food and Agricultural Immunology.2025;[Epub] CrossRef
Associations Between Shift Work and Insulin Resistance Markers in 53,053 Spanish Workers: A Sex-Stratified Cross-Sectional Analysis Using TyG, TyG-BMI, METS-IR, and SPISE-IR Indices
Javier Tosoratto, Pedro Juan Tárraga López, Ángel Arturo López-González, Carla Busquets-Cortes, Joan Obrador de Hevia, José Ignacio Ramirez-Manent
Journal of Clinical Medicine.2025; 14(13): 4604. CrossRef
Roles of foods and related components: an overview on cancer causatives, and plausible preventions
Hamdoon A. Mohammed, Ghassan M. Sulaiman, Ali Z. Al-Saffar, Mosleh M. Abomughaid, Nehia N. Hussein, Zeina T. Salih, Noora A. Hadi, Mayyadah H. Mohsin, Hayder M. Al-kuraishy, Riaz A. Khan, Ahmed Ismail
Applied Food Research.2025; 5(2): 101132. CrossRef
Machine learning analysis of survival outcomes in breast cancer patients treated with chemotherapy, hormone therapy, surgery, and radiotherapy
Eyachew Misganew Tegaw, Betelhem Bizuneh Asfaw
Scientific Reports.2025;[Epub] CrossRef
Co-morbid diabetes mellitus in cancer patients undergoing treatment: a case series and perspective
Aisiri H. U. V., Maanas R. Rao, Vinod K. Ramani, Radheshyam Naik
Frontiers in Oncology.2025;[Epub] CrossRef
Nanocarrier-enabled delivery of natural antiobesity agents
Yu-Kuo Chung, Ching-Yun Hsu, Yu-Ting Wang, Thi Thu Phuong Tran, Ahmed Alalaiwe, Jia-You Fang
Nanomedicine.2025; 20(16): 2167. CrossRef
Targeting the molecular crosstalk between diabetes and lung cancer for therapeutic intervention
Alireza Azani, Nahal Aghajamal Avval, Mohammad Saeed Soleimani Meigoli, Mahshid Imankhan, Pouya Asgari, Gholamreza Ebrahimisaraj, Reza Morovatshoar, Ahmad Mir Hosseini, Seyedeh Tarlan Mirzohreh, Masoumeh Nouri, Hossein Azari Bostanabad, Qumars Behfar, Fah
Discover Oncology.2025;[Epub] CrossRef
Ketogenic diet with medium-chain triglycerides inhibits preneoplastic colon lesions by modulation of endogenous antioxidants and anti-inflammatory and cell proliferation pathways
Michele Oliveira Carvalho, Bruna Pereira Marquezini, Letícia Misuraca Meirelles, Carolina Sales de Oliveira, Mariane Minussi Baptistella, Bruno Martins Dala-Paula, Ester Siqueira Caixeta, Pollyanna Francielli de Oliveira
Food Bioscience.2025; 71: 107192. CrossRef
High-amylose barley bread improves postprandial glycemia compared to regular barley and wheat bread in subjects with or without type 2 diabetes
Mette Bohl, Søren Gregersen, Zhihang Li, Andreas Blennow, Kim H. Hebelstrup, Kjeld Hermansen
European Journal of Clinical Nutrition.2025; 79(10): 1000. CrossRef
The impact of obesity and lipids on cancer: Insights into mechanisms and potential interventions
Montserrat Romero, Yi-Fan Lian, Albert Piquer, Núria Borràs-Ferré, Antonio Zorzano, Saška Ivanova
Seminars in Cancer Biology.2025; 115: 53. CrossRef
Mitophagy: A key regulator of radiotherapy resistance in the tumor immune microenvironment
Jing Xia, Jing Jin, Shuang Dai, HaoHan Fan, KeLiang Chen, JianMei Li, Feng Luo, Xingchen Peng
Molecular Aspects of Medicine.2025; 105: 101385. CrossRef
Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice
Syed Tareq, Heba A. Ewida, Sumaih Zoubi, Harrison Benson, Dhavalkumar Patel, Hanin Diab, Souvik Patra, Daniela Redrovan, Ehsan Nozohouri, Taysa Berivan Bassani, Alisson Campos Cardoso, Kofi Frimpong-Manson, Lida Khodavirdilou, Md Tareq Aziz, Jenny L. Wilk
Pharmacological Research.2025; 219: 107900. CrossRef
Breast Cancer Cell Line-Specific Responses to Insulin: Effects on Proliferation and Migration
Mattia Melloni, Domenico Sergi, Angelina Passaro, Luca Maria Neri
International Journal of Molecular Sciences.2025; 26(15): 7523. CrossRef
PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune Activation
Shannon E. Lynch, Heba M. Alsheikh, Patrick N. Song, Candace C. Parker, Yujun Zhang, Clayton C. Yates, Benjamin M. Larimer, Suzanne E. Lapi, Lalita A. Shevde, Anna G. Sorace
Molecular Imaging and Biology.2025; 27(5): 839. CrossRef
The Role of Obesity in the Regulation of Immunosuppressive Cell Infiltration and Immunosurveillance in Cancers
Chunye Zhang, Keyao Zhu, Jiazheng Liu, Ming Yang
Diseases.2025; 13(8): 271. CrossRef
The current status of serum insulin measurements and the need for standardization
Curt Rohlfing, Gregory Petroski, Maya Hatten-Beck, Steven Hanson, Andrew N. Hoofnagle, Randie R. Little, Kuanysh Kabytaev
Clinical Chemistry and Laboratory Medicine (CCLM).2025; 63(12): 2442. CrossRef
GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
Hao Dai, Yongqiu Li, Yao An Lee, Ying Lu, Thomas J. George, William T. Donahoo, Kelvin P. Lee, Harikrishna Nakshatri, John Allen, Yi Guo, Ramon C. Sun, Jingchuan Guo, Jiang Bian
JAMA Oncology.2025; 11(10): 1186. CrossRef
Comparative effects of ketogenic and carbohydrate loading diets on body weight management and glycemic control in male obese diabetic rats
Nourhan Magdy, Anwar B. Mansour, Hanan R. H. Mohamed, Atef A. Ali
The Journal of Basic and Applied Zoology.2025;[Epub] CrossRef
Objective Assessment of Physical Activity in Breast Cancer Survivors: Associations With Adiposity and Metabolic Parameters of Glucose and Insulin—Insights From NHANES
Jose J. Cao‐Alvira, Emilia F. Luciano, Moira Sauane, Columba de la Parra
Cancer Reports.2025;[Epub] CrossRef
The impact of hyperinsulinemia on short-term prognosis in patients with hypertriglyceridemia-induced acute pancreatitis
Mengjun Wang, Lei Zheng, Long Qian, Maoqi Xu
Frontiers in Endocrinology.2025;[Epub] CrossRef
The Pivotal Role of the Western Diet, Hyperinsulinemia, Ectopic Fat, and Diacylglycerol-Mediated Insulin Resistance in Type 2 Diabetes
Joseph A. M. J. L. Janssen
International Journal of Molecular Sciences.2025; 26(18): 9191. CrossRef
Association between genetic mutations in lung adenocarcinoma and adult body mass index: a retrospective cohort study
Yan qiao Wu, Lei Yang, Depeng Jiang
Frontiers in Oncology.2025;[Epub] CrossRef
Bioinformatic Characterization of Genes That Are Correlated to the Progression of Breast Cancer to Breast Cancer Brain Metastasis
Mageshree Pillay, Oliver Tendayi Zishiri
Cancer Reports.2025;[Epub] CrossRef
Influence of healthy lifestyle on the incidence and survival of cancer and its comorbidities: evidence from a longitudinal cohort study
Xinran Cheng, Yuelun Zhang, Chenyu Luo, Bin Lu, Na Li, Yueyang Zhou, Yuqing Chen, Min Dai, Hongda Chen
Journal of Translational Medicine.2025;[Epub] CrossRef
Bidirectional interactions between sleep and metabolism: mechanisms and therapeutic implications for insulin resistance

New Medicine.2025; : 1. CrossRef
The heterogeneity of thoracic Castleman disease: implications for classification and personalized management
Yuansheng Zheng, Junkan Zhu, Jiahao Jiang, Xiaowen Ge, Junzhen Liu, Wei Jiang, Qun Wang, Zheng Wei, Shuai Wang, Jianyong Ding
Annals of Hematology.2025; 104(11): 5891. CrossRef
Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer
Dhanir Tailor, Fernando Jose Garcia-Marques, Abel Bermudez, Annah S. Rolig, Benedikt Grau, Arpit Dheeraj, Dhanya K. Nambiar, Wenqi Li, Kirsten Stefan, Shawn Campbell, Sharon J. Pitteri, Sanjay V. Malhotra
Cell Reports Medicine.2025; 6(11): 102451. CrossRef
Global burden, trends, and inequalities in cancer and subtypes attributable to high BMI among older adults, 1990–2021: a secondary analysis of the global burden of disease study 2021
Yitong Huang, Di Qiu, Feng Xuan
Frontiers in Nutrition.2025;[Epub] CrossRef
Association between TyG‐related indices and colorectal cancer risk: A prospective cohort study
Runxue Jiang, Shushan Xing, Xia Wang, Shuohua Chen, Shouling Wu
International Journal of Cancer.2025;[Epub] CrossRef
Effects of carnitine supplementation on glycemic markers in women with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials
Huiyu Liu, Hongjun Zhang, Bin Zhao, Kousalya Prabahar, Hamed Kord-Varkaneh, Xia Liu
Diabetes Research and Clinical Practice.2025; 230: 112981. CrossRef
GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research
Estefania Valencia-Rincón, Rajani Rai, Vishal Chandra, Elizabeth A. Wellberg
Journal of Clinical Investigation.2025;[Epub] CrossRef
Triglyceride glucose related indices predict incident breast cancer risk in a population based cohort study
Qing Xie, Yaolan Zhen, Zhixing Fan, Ying Hu
Discover Oncology.2025;[Epub] CrossRef
Anacardic acid ameliorates insulin resistance and diabetic nephropathy: network pharmacology, in vivo and molecular docking studies targeting TNF- α / TGFβR1 signaling
Gehad Elshamy, Hany M. El-Bassossy, Shimaa M. Elshazly, Nesreen M. I. M. Elkomy
Journal of Natural Medicines.2025;[Epub] CrossRef
Association of estimated glucose disposal rate with all-cause and breast cancer-specific mortality in US breast cancer survivors: a population-based study
Jinhao Li, Jiasheng Liu, Bingliang Cai, Chuansheng Yang
BMC Cancer.2025;[Epub] CrossRef
Association between the triglyceride-glucose index and carotid plaque progression in patients with type 2 diabetes mellitus: a retrospective cohort study
Zhangxiang Zhu, Xuan Xu, Guojuan Wang, Qianqian Zhang, Ying Li, Jun Zhu, Li Chen, Qibao Ye, Mingwei Chen
Frontiers in Endocrinology.2025;[Epub] CrossRef
Insulin as an Accelerator and Brake of Aging: From Molecular Landscape to Clinical Interventions
Shi‐Cheng Chen, Xiao‐Dong Sun, Yuan‐Yuan Zhang
Comprehensive Physiology.2025;[Epub] CrossRef
Microbial Metabolite, Macro Impact: Urolithin A in the Nexus of Insulin Resistance and Colorectal Tumorigenesis
Vennila Joseph, Slavomir Hornak, Peter Kubatka, Dietrich Büsselberg
Nutrients.2025; 17(23): 3712. CrossRef
PARP-1 inhibition attenuates tumor pathology in a novel murine model of diabetes-associated colitis-induced colorectal cancer
Shivani Singla, Gopabandhu Jena
Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef
Human Cancers Derived from Either Genetic or Lifestyle Factors Are Initiated by Impaired Estrogen Signaling
Zsuzsanna Suba
Cancers.2025; 18(1): 78. CrossRef
Endometrial Hyperplasia: Current Insights into Epidemiology, Risk Factors, and Clinical Management
Apostolia Galani, Sofoklis Stavros, Efthalia Moustakli, Anastasios Potiris, Athanasios Zikopoulos, Ismini Anagnostaki, Konstantinos Zacharis, Maria Paraskevaidi, Deirdre Lyons, Stefania Maneta-Stavrakaki, Nikolaos Thomakos, Maria Kyrgiou, Ekaterini Domali
Cancers.2025; 18(1): 148. CrossRef
Comprehensive evaluation of the prevalent insulin resistance indices for pan-cancer incidence and mortality prediction
Shuhang Luo, Shengjie Lin, Li Ma, Runhua Tang, Ying Song, Li Ma, Jianye Wang
Tropical Medicine and Health.2025;[Epub] CrossRef
A review of the last decade: pancreatic cancer and type 2 diabetes
Jiaqi Wu, Liang Tang, Feng Zheng, Xun Chen, Lei Li
Archives of Physiology and Biochemistry.2024; 130(6): 660. CrossRef
High adherence to Western dietary pattern increases breast cancer risk (an EPIC-Spain study)
Adela Castelló, Miguel Rodríguez-Barranco, Virginia Lope, Marcela Guevara, Sandra Colorado-Yohar, Ane Dorronsoro, José Ramón Quirós, Carlota Castro-Espin, Carmen Sayon-Orea, Carmen Santiuste, Pilar Amiano, Cristina Lasheras, María-José Sanchez, Marina Pol
Maturitas.2024; 179: 107868. CrossRef
Dietary Diabetes Risk Reduction Score (DDRRS) and Breast Cancer Risk: A Case-Control Study in Iran
Milad Mohammadzadeh, Alireza Bahrami, Fatemeh Abdi, Fatemeh Ghafouri-Taleghani, Amin Paydareh, Saba Jalali, Zeinab Heidari, Bahram Rashidkhani
Nutrition and Cancer.2024; 76(1): 106. CrossRef
White adipocyte dysfunction and obesity-associated pathologies in humans
Carolina E. Hagberg, Kirsty L. Spalding
Nature Reviews Molecular Cell Biology.2024; 25(4): 270. CrossRef
Cumulative exposure to impaired fasting glucose and gastrointestinal cancer risk: A nationwide cohort study
Byeong Yun Ahn, Bokyung Kim, Sanghyun Park, Sang Gyun Kim, Kyungdo Han, Soo‐Jeong Cho
Cancer.2024; 130(10): 1807. CrossRef
Leptin receptor deficiency impedes metabolic surgery related-weight loss through inhibition of energy expenditure in db/db mice
Dan Tong, Jie Xiang, Wei Liu, Fang Sun, Lijuan Wang, Aidi Mou, Tingbing Cao, Qing Zhou, Mei You, Yingying Liao, Peng Gao, Daoyan Liu, Zongshi Lu, Zhiming Zhu
Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
Obesity and Cancer Rehabilitation for Functional Recovery and Quality of Life in Breast Cancer Survivors: A Comprehensive Review
Lorenzo Lippi, Alessandro de Sire, Arianna Folli, Alessio Turco, Stefano Moalli, Marco Marcasciano, Antonio Ammendolia, Marco Invernizzi
Cancers.2024; 16(3): 521. CrossRef
Exploring the Role of Hyperinsulinemia in Obesity-Associated Tumor Development
Ericka Vélez-Bonet, Kristyn Gumpper-Fedus, Zobeida Cruz-Monserrate
Cancer Research.2024; 84(3): 351. CrossRef
Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis
Omar Hegazi, Samer Alalalmeh, Moyad Shahwan, Ammar Jairoun, Mansour Alourfi, Ghfran Bokhari, Abdullah Alkhattabi, Saeed Alsharif, Mohannad Aljehani, Abdulmalik Alsabban, Mohammad Almtrafi, Ysear Zakri, Abdullah AlMahmoud, Khalid Alghamdi, Ahmed Ashour, Na
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 545. CrossRef
Predictors of Cardiac Autonomic Dysfunction in Obesity-Related Hypertension
Aqsa Mujaddadi, Saima Zaki, Majumi M Noohu, Irshad Husain Naqvi, Zubia Veqar
High Blood Pressure & Cardiovascular Prevention.2024; 31(1): 77. CrossRef
The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives
Amir Barzegar Behrooz, Marco Cordani, Alessandra Fiore, Massimo Donadelli, Joseph W. Gordon, Daniel J. Klionsky, Saeid Ghavami
Seminars in Cancer Biology.2024; 99: 24. CrossRef
Metformin’s role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study
Thomas Lawler, Zoe L. Walts, Lauren Giurini, Mark Steinwandel, Loren Lipworth, Harvey J. Murff, Wei Zheng, Shaneda Warren Andersen
Cancer Epidemiology.2024; 90: 102566. CrossRef
Sex differences in insulin regulation of skeletal muscle glycogen synthase and changes during weight loss and exercise in adults
Alice S. Ryan, Guoyan Li, Shawna McMillin, Heidi K. Ortmeyer
Obesity.2024; 32(4): 667. CrossRef
Therapeutic Repurposing of Antidiabetic Drugs in Diabetes-associated Comorbidities
Kalyani Pathak, Manash Pratim Pathak, Riya Saikia, Urvashee Gogoi, Ratna Jyoti Das, Pompy Patowary, Partha Pratim Kaishap, Smita Bordoloi, Jyotirmoy Das, Himangshu Sarma, Mohammad Zaki Ahmad, Aparoop Das
Current Drug Therapy.2024; 19(2): 178. CrossRef
The effect of metabolic syndrome on prognosis of diffuse large B-cell lymphoma
Wenjing Xiong, Liru Li, Xue Hui, Yue Liu, Hongbin Li, Yue Zhang, Shu Zhao
Clinical and Translational Oncology.2024; 26(9): 2240. CrossRef
Impact of Obesity-Related Endoplasmic Reticulum Stress on Cancer and Associated Molecular Targets
Joud AlBashtawi, Hend Al-Jaber, Sara Ahmed, Layla Al-Mansoori
Biomedicines.2024; 12(4): 793. CrossRef
Healthcare Management of an Obese Person
Syeda Rida Baqir, Shafaque Aslam Khan, Bushra Marium Zaman, Tahira Hamid Ali, Nazish Saeed Bangash, Muhammad Amjad Ali, Fatima Zaidi, Jahan Ara Farooq
DIET FACTOR (Journal of Nutritional and Food Sciences).2024; : 10. CrossRef
Associations between diabetes and cancer: A 10-year national population-based retrospective cohort study
Heléna Safadi, Ágnes Balogh, Judit Lám, Attila Nagy, Éva Belicza
Diabetes Research and Clinical Practice.2024; 211: 111665. CrossRef
Association of adipose tissue mediators with the development of cancer in patients with metabolic syndrome
E. E. Sereda, A. L. Chernyshova, T. Yu. Mamonova, G. V. Kakurina, N. V. Yunusova, E. A. Sidenko, D. A. Korshunov, I. V. Kondakova
Siberian journal of oncology.2024; 23(2): 101. CrossRef
DIABETES MELLITUS TIPO 2 E OBESIDADE, PRÓGONOS DE NEOPLASIAS?
Victor Becchi, Luísa Emanoela Bandolin Goinski, Ana Letícia Loesch Wojcik, Patrícia Costa Mincoff Barbanti
Revista Contemporânea.2024; 4(7): e5071. CrossRef
Therapeutic Insulin Analogue Concentrations at Infusion Sites Enhanced the Pro-Inflammatory Response and Apoptosis in an In Vitro Macrophage-Material Interaction Model
Yuxi Zhang, Luke Kuo, Kimberly A. Woodhouse, Lindsay E. Fitzpatrick
ACS Pharmacology & Translational Science.2024; 7(8): 2544. CrossRef
Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease
Jelena Kolic, WenQing Grace Sun, Haoning Howard Cen, Jessica D. Ewald, Jason C. Rogalski, Shugo Sasaki, Han Sun, Varsha Rajesh, Yi Han Xia, Renata Moravcova, Søs Skovsø, Aliya F. Spigelman, Jocelyn E. Manning Fox, James Lyon, Leanne Beet, Jianguo Xia, Fra
Cell Metabolism.2024; 36(7): 1619. CrossRef
Aging and “Age-Related” Diseases - What Is the Relation?
Wolfgang Kopp
Aging and disease.2024;[Epub] CrossRef
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications
Mohamed El-Tanani, Syed Arman Rabbani, Alaa A. Aljabali, Ismail I. Matalka, Yahia El-Tanani, Manfredi Rizzo, Murtaza M. Tambuwala
Nutrition and Cancer.2024; 76(8): 683. CrossRef
Gut microbiota and fecal volatilome profile inspection in metabolically healthy and unhealthy obesity phenotypes
F. M. Calabrese, V. A. Genchi, N. Serale, G. Celano, M. Vacca, G. Palma, M. Svelto, L. Gesualdo, M. De Angelis, F. Giorgino, S. Perrini
Journal of Endocrinological Investigation.2024; 47(12): 3077. CrossRef
Targeting SIRT3 signaling alleviates lung carcinoma progression by reducing hyperinsulinemia in postmenopausal obese mice: Protective intervention of betaxanthin
Bobo Li, Jie Liu, Yuhui Sun, Mengmeng Song, Xiaoming Zhao, Yulan Sun
Journal of Functional Foods.2024; 119: 106313. CrossRef
Mechanisms Underlying the Rarity of Skeletal Muscle Cancers
David S. Kump
International Journal of Molecular Sciences.2024; 25(12): 6480. CrossRef
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, Yueze Liu, Jiangdong Qiu, Dan Su, Ruobing Wang, Wenhao Luo, Zhe Cao, Guihu Weng, Taiping Zhang, Yupei Zhao
Molecular Cancer.2024;[Epub] CrossRef
Beta-Hydroxybutyrate Promotes Basal Insulin Secretion While Decreasing Glucagon Secretion in Mouse and Human Islets
Risha Banerjee, Ying Zhu, George P Brownrigg, Renata Moravcova, Jason C Rogalski, Leonard J Foster, James D Johnson, Jelena Kolic
Endocrinology.2024;[Epub] CrossRef
Oligomalt, a New Slowly Digestible Carbohydrate, Reduces Post-Prandial Glucose and Insulin Trajectories Compared to Maltodextrin across Different Population Characteristics: Double-Blind Randomized Controlled Trials in Healthy Individuals, People with Obe
Odd Erik Johansen, Joel Neutel, Sanjay Gupta, Barbara Mariani, Gerhard Ufheil, Emilie Perrin, Andreas Rytz, Anirban Lahiry, Frederik Delodder, Jaclyn Lerea-Antes, Naomi Ocampo, Maximilian von Eynatten
Metabolites.2024; 14(8): 410. CrossRef
Forkhead box protein FOXK1 disrupts the circadian rhythm to promote breast tumorigenesis in response to insulin resistance
Zhaohan Zhang, Minghui Zhao, Qian Wang, Xilin Wang, Yu Wang, Yuze Ge, Zicheng Wu, Wenjuan Wang, Lin Shan
Cancer Letters.2024; 599: 217147. CrossRef
Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
Yan Zhang, Shibo Wei, Eun-Ju Jin, Yunju Jo, Chang-Myung Oh, Gyu-Un Bae, Jong-Sun Kang, Dongryeol Ryu
Diabetes & Metabolism Journal.2024; 48(4): 487. CrossRef
Body Mass Index and Metabolic Phenotypes in Breast Cancer Risk: A Meta-Analysis and Systematic Review
Víctor Juan Vera-Ponce, Joan A. Loayza-Castro, Luisa Erika Milagros Vásquez-Romero, Fiorella Elvira Zuzunaga-Montoya
International Journal of Statistics in Medical Research.2024; 13: 107. CrossRef
The Association Between Telomere Length and Diabetes Mellitus: Accumulated Evidence From Observational Studies
Xinxin He, Lu Cao, Xueru Fu, Yuying Wu, Hongwei Wen, Yajuan Gao, Weifeng Huo, Mengdi Wang, Mengna Liu, Yijia Su, Ge Liu, Ming Zhang, Fulan Hu, Dongsheng Hu, Yang Zhao
The Journal of Clinical Endocrinology & Metabolism.2024; 110(1): e177. CrossRef
Metabolic dysfunction-associated steatotic liver disease and its link to cancer
Markos Kalligeros, Linda Henry, Zobair M. Younossi
Metabolism.2024; 160: 156004. CrossRef
Uncovering the Links Between Dietary Sugar and Cancer: A Narrative Review Exploring the Impact of Dietary Sugar and Fasting on Cancer Risk and Prevention
Ashik Anil , Ronak Raheja, Diya Gibu, Aravind S Raj, S Spurthi
Cureus.2024;[Epub] CrossRef
Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms
Yu-Yuan Zhang, Yong-Jiang Li, Chun-Dong Xue, Shen Li, Zheng-Nan Gao, Kai-Rong Qin
Frontiers in Endocrinology.2024;[Epub] CrossRef
Associations between different insulin resistance indices and the risk of all-cause mortality in peritoneal dialysis patients
Guowen Zhao, Sijia Shang, Na Tian, Xiaojiang Zhan, Fenfen Peng, Xiaoyang Wang, Yueqiang Wen, Qingdong Xu, Xiaoran Feng, Xingming Tang, Xianfeng Wu, Qian Zhou, Yuanyuan Yang, Xing Zhang, Ning Su
Lipids in Health and Disease.2024;[Epub] CrossRef
Relationship between the Mediterranean Diet and Vascular Function in Subjects with and without Increased Insulin Resistance
Marta Gómez-Sánchez, Leticia Gómez-Sánchez, Rocío Llamas-Ramos, Emiliano Rodríguez-Sánchez, Luis García-Ortiz, Ruth Martí-Lluch, María Cortés Rodríguez, Inés Llamas-Ramos, Manuel A. Gómez-Marcos
Nutrients.2024; 16(18): 3106. CrossRef
Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae
Domenico Sergi, Mattia Melloni, Angelina Passaro, Luca Maria Neri
Nutrients.2024; 16(19): 3243. CrossRef
Intestinal ABC transporters: Influence on the metronomic cyclophosphamide-induced toxic effect in an obese mouse mammary cancer model
María Manuela Barranco, Felipe Zecchinati, Virginia Gabriela Perdomo, Martín José Habib, María José Rico, Viviana Rosa Rozados, Mario Salazar, Matías Ezequiel Fusini, Olga Graciela Scharovsky, Silvina Stella Maris Villanueva, Leandro Ernesto Mainetti, Fab
Toxicology and Applied Pharmacology.2024; 492: 117130. CrossRef
Association Between Physical Activity and Pancreatic Cancer Risk and Mortality: A Systematic Review and Meta-Analysis
Mylena D. Bos, Jelmer E. Oor, Lucas Goense, N. Helge Meyer, Maximilian Bockhorn, Frederik J. H. Hoogwater, Joost M. Klaase, Maarten W. Nijkamp
Cancers.2024; 16(21): 3594. CrossRef
The risk of cancer among insulin glargine users in Lithuania: A retrospective population-based study
Justinas Jonusas, Mingailė Drevinskaitė, Donata Linkeviciute-Ulinskiene, Adomas Ladukas, Aušvydas Patašius, Lina Zabulienė, Giedrė Smailytė
Open Medicine.2024;[Epub] CrossRef
Risk Factors for Early Post-transplant Weight Changes Among Simultaneous Pancreas-kidney Recipients and Impact on Outcomes
Sandesh Parajuli, Riccardo Tamburrini, Fahad Aziz, Ban Dodin, Brad C. Astor, Didier Mandelbrot, Dixon Kaufman, Jon Odorico
Transplantation Direct.2024; 10(11): e1720. CrossRef
Transitions in metabolic syndrome and metabolic obesity status over time and risk of urologic cancer: A prospective cohort study
Xia Wang, Runxue Jiang, Jianglun Shen, Shuohua Chen, Shouling Wu, Hailong Hu, Haifeng Cai, Yuki Arita
PLOS ONE.2024; 19(10): e0311492. CrossRef
Probiotic, Postbiotic, and Paraprobiotic Effects of Lactobacillus rhamnosus as a Modulator of Obesity-Associated Factors
Gabriela López-Almada, María Esther Mejía-León, Norma Julieta Salazar-López
Foods.2024; 13(22): 3529. CrossRef
Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021
Zhouwei Zhan, Xiamei Chen, Shaohua Xu, Qifei Li, Jiami Yu, Zengqing Guo, Bijuan Chen
World Journal of Surgical Oncology.2024;[Epub] CrossRef
The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment
Hao Lyu, Jinghua Kong, Jiasi Chen, Rui Zhang, Shuai Xiao, Dong Guo, Qi Zhang, Xing-Zhen Chen, Jingfeng Tang, Cefan Zhou
International Journal of Molecular Sciences.2024; 25(24): 13334. CrossRef
Association Between Polycystic Ovary Syndrome and Pancreatic Cancer in a Retrospective Case‐Control Study
Pei-Ying Chung, Kuan-Fu Liao, Yu-Hung Kuo, Shih-Wei Lai, Bing Niu
International Journal of Clinical Practice.2024;[Epub] CrossRef
Anti-Diabetic Therapies and Cancer: From Bench to Bedside
Dimitris Kounatidis, Natalia G. Vallianou, Irene Karampela, Eleni Rebelos, Marina Kouveletsou, Vasileios Dalopoulos, Petros Koufopoulos, Evanthia Diakoumopoulou, Nikolaos Tentolouris, Maria Dalamaga
Biomolecules.2024; 14(11): 1479. CrossRef
Dietary insulin index and dietary insulin load in relation to non-alcoholic fatty liver disease: a cross-sectional study
Amir Motamedi, Shahab Alizadeh, Saeed Osati, Tahereh Raeisi, Reza Homayounfar
Public Health Nutrition.2024;[Epub] CrossRef
Advances in “adiponcosis”: Insights in the inner mechanisms at the base of adipose and tumour tissues interplay
Cristina Pagano, Erika di Zazzo, Giorgio Avilia, Beatrice Savarese, Giovanna Navarra, Maria Chiara Proto, Donatella Fiore, Monica Rienzo, Patrizia Gazzerro, Chiara Laezza, Maurizio Bifulco
International Journal of Cancer.2023; 152(12): 2464. CrossRef
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment
Andrea Pretta, Pina Ziranu, Riccardo Giampieri, Clelia Donisi, Erika Cimbro, Dario Spanu, Eleonora Lai, Federica Pecci, Francesca Balconi, Alessio Lupi, Marta Pozzari, Mara Persano, Sara Murgia, Valeria Pusceddu, Marco Puzzoni, Rossana Berardi, Mario Scar
Digestive and Liver Disease.2023; 55(5): 655. CrossRef
Islet amyloid polypeptide does not suppress pancreatic cancer
Austin J. Taylor, Evgeniy Panzhinskiy, Paul C. Orban, Francis C. Lynn, David F. Schaeffer, James D. Johnson, Janel L. Kopp, C. Bruce Verchere
Molecular Metabolism.2023; 68: 101667. CrossRef
Pathophysiology of obesity and its associated diseases
Xin Jin, Tingting Qiu, Li Li, Rilei Yu, Xiguang Chen, Changgui Li, Christopher G. Proud, Tao Jiang
Acta Pharmaceutica Sinica B.2023; 13(6): 2403. CrossRef
Metabolic syndrome as a risk factor for oncogenesis
M.A. Osadchuk, I.N. Vasilieva, V.V. Kozlov, O.I. Mitrokhina
Russian Journal of Preventive Medicine.2023; 26(1): 70. CrossRef
Polycystic ovary syndrome: Causes, symptoms, pathophysiology, and remedies
Ananya Chaudhuri
Obesity Medicine.2023; 39: 100480. CrossRef
Metformin and long non-coding RNAs in breast cancer
Morteza Gholami, Zeynab Nickhah Klashami, Pirooz Ebrahimi, Amir Ali Mahboobipour, Amir Salehi Farid, Aida Vahidi, Marziyeh Zoughi, Mojgan Asadi, Mahsa M. Amoli
Journal of Translational Medicine.2023;[Epub] CrossRef
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
International Journal of Molecular Sciences.2023; 24(5): 4974. CrossRef
Degree of obesity and gastrointestinal adverse reactions influence the weight loss effect of liraglutide in overweight or obese patients with type 2 diabetes
Fang Zhou, Lu Jiang, Jiamei Guo, Yuting Fan, Qin Pan, Tianlian Li, Xiaoshi Sun, Ping Li
Therapeutic Advances in Chronic Disease.2023;[Epub] CrossRef
Both early and late maternal age at childbirth is associated with increasing odds of central obesity in offspring
Hongyun Chen, Yinhua Feng, Changying Chen, Songcheng Yu
American Journal of Human Biology.2023;[Epub] CrossRef
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings
Teresa L. Mastracci, Minoti Apte, Laufey T. Amundadottir, Alexandra Alvarsson, Steven Artandi, Melena D. Bellin, Ernesto Bernal-Mizrachi, Alejandro Caicedo, Martha Campbell-Thompson, Zobeida Cruz-Monserrate, Abdelfattah El Ouaamari, Kyle J. Gaulton, Andre
Diabetes.2023; 72(4): 433. CrossRef
Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism
Miriam Lee-Rueckert, Marina Canyelles, Mireia Tondo, Noemi Rotllan, Petri T. Kovanen, Vicenta Llorente-Cortes, Joan Carles Escolà-Gil
Seminars in Cancer Biology.2023; 93: 36. CrossRef
PIK3CA mutation in endometriotic epithelial cells promotes viperin-dependent inflammatory response to insulin
Mike R. Wilson, Shannon Harkins, Jake J. Reske, Rebecca A. Siwicki, Marie Adams, Victoria L. Bae-Jump, Jose M. Teixeira, Ronald L. Chandler
Reproductive Biology and Endocrinology.2023;[Epub] CrossRef
Gut microbiome modified by bariatric surgery improves insulin sensitivity and correlates with increased brown fat activity and energy expenditure
Jitender Yadav, Tao Liang, Tairan Qin, Nayanan Nathan, Katherine J.P. Schwenger, Lauren Pickel, Li Xie, Helena Lei, Daniel A. Winer, Heather Maughan, Susan J. Robertson, Minna Woo, Wendy Lou, Kate Banks, Timothy Jackson, Allan Okrainec, Susy S. Hota, Susa
Cell Reports Medicine.2023; 4(5): 101051. CrossRef
Prevalence of Type 2 Diabetes, Impaired Fasting Glucose, and Diabetes Risk in an Adult and Older North-Eastern Portuguese Population
Pedro M. Magalhães, José E. Teixeira, João P. Bragada, Carlos M. Duarte, José A. Bragada
Healthcare.2023; 11(12): 1712. CrossRef
Hyperinsulinemia Influences the Short-Term Efficiency of Laparoscopic Sleeve Gastrectomy for Patients with Obesity and Insulin Resistance
Zilong Yue, Long Qian, Yan Jin, Yabin Xia, Hui Sha, Qin Wu, Kaifeng Hu
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1745. CrossRef
Acetyl-11-Keto-Beta-Boswellic Acid Has Therapeutic Benefits for NAFLD Rat Models That Were Given a High Fructose Diet by Ameliorating Hepatic Inflammation and Lipid Metabolism
Reza Ataei Kachouei, Alireza Doagoo, Maral Jalilzadeh, Seyyed Hossein Khatami, Shima Rajaei, Ali Jahanbazi Jahan-Abad, Farzaneh Salmani, Roya Pakrad, Somayeh Mahmoodi Baram, Mitra Nourbakhsh, Mohammad-Amin Abdollahifar, Hojjat Allah Abbaszadeh, Shokoofeh
Inflammation.2023; 46(5): 1966. CrossRef
Cancer Risk and its Association With Diabetes Mellitus in Patients With Acromegaly: A Two Center-based Study
Zhe-Hao Xiao, Cheng Wang, Yong Wang, Shang-Kun Yuan, Cheng Huang, Ren-Fang Chen, Yong Li
Endocrine Practice.2023; 29(9): 699. CrossRef
Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions
Leonardo de Andrade Mesquita, Laura Fink Wayerbacher, Gilberto Schwartsmann, Fernando Gerchman
Archives of Endocrinology and Metabolism.2023;[Epub] CrossRef
Insulin Stimulates IL-23 Expression in Human Adipocytes: A Possible Explanation for the Higher Prevalence of Psoriasis in Obesity
Angelo Di Vincenzo, Marnie Granzotto, Marika Crescenzi, Camilla Costa, Stefano Piaserico, Vincenzo Vindigni, Roberto Vettor, Marco Rossato
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1885. CrossRef
Immunometabolic aspects of chronic nonspecific inflammation in obesity
O. V. Skvortsova, N. B. Migacheva, E. G. Mikhailova
Meditsinskiy sovet = Medical Council.2023; (12): 75. CrossRef
The Reponic Classification of Insulin
Joshua Moen
Canadian Journal of Diabetes.2023; 47(8): 680. CrossRef
Dietary Acid Load and Cancer Risk: A Review of the Uruguayan Experience
Alvaro Luis Ronco, Maximilian Andreas Storz
Nutrients.2023; 15(14): 3098. CrossRef
Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
Stephanie Talamantes, Michela Lisjak, Eduardo H. Gilglioni, Camilo J. Llamoza-Torres, Bruno Ramos-Molina, Esteban N. Gurzov
JHEP Reports.2023; 5(9): 100811. CrossRef
Alteration of Metabolic Syndrome Is Associated with the Decreased Risk of Colorectal Cancer
Eun Hyo Jin, Yoon Jin Choi, Joo Hyun Lim, Cheol Min Shin, Kyungdo Han, Dong Ho Lee
Journal of Clinical Medicine.2023; 12(15): 4889. CrossRef
Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes
Stephanie A. Eid, Phillipe D. O'Brien, Katharina H. Kretzler, Dae‐Gyu Jang, Faye E. Mendelson, John M. Hayes, Andrew Carter, Hongyu Zhang, Subramaniam Pennathur, Frank C. Brosius, Emily J. Koubek, Eva L. Feldman
The FASEB Journal.2023;[Epub] CrossRef
Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer
Vanda Marques, Fabiola Arella, Marta B. Afonso, André A. Santos, Cecília M.P. Rodrigues
Clinical Science.2023; 137(15): 1095. CrossRef
Metformin Can Attenuate Beta-Cell Hypersecretion—Implications for Treatment of Children with Obesity
Quan Wen, Rasmus Stenlid, Azazul Islam Chowdhury, Iris Ciba, Banu Aydin, Sara Y. Cerenius, Hannes Manell, Anders Forslund, Peter Bergsten
Metabolites.2023; 13(8): 917. CrossRef
The Effectiveness of a Low Glycemic Index/Load Diet on Cardiometabolic, Glucometabolic, and Anthropometric Indices in Children with Overweight or Obesity: A Systematic Review and Meta-Analysis
Ioustini Kalaitzopoulou, Xenophon Theodoridis, Evangelia Kotzakioulafi, Kleo Evripidou, Michail Chourdakis
Children.2023; 10(9): 1481. CrossRef
Characteristics of Children and Adolescents with Hyperinsulinemia Undergoing Oral Glucose Tolerance Test: A Single-Center Retrospective Observational Study
Clelia Cipolla, Ilaria Lazzareschi, Antonietta Curatola, Claudia Lasorella, Lucia Celeste Pane, Linda Sessa, Giulia Rotunno, Donato Rigante, Giorgio Sodero
Diseases.2023; 11(3): 110. CrossRef
Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation
Anni M.Y. Zhang, Yi Han Xia, Jeffrey S.H. Lin, Ken H. Chu, Wei Chuan K. Wang, Titine J.J. Ruiter, Jenny C.C. Yang, Nan Chen, Justin Chhuor, Shilpa Patil, Haoning Howard Cen, Elizabeth J. Rideout, Vincent R. Richard, David F. Schaeffer, Rene P. Zahedi, Chr
Cell Metabolism.2023; 35(12): 2119. CrossRef
Dairy Intake Modifies the Level of the Bile Acid Precursor and Its Correlation with Serum Proteins Associated with Cholesterol Clearance in Subjects with Hyperinsulinemia
Atena Mahdavi, Jocelyn Trottier, Olivier Barbier, Michel Lebel, Iwona Rudkowska
Nutrients.2023; 15(22): 4707. CrossRef
Trapa Bispinosa Roxb. Inhibits the Insulin-Dependent AKT/WNK1 Pathway to Induce Autophagy in Mice with Type 2 Diabetes
Takahiro Suzuki, Takehito Sato, Kaori Masuhara, Mizuki Tokusanai, Hisako Akatsuka, Tomohiro Kashikawa, Yasuyuki Suzuki
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3095. CrossRef
Effects of Functional and Nutraceutical Foods in the Context of the Mediterranean Diet in Patients Diagnosed with Breast Cancer
Giovanna Flore, Andrea Deledda, Mauro Lombardo, Andrea Armani, Fernanda Velluzzi
Antioxidants.2023; 12(10): 1845. CrossRef
A systematic review exploring the mechanisms by which citrus bioflavonoid supplementation benefits blood glucose levels and metabolic complications in type 2 diabetes mellitus
Ankit Gupta, Abdulsatar Jamal, Dina A. Jamil, Hayder A. Al-Aubaidy
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(11): 102884. CrossRef
Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms
Li Wang, Zhe Zhang, Eusebio Chiefari
Journal of Diabetes Research.2023; 2023: 1. CrossRef
EXPLORATORY ANALYSIS OF DIETARY PATTERNS OF PATIENTS WITH GASTRIC ADENOCARCINOMA: A CASE-CONTROL STUDY IN CENTRAL BRAZIL
Silvana Barbosa SANTIAGO, Gabriela Rodrigues de SOUSA, Amanda Ferreira Paes Landim RAMOS, Gisele Aparecida FERNANDES, Maria Paula CURADO, Mônica Santiago BARBOSA
Arquivos de Gastroenterologia.2023; 60(4): 419. CrossRef
Risk of cancer in acromegaly patients: An updated meta-analysis and systematic review
Zhehao Xiao, Pingping Xiao, Yong Wang, Chen Fang, Yong Li, Alvaro Galli
PLOS ONE.2023; 18(11): e0285335. CrossRef
Long Follow-Up Times Weaken Observational Diet–Cancer Study Outcomes: Evidence from Studies of Meat and Cancer Risk
William B. Grant
Nutrients.2023; 16(1): 26. CrossRef
Serum Lipid Profiles and Cholesterol-Lowering Medication Use in Relation to Subsequent Risk of Colorectal Cancer in the UK Biobank Cohort
Fangcheng Yuan, Wanqing Wen, Guochong Jia, Jirong Long, Xiao-Ou Shu, Wei Zheng
Cancer Epidemiology, Biomarkers & Prevention.2023; 32(4): 524. CrossRef
Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries
Christoph Roderburg, Sven H. Loosen, Laura Hoyer, Tom Luedde, Karel Kostev
Journal of Cancer Research and Clinical Oncology.2022; 148(5): 1057. CrossRef
The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
Junyuan Deng, Yujie Guo, Jiali Du, Jichun Gu, Lei Kong, Boan Tao, Ji Li, Deliang Fu
Frontiers in Cell and Developmental Biology.2022;[Epub] CrossRef
Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics
Anni M. Y. Zhang, Ken H. Chu, Brian F. Daly, Titine Ruiter, Yan Dou, Jenny C. C. Yang, Twan J. J. de Winter, Justin Chhuor, Su Wang, Stephane Flibotte, Yiwei Bernie Zhao, Xiaoke Hu, Hong Li, Elizabeth J. Rideout, David F. Schaeffer, James D. Johnson, Jane
Cancer & Metabolism.2022;[Epub] CrossRef
Ghrelin and Cancer: Examining the Roles of the Ghrelin Axis in Tumor Growth and Progression
Anuhya S. Kotta, Abigail S. Kelling, Karen A. Corleto, Yuxiang Sun, Erin D. Giles
Biomolecules.2022; 12(4): 483. CrossRef
Influence of obesity on reproductive health before andduring pregnancy
A. Konwisser, O. Korytko
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(8): 446. CrossRef
Research Status of the Correlation between Type 2 Diabetes Mellitus and the Occurrence and Development of Breast Cancer
聪李
Advances in Clinical Medicine.2022; 12(04): 3010. CrossRef
Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hype
Jong Han Choi, Yoon Jeong Cho, Hyun-Jin Kim, Seung-Hyun Ko, Suk Chon, Jee-Hyun Kang, Kyoung-Kon Kim, Eun Mi Kim, Hyun Jung Kim, Kee-Ho Song, Ga Eun Nam, Kwang Il Kim
Diabetes & Metabolism Journal.2022; 46(3): 355. CrossRef
Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery
Shuhei Shinoda, Naohiko Nakamura, Brett Roach, David A. Bernlohr, Sayeed Ikramuddin, Masato Yamamoto
Biomedicines.2022; 10(6): 1284. CrossRef
Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management: consensus statement of the Korean Society for the Study of obesity, Korean Diabetes Association, and Korean Society of Hype
Jong Han Choi, Yoon Jeong Cho, Hyun-Jin Kim, Seung-Hyun Ko, Suk Chon, Jee-Hyun Kang, Kyoung-Kon Kim, Eun Mi Kim, Hyun Jung Kim, Kee-Ho Song, Ga Eun Nam, Kwang Il Kim
Clinical Hypertension.2022;[Epub] CrossRef
Vitamin D and Risk of Obesity-Related Cancers: Results from the SUN (‘Seguimiento Universidad de Navarra’) Project
Rodrigo Sánchez-Bayona, Maira Bes-Rastrollo, Cesar I. Fernández-Lázaro, Maite Bastyr, Ainhoa Madariaga, Juan J. Pons, Miguel A. Martínez-González, Estefanía Toledo
Nutrients.2022; 14(13): 2561. CrossRef
Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Nathalie Kliemann, Romain Ould Ammar, Carine Biessy, Audrey Gicquiau, Verena Katzke, Rudolf Kaaks, Anne Tjønneland, Anja Olsen, Maria-Jose Sánchez, Marta Crous-Bou, Fabrizio Pasanisi, Sandar Tin Tin, Aurora Perez-Cornago, Dagfinn Aune, Sofia Christakoudi,
Cancer Epidemiology, Biomarkers & Prevention.2022; 31(7): 1359. CrossRef
Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hype
Jong Han Choi, Yoon Jeong Cho, Hyun-Jin Kim, Seung-Hyun Ko, Suk Chon, Jee-Hyun Kang, Kyoung-Kon Kim, Eun Mi Kim, Hyun Jung Kim, Kee-Ho Song, Ga Eun Nam, Kwang Il Kim
Journal of Obesity & Metabolic Syndrome.2022; 31(2): 100. CrossRef
Detangling the interrelations between MAFLD, insulin resistance, and key hormones
Shreya C. Pal, Mohammed Eslam, Nahum Mendez-Sanchez
Hormones.2022; 21(4): 573. CrossRef
Obesity, cancer risk, and time-restricted eating
Manasi Das, Nicholas J. G. Webster
Cancer and Metastasis Reviews.2022; 41(3): 697. CrossRef
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study
Michael K. Odutola, Marina T. van Leeuwen, Jennifer Turner, Fiona Bruinsma, John F. Seymour, H. Miles Prince, Samuel T. Milliken, Mark Hertzberg, Judith Trotman, Stephen S. Opat, Robert Lindeman, Fernando Roncolato, Emma Verner, Michael Harvey, Campbell T
Cancer Epidemiology.2022; 80: 102241. CrossRef
Differential expression of Ago2‐mediated microRNA signaling in adipose tissue is associated with food‐induced obesity
Hansi Zhang, Liang Qiao, Xiaoxuan Liu, Xiaojing Han, Jing Kang, Yanli Liu, Juntang Lin, Xin Yan
FEBS Open Bio.2022; 12(10): 1828. CrossRef
Proposal for standardizing normal insulin ranges in Brazilian patients and a new classification of metabolic syndrome
Pedro Renato Chocair, Precil Diego Miranda de Menezes Neves, Victor Augusto Hamamoto Sato, Sara Mohrbacher, Érico Souza Oliveira, Leonardo Victor Barbosa Pereira, Alessandra Martins Bales, Fagner Pereira da Silva, John A. Duley, Américo Lourenço Cuvello-N
Frontiers in Medicine.2022;[Epub] CrossRef
Two models of insulin resistance development and the strategy to combat age-related diseases: literature review
A. V. Martyushev-Poklad, D. S. Yankevich, M. V. Petrova, N. G. Savitskaya
Problems of Endocrinology.2022; 68(4): 59. CrossRef
In Vitro Mimicking of Obesity-Induced Biochemical Environment to Study Obesity Impacts on Cells and Tissues
Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Diseases.2022; 10(4): 76. CrossRef
Long‐term survival analysis of patients with stage IIIB‐IV non‐small cell lung cancer complicated by type 2 diabetes mellitus: A retrospective propensity score matching analysis
Xuejiao Li, Haiyan Fang, Dongwei Zhang, Liming Xia, Xiang Wang, Jingping Yang, Shaohu Zhang, Ya Su, Yongfu Zhu
Thoracic Cancer.2022; 13(23): 3268. CrossRef
Diabetes and skin cancers: Risk factors, molecular mechanisms and impact on prognosis
Elena-Codruta Dobrică, Madalina Laura Banciu, Vincent Kipkorir, Mohammad Amin Khazeei Tabari, Madeleine Jemima Cox, L V Simhachalam Kutikuppala, Mihnea-Alexandru Găman
World Journal of Clinical Cases.2022; 10(31): 11214. CrossRef
The role of the mTOR pathway in diabetic retinopathy
Fabio Casciano, Enrico Zauli, Erika Rimondi, Marco Mura, Maurizio Previati, Massimo Busin, Giorgio Zauli
Frontiers in Medicine.2022;[Epub] CrossRef
Hyperinsulinemia-induced microglial mitochondrial dynamic and metabolic alterations lead to neuroinflammation in vivo and in vitro
Xiaohan Yang, Yuan Xu, Wenting Gao, Li Wang, Xinnan Zhao, Gang Liu, Kai Fan, Shuang Liu, Huimin Hao, Siyan Qu, Renhou Dong, Xiaokai Ma, Jianmei Ma
Frontiers in Neuroscience.2022;[Epub] CrossRef
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases
Teresa L. Mastracci, Minoti Apte, Laufey T. Amundadottir, Alexandra Alvarsson, Steven Artandi, Melena D. Bellin, Ernesto Bernal-Mizrachi, Alejandro Caicedo, Martha Campbell-Thompson, Zobeida Cruz-Monserrate, Abdelfattah El Ouaamari, Kyle J. Gaulton, Andre
Pancreas.2022; 51(9): 1061. CrossRef
Intestinal Microbiome Modified by Bariatric Surgery Improves Insulin Sensitivity and Correlates with Increased Brown Fat Activity and Energy Expenditure
jitender Yadav, Tao Liang, Tairan Qin, Nayanan N. Nathan, Katherine J.P Schwenger, Lauren Pickel, Li Xie, Helena Lei, Daniel A. Winer, Heather Maughan, Susan J. Robertson, Minna Woo, Wendy Y. W. Lou, Kate Banks, Timothy Jackson, Allan Okrainec, Susy S. Ho
SSRN Electronic Journal .2022;[Epub] CrossRef
Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases
Alison H. Affinati, Amisha Wallia, Roma Y. Gianchandani
Clinical Diabetes and Endocrinology.2021;[Epub] CrossRef
Promises and pitfalls of beta cell–replacement therapies
Jelena Kolic, James D. Johnson
Nature Metabolism.2021; 3(8): 1036. CrossRef
Hiding unhealthy heart outcomes in a low-fat diet trial: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial finds that postmenopausal women with established coronary heart disease were at increased risk of an adverse outcome if
Timothy David Noakes
Open Heart.2021; 8(2): e001680. CrossRef
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes
James D. Johnson
Diabetologia.2021; 64(10): 2138. CrossRef
Diabetes mellitus and cancer: a system of insulin-like growth factors
E. M. Frantsiyants, E. I. Surikova, I. V. Kaplieva, V. A. Bandovkina, I. V. Neskubina, E. A. Sheiko, M. I. Morozova, I. M. Kotieva
Problems of Endocrinology.2021; 67(5): 34. CrossRef

Basic Research
Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases: Siqi Hu, Eun-Hee Cho, Ji-Young Lee; Diabetes Metab J. 2020;44(2):234-244. Published online March 24, 2020; DOI: https://doi.org/10.4093/dmj.2019.0243

11,453 View
189 Download
28 Web of Science
29 Crossref

Abstract PDF PubReader ePub

As a member of the class IIa histone deacetylases (HDACs), HDAC9 catalyzes the deacetylation of histones and transcription factors, commonly leading to the suppression of gene transcription. The activity of HDAC9 is regulated transcriptionally and post-translationally. HDAC9 is known to play an essential role in regulating myocyte and adipocyte differentiation and cardiac muscle development. Also, recent studies have suggested that HDAC9 is involved in the pathogenesis of chronic diseases, including cardiovascular diseases, osteoporosis, autoimmune disease, cancer, obesity, insulin resistance, and liver fibrosis. HDAC9 modulates the expression of genes related to the pathogenesis of chronic diseases by altering chromatin structure in their promotor region or reducing the transcriptional activity of their respective transcription factors. This review summarizes the current knowledge of the regulation of HDAC9 expression and activity. Also, the roles of HDAC9 in the pathogenesis of chronic diseases are discussed, along with potential underlying mechanisms.

Citations

Citations to this article as recorded by

Palmitic acid alters enhancers/super-enhancers near inflammatory and efferocytosis-associated genes in human monocytes
Vinay Singh Tanwar, Marpadga A Reddy, Suchismita Dey, Vajir Malek, Linda Lanting, Zhuo Chen, Rituparna Ganguly, Rama Natarajan
Journal of Lipid Research.2025; 66(4): 100774. CrossRef
Exploration of Fingerprints and Data Mining-based Prediction of Some Bioactive Compounds from Allium sativum as Histone Deacetylase 9 (HDAC9) Inhibitors
Totan Das, Arijit Bhattacharya, Tarun Jha, Shovanlal Gayen
Current Computer-Aided Drug Design.2025; 21(3): 270. CrossRef
HDAC9 as a Sex‐Dependent Epigenetic Driver of Hepatic Steatosis and Adipose Inflammation
Yu Ji Kim, Jong‐Won Kim
Journal of Gastroenterology and Hepatology.2025; 40(10): 2632. CrossRef
Downregulation of HDAC9 Alleviates Autophagy Dysfunction by Inducing Acetylation of ATG4B in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Xiao‐Han Ma, Guang‐Peng Liu, Le Liu, Zi‐yue Dou, Xue He, Xi Chen
The FASEB Journal.2025;[Epub] CrossRef
Molecular mechanisms of bamboo-derived miRNA-mediated gene regulation and dietary adaptation in giant pandas
Zheng Yan, Qin Xu, Xin He, Ying Yao, Dingzhen Liu, Hairui Wang
BMC Genomics.2025;[Epub] CrossRef
The multifactorial role of HDAC9 at the maternal–fetal interface in the pathogenesis of preeclampsia
Megan A. Opichka, Jennifer J. McIntosh, Justin L. Grobe
Clinical Science.2025; 139(24): 1769. CrossRef
Impact of housing temperature on adipose tissue HDAC9 expression and adipogenic differentiation in high fat‐fed mice
Samah Ahmadieh, Brandee Goo, Abdalrahman Zarzour, David Kim, Hong Shi, Praneet Veerapaneni, Ronnie Chouhaita, Nicole K. H. Yiew, Carla Dominguez Gonzalez, Akash Chakravartty, James Pennoyer, Nazeera Hassan, Tyler W. Benson, Mourad Ogbi, David J. Fulton, R
Obesity.2024; 32(1): 107. CrossRef
HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD
Guixian Zheng, Chao Li, Xiaoli Chen, Zhaohui Deng, Ting Xie, Zengyu Huo, Xinyan Wei, Yanbing Huang, Xia Zeng, Yu Luo, Jing Bai
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(4): 167023. CrossRef
Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes
Jing Liu, Lingzhen Meng, Zhihong Liu, Ming Lu, Ruiying Wang
Scientific Reports.2024;[Epub] CrossRef
HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors
Totan Das, Samima Khatun, Tarun Jha, Shovanlal Gayen
Mini-Reviews in Medicinal Chemistry.2024; 24(7): 767. CrossRef
The role of histone deacetylases in inflammatory respiratory diseases: an update
Sicen Pan, Xiangdong Wang, Jian Jiao, Luo Zhang
Expert Review of Clinical Immunology.2024; 20(10): 1193. CrossRef
The Human Genetic Differences in the Outcomes of mRNA Vaccination against COVID-19: A Prospective Cohort Study
Ha-Eun Ryu, Jihyun Yoon, Ja-Eun Choi, Seok-Jae Heo, Kyung-Won Hong, Dong-Hyuk Jung
Vaccines.2024; 12(6): 626. CrossRef
Targeting histone deacetylases for cancer therapy: Trends and challenges
Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
Acta Pharmaceutica Sinica B.2023; 13(6): 2425. CrossRef
Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
Guokai Zhang, Zhenying Liu, Zihan Li, Bing Zhang, Pengyu Yao, Yun Qiao
Frontiers in Genetics.2023;[Epub] CrossRef
Research Progress on Histone Deacetylase Inhibitors
玉姜汤
Hans Journal of Medicinal Chemistry.2023; 11(02): 116. CrossRef
HDAC9 Inhibition as a Novel Treatment for Stroke
Hugh S. Markus
Stroke.2023; 54(12): 3182. CrossRef
Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi
Pharmacological Research.2023; 198: 107009. CrossRef
Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration
Ming Lei, Hui Lin, Deyao Shi, Pan Hong, Hui Song, Bomansaan Herman, Zhiwei Liao, Cao Yang
Cellular & Molecular Biology Letters.2023;[Epub] CrossRef
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
Sylvia Fong, Bridget Yates, Choong-Ryoul Sihn, Aras N. Mattis, Nina Mitchell, Su Liu, Chris B. Russell, Benjamin Kim, Adebayo Lawal, Savita Rangarajan, Will Lester, Stuart Bunting, Glenn F. Pierce, K. John Pasi, Wing Yen Wong
Nature Medicine.2022; 28(4): 789. CrossRef
Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
Michael Hauke, Robert Eckenstaler, Anne Ripperger, Anna Ender, Heike Braun, Ralf A. Benndorf
Journal of the American Heart Association.2022;[Epub] CrossRef
HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
Long Xu, Jian Wang, Buhan Liu, Jiaying Fu, Yuanxin Zhao, Sihang Yu, Luyan Shen, Xiaoyu Yan, Jing Su
Biomedicines.2022; 10(2): 374. CrossRef
Common protein-coding variants influence the racing phenotype in galloping racehorse breeds
Haige Han, Beatrice A. McGivney, Lucy Allen, Dongyi Bai, Leanne R. Corduff, Gantulga Davaakhuu, Jargalsaikhan Davaasambuu, Dulguun Dorjgotov, Thomas J. Hall, Andrew J. Hemmings, Amy R. Holtby, Tuyatsetseg Jambal, Badarch Jargalsaikhan, Uyasakh Jargalsaikh
Communications Biology.2022;[Epub] CrossRef
Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life
Zahra Salehi, Masoud Arabfard, Omid Sadatpour, Mina Ohadi
Neurological Sciences.2021; 42(3): 951. CrossRef
Emerging roles of SIRT6 in human diseases and its modulators
Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou
Medicinal Research Reviews.2021; 41(2): 1089. CrossRef
Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9
Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, Teresa Gagliano
Life.2021; 11(2): 90. CrossRef
circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis
Huan Wan, Ting You, Wei Luo
Frontiers in Cardiovascular Medicine.2021;[Epub] CrossRef
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Chun Yang, Stéphane Croteau, Pierre Hardy
Cellular Oncology.2021; 44(5): 997. CrossRef
Dual HDAC/BRD4 inhibitors against cancer
Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
Medicinal Chemistry Research.2021; 30(10): 1822. CrossRef
miR‐211‐5p is down‐regulated and a prognostic marker in bladder cancer
Weisheng Wang, Zhiming Liu, Xuegang Zhang, Junning Liu, Junqing Gui, Maorong Cui, Yong Li
The Journal of Gene Medicine.2020;[Epub] CrossRef

Complications
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment: Sunghwan Suh, Kwang-Won Kim; Diabetes Metab J. 2019;43(6):733-743. Published online December 23, 2019; DOI: https://doi.org/10.4093/dmj.2019.0177

15,765 View
314 Download
130 Web of Science
135 Crossref

Abstract PDF PubReader ePub

Cancer incidence appears to be increased in both type 1 and type 2 diabetes mellitus (DM). DM represents a risk factor for cancer, particularly hepatocellular, hepatobiliary, pancreas, breast, ovarian, endometrial, and gastrointestinal cancers. In addition, there is evidence showing that DM is associated with increased cancer mortality. Common risk factors such as age, obesity, physical inactivity and smoking may contribute to increased cancer risk in patients with DM. Although the mechanistic process that may link diabetes to cancer is not completely understood yet, biological mechanisms linking DM and cancer are hyperglycemia, hyperinsulinemia, increased bioactivity of insulin-like growth factor 1, oxidative stress, dysregulations of sex hormones, and chronic inflammation. However, cancer screening rate is significantly lower in people with DM than that in people without diabetes. Evidence from previous studies suggests that some medications used to treat DM are associated with either increased or reduced risk of cancer. However, there is no strong evidence supporting the association between the use of anti-hyperglycemic medication and specific cancer. In conclusion, all patients with DM should be undergo recommended age- and sex appropriate cancer screenings to promote primary prevention and early detection. Furthermore, cancer should be screened in routine diabetes assessment.

Citations

Citations to this article as recorded by

Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study
Dong‐Hoe Koo, Jin‐Hyung Jung, Kyungdo Han, Cheol‐Young Park
Journal of Diabetes Investigation.2026; 17(2): 338. CrossRef
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2026
Mandeep Bajaj, Rozalina G. McCoy, Kirthikaa Balapattabi, Raveendhara R. Bannuru, Natalie J. Bellini, Allison K. Bennett, Elizabeth A. Beverly, Kathaleen Briggs Early, Sathyavathi ChallaSivaKanaka, Justin B. Echouffo-Tcheugui, Brendan M. Everett, Rajesh Ga
Diabetes Care.2026; 49(Supplement): S61. CrossRef
Diabetes and cancer: therapeutic implications
Stavros Fay, Gabriella Bayshtok, Carine E. Hamo, Javed Butler, Michelle Bloom
Cardio-Oncology.2026;[Epub] CrossRef
Glycation‐Driven Impairment of Cytoskeletal Homeostasis and Viability Disables Glyoxalase‐Low Mesothelia From Resisting Cancer Colonization
Satyarthi Mishra, Kottpalli Vidhipriya, Anchita Gopikrishnan, Purba Sarkar, Sudiksha Mishra, Chigicherla V. S. Prasanna, P. S. Hari, Aruna Korlimarla, Prosenjit Sen, Ramray Bhat
Journal of Cellular Physiology.2026;[Epub] CrossRef
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, Mandeep Bajaj, Kirthikaa Balapattabi, Elizabeth A. Beverly, Kathaleen Briggs Early, Dennis Bruemmer, Kenneth Cusi, Justin B. Echouffo-Tcheugui, Laya Ekhlaspour, Talya K. Fleming, Rajesh Garg, Kamlesh Khun
Diabetes Care.2025; 48(Supplement): S59. CrossRef
Diabetes and cardiovascular disease in older adults
Anika Bilal, Richard Pratley
Annals of the New York Academy of Sciences.2025; 1543(1): 42. CrossRef
Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
Mijin Kim, Seung Chan Kim, Jinmi Kim, Bo Hyun Kim
Diabetes & Metabolism Journal.2025; 49(1): 49. CrossRef
Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Thyroid Cancer
Sang Yi Moon, Minkook Son, Jung-Hwan Cho, Hye In Kim, Ji Min Han, Ji Cheol Bae, Sunghwan Suh
Thyroid®.2025; 35(1): 79. CrossRef
Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions
Wei-Ming Cheng, Po-Chen Li, Minh Tran-Binh Nguyen, Yu-Teng Lin, Yu-Tang Huang, Tai-Shan Cheng, Thi-Huong Nguyen, Thu-Ha Tran, Tzu-Yi Huang, Thu-Huyen Hoang, Sin-Yu Chen, Yu-Chieh Chu, Chih-Wei Wu, Ming-Fen Lee, Yi-Shiou Chiou, Hsiao-Sheng Liu, Yi-Ren Hong
Cancer Cell International.2025;[Epub] CrossRef
Diabetes Comorbidity and Quality of Life in Patients with Cancer: A Prospective Study in an Integrative Oncology Setting
Sameer Kassem, Noah Samuels, Orit Gressel, Nili Stein, Miri Golan, Eran Ben-Arye
Journal of Clinical Medicine.2025; 14(6): 1800. CrossRef
Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms
Ya. V. Dvoryanchikov, S. M. Deunezhewa, I. A. Yatskov, V. A. Beloglazov
Problems of Endocrinology.2025; 71(2): 75. CrossRef
Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer
Xinyi Zhang, Zhikai Xiahou, Fu Zhao, Qing Wu, Wei Nie, Shouyan Wang
Frontiers in Molecular Biosciences.2025;[Epub] CrossRef
Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus
Kinfe G. Bishu, Andrew D. Schreiner, Nicholas Shungu, Vanessa A. Diaz, Macelyn Batten, Mulugeta Gebregziabher
Cancer Research Communications.2025; 5(8): 1256. CrossRef
Mendelian Randomization and Transcriptome Data Analysis Reveal Bidirectional Causal Relationships and Mechanisms between Type 2 Diabetes and Gastric Cancer
Junyang Ma, Yuan Gao, Shufu Hou, Shichang Cui, Jiankang Zhu
Current Medicinal Chemistry.2025; 32(21): 4284. CrossRef
Association of diabetes mellitus and breast cancer in adult men and women: a cross-sectional survey
Rabiya Saroosh, Nazir Ahmad, Beenish Israr, Anum Nazir, Nizwa Itrat, Abdul Momin Rizwan Ahmad
BMC Cancer.2025;[Epub] CrossRef
The Role of Insulin Resistance in Cancer
Bal Krishna Subedi, Charishma Bhimineni, Shivani Modi, Atousa Jahanshahi, Katherine Quiza, Daniel Bitetto
Current Oncology.2025; 32(9): 477. CrossRef
Antioxidant, Anti‐Proliferative and Porcine α‐Amylase Inhibitory Potential of Flavonoids From Hydnocarpus pentandrus (Buch.–Ham.) Oken (In Vitro and In Silico Studies)
Mugdha G. Juwale, Anuja D. Kamble, Hitendra Munot, Anjali A. Kulkarni
Chemistry & Biodiversity.2025;[Epub] CrossRef
Type 2 Diabetes and Gastrointestinal Cancers: Risk Associations and Awareness of Screening Challenges
Monika Storman, Leszek Czupryniak
Cancers.2025; 17(18): 2989. CrossRef
The co-impact of diabetes and psoriasis on mortality risk for all causes and specific causes
Na Liu, Xiaoe Chen
Scientific Reports.2025;[Epub] CrossRef
Identification of Key Genes Involved in the Occurrence and Development of Endometrial Cancer
Meiyuan Huang, Qiong Zhu, Kai Tan, Xupeng Chen
International Journal of Women's Health.2025; Volume 17: 4311. CrossRef
Associations of Alcohol Consumption with All-Cause and Cancer Mortalities in Patients with Type 2 Diabetes Mellitus: A Nationwide Population Cohort Study
Da Yeon Lee, Sun-Joon Moon, Kyung-Do Han, Ji-Hee Ko, Han-na Jang, Hye-Mi Kwon, Se-Eun Park, Eun-Jung Rhee, Won-Young Lee
Endocrinology and Metabolism.2025; 40(6): 893. CrossRef
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Laya Ekhlaspour, Talya K. Fleming, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Nicola Napoli
Diabetes Care.2024; 47(Supplement): S52. CrossRef
Editorial: The relationship between diabetes and cancers and its underlying mechanisms, volume II
Qiang Huo, Shuo Wang, Ying Hou, Reginald M. Gorczynski, Yining Shen, Bin Wang, Hanyi Ge, Tao Li
Frontiers in Endocrinology.2024;[Epub] CrossRef
Factors associated with gastric and duodenal neuroendocrine tumors: A multicenter case-control study
Kwangwoo Nam, Su Youn Nam, Jun Chul Park, Young Sin Cho, Hyuk Soon Choi, Kyoungwon Jung, Seon-Young Park, Joon Hyun Cho, Hyonho Chun
Digestive and Liver Disease.2024; 56(9): 1592. CrossRef
Exploring Perspectives on Cancer Screening in People Aged 30-70: A Comparative Study of Those With and Without Type 2 Diabetes
Yunus GÜR, Egemen TURAL, Akın DAYAN
Konuralp Tıp Dergisi.2024; 16(1): 26. CrossRef
Prognostic significance of glucose‐lipid metabolic index in pancreatic cancer patients with diabetes mellitus
Hailiang Wang, Shiye Ruan, Zelong Wu, Qian Yan, Yubin Chen, Jinwei Cui, Zhongyan Zhang, Shanzhou Huang, Baohua Hou, Chuanzhao Zhang
Cancer Medicine.2024;[Epub] CrossRef
Preoperative glucose-to-lymphocyte ratio predicts survival in cancer
Le Liu, Bei-bei Zhang, Yuan-zhou Li, Wen-juan Huang, Ye Niu, Qing-chun Jia, Wen Wang, Jia-rui Yuan, Shi-di Miao, Rui-tao Wang, Guang-yu Wang
Frontiers in Endocrinology.2024;[Epub] CrossRef
Higher Prevalence of Cancer in Patients with Diabetic Foot Syndrome
Chiara Goretti, Alessandro Prete, Alex Brocchi, Elisabetta Iacopi, Letizia Pieruzzi, Alberto Piaggesi
Journal of Clinical Medicine.2024; 13(5): 1448. CrossRef
Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
Ling-Hsiang Chuang, Huanlan Zhang, Tianqi Hong, Shitong Xie
The Patient - Patient-Centered Outcomes Research.2024; 17(5): 565. CrossRef
Diabetes and the social, biologic, and behavioral determinants of endometrial cancer in the United States
Nour Massouh, Ayad A. Jaffa, Miran A. Jaffa
BMC Cancer.2024;[Epub] CrossRef
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
O. M. Drapkina, A. V. Kontsevaya, A. M. Kalinina, S. N. Avdeev, M. V. Agaltsov, L. I. Alekseeva, I. I. Almazova, E. Yu. Andreenko, D. N. Antipushina, Yu. A. Balanova, S. A. Berns, A. V. Budnevsky, V. V. Gainitdinova, A. A. Garanin, V. M. Gorbunov, A. Yu.
Cardiovascular Therapy and Prevention.2024; 23(3): 3696. CrossRef
Association between glycemic status and the risk of gastric cancer in pre/peri-and postmenopausal women: A nationwide cohort study
Kyung Hee Han, Yoon Jin Choi, Tae Il Kim, Noh Hyun Park, Kyung-do Han, Dong Ho Lee
Annals of Epidemiology.2024; 94: 106. CrossRef
Severity of Complications and Duration of Type 2 Diabetes and the Risk of Cancer: A Population-Based Study
Yu-Wen Hu, Chiu-Mei Yeh, Chia-Jen Liu, Tzeng-Ji Chen, Nicole Huang, Yiing-Jenq Chou
Cancer Epidemiology, Biomarkers & Prevention.2024; 33(5): 739. CrossRef
Incident Cancer Risk in Patients with Incident Type 2 Diabetes Mellitus in Hungary (Part 1)
Zsolt Abonyi-Tóth, György Rokszin, Ibolya Fábián, Zoltán Kiss, György Jermendy, Péter Kempler, Csaba Lengyel, István Wittmann, Gergő A. Molnár, Gábor Sütő
Cancers.2024; 16(9): 1745. CrossRef
Diabetes and obesity: the role of stress in the development of cancer
Angelo Avogaro
Endocrine.2024; 86(1): 48. CrossRef
DIABETES MELLITUS TIPO 2 E OBESIDADE, PRÓGONOS DE NEOPLASIAS?
Victor Becchi, Luísa Emanoela Bandolin Goinski, Ana Letícia Loesch Wojcik, Patrícia Costa Mincoff Barbanti
Revista Contemporânea.2024; 4(7): e5071. CrossRef
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study
Niels A. D. Guchelaar, Stefan A. J. Buck, Leni van Doorn, Koen G. A. M. Hussaarts, Yorick Sandberg, Annemieke van der Padt-Pruijsten, Robbert J. van Alphen, Laura Poppe-Manenschijn, Isolde Vleut, Peter de Bruijn, Roelof W. F. van Leeuwen, Bianca Mostert,
Clinical Pharmacokinetics.2024; 63(7): 1037. CrossRef
Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, Jafar Fallahi
European Journal of Pharmacology.2024; 978: 176803. CrossRef
Associations between Diabetes Mellitus and Selected Cancers
Monika Pliszka, Leszek Szablewski
International Journal of Molecular Sciences.2024; 25(13): 7476. CrossRef
Exploring the Interplay of Diabetes, Deaf Patient Reported Outcomes, and Cancer Screening in Deaf and Hard of Hearing Women
Emmanuel Perrodin-Njoku, Sowmya Rao, Regina Wang, Christopher Moreland, Poorna Kushalnagar
International Journal of Women's Health.2024; Volume 16: 1235. CrossRef
Causal relationship between type 2 diabetes and glioblastoma: bidirectional Mendelian randomization analysis
Wei Chen, Taoyuan Zhang, Hui Zhang
Scientific Reports.2024;[Epub] CrossRef
Findings on Age at Onset of Cancer in Diabetic and Non-diabetic Populations
Ángel Gómez-Villanueva, Sharon I Martínez-Gómez, David E González-Mendoza, Edgar A Ramos-Gutiérrez, Roosvelth G Hernández-Ramírez, Lesly D Delgado-Villarejo, José J Garduño-García
Cureus.2024;[Epub] CrossRef
Association between prediabetes and the incidence of gastric cancer: A meta-analysis
Shenggang Wang, Jiamin Zhao, Chong Liu
Medicine.2024; 103(34): e39411. CrossRef
Lifestyle and metabolic factors affect risk for meningioma in women: a prospective population-based study (The Cohort of Norway)
Anamaria Gheorghiu, Cathrine Brunborg, Tom B. Johannesen, Eirik Helseth, John-Anker Zwart, Markus K. H. Wiedmann
Frontiers in Oncology.2024;[Epub] CrossRef
Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis
Jinli Zhao, Wenjin Li, Libo Chen, Mingyong Li, Weiming Deng
Frontiers in Endocrinology.2024;[Epub] CrossRef
Changes in serum uteroglobin level in type 2 diabetes mellitus patients
Joung Youl Lim, Sang-Hyeon Ju, Ji Min Kim, Hyon-Seung Yi, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku, Kyong Hye Joung
Frontiers in Endocrinology.2024;[Epub] CrossRef
Continuum of type 2 diabetes mellitus and its comorbidity with other somatic diseases
M.N. Mamedov, I.V. Druk, G.G. Arabidze, Kh.R. Akhundova
Russian Journal of Preventive Medicine.2024; 27(9): 123. CrossRef
The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic Insights
Abutaleb Asiri, Ali Al Qarni, Ahmed Bakillah
Diagnostics.2024; 14(19): 2132. CrossRef
The Effect of Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic on the Metabolic Tumor Markers: A Real-World Retrospective Study
Song Wen, Dongxiang Xu, Yue Yuan, Zhimin Xu, Yanyan Li, Min Gong, Xinlu Yuan, Ligang Zhou
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 4115. CrossRef
Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies
Agnieszka Drab, Wiesław Kanadys, Maria Malm, Krystian Wdowiak, Joanna Dolar-Szczasny, Bartłomiej Barczyński
Scientific Reports.2024;[Epub] CrossRef
Glycemic load impacts the response of acquired resistance in breast cancer cells to chemotherapeutic drugs in vitro
Sirin A. Adham, Azza Al Kalbani, Noura Al Zeheimi, Muna Al Dalali, Noor Al Kharusi, Azeeza Siddiqi, Aliya Al Maskari, Muhammad Muzamil Khan
PLOS ONE.2024; 19(11): e0311345. CrossRef
Application value of high-pressure-resistant peripherally inserted central catheters in enhanced computer tomography of diabetic patients with malignant tumors
Li Zhang, Hui-Feng Yan
World Journal of Diabetes.2024; 15(12): 2293. CrossRef
Life-style and metabolic factors do not affect risk for glioma: a prospective population-based study (The Cohort of Norway)
Anamaria Gheorghiu, Cathrine Brunborg, Tom B. Johannesen, Eirik Helseth, John-Anker Zwart, Markus K. H. Wiedmann
Frontiers in Oncology.2024;[Epub] CrossRef
RETRACTED: Investigating the relationship between insulin use and all-cause mortality, breast cancer mortality, and recurrence risk in diabetic patients with breast cancer: A comprehensive systematic review and meta-analysis
Marina V. Loktionova, Mahdi Mohammadian, Roya Choopani, Soleiman Kheiri, Abdollah Mohammadian-Hafshejani, Kathleen Bennett
PLOS ONE.2024; 19(12): e0314565. CrossRef
Anxiety, Depression, and Quality of Life in Women with Breast Cancer and Type 2 Diabetes: A Pilot Study in North Greece
Maria Parpori, Ioannis Tsamesidis, Evangelos Karamitrousis, Aikaterini Giakidou, Evangelia Kroustalidou, Polixeni Liamopoulou, Maria Lavdaniti
Journal of Personalized Medicine.2024; 14(12): 1154. CrossRef
Patterns and Trends in Mortality Associated With and Due to Diabetes Mellitus in a Transitioning Region With 3.17 Million People: Observational Study
Xiaopan Li, Ru Liu, Yichen Chen, Yan Han, Qizhe Wang, Yaxin Xu, Jing Zhou, Sunfang Jiang
JMIR Public Health and Surveillance.2023; 9: e43687. CrossRef
Diabetes and cancer: Optimising glycaemic control
Nalinie Joharatnam‐Hogan, Daniel L. Morganstein
Journal of Human Nutrition and Dietetics.2023; 36(2): 504. CrossRef
Need for improving immunization status and preventive care in diabetes mellitus patients
Teresa Gisinger, Alexandra Kautzky-Willer, Michael Leutner
Wiener klinische Wochenschrift.2023; 135(13-14): 336. CrossRef
Impact of cumulative hyperglycemic burden on the pancreatic cancer risk: A nationwide cohort study
Dong-Hoe Koo, Kyungdo Han, Cheol-Young Park
Diabetes Research and Clinical Practice.2023; 195: 110208. CrossRef
Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
Zhihong Yue, Lin Pei, Guangyan Meng, Aimin Zhang, Meng Li, Mei Jia, Hui Wang, Linlin Cao
Metabolites.2023; 13(1): 90. CrossRef
Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis
Margaret A. Heller, Sarah C. Nyirjesy, Robert Balsiger, Nicholas Talbot, Kyle K. VanKoevering, Catherine T. Haring, Matthew O. Old, Stephen Y. Kang, Nolan B. Seim
Oral Oncology.2023; 137: 106300. CrossRef
Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
Alessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli, Francesco Perri, Marco Cascella, Francesco Sabbatino, Maurizio Capuozzo, Vincenza Granata, Silvia Zappavigna, Angela Lombardi, Marianna Scrima, Nadia Petrillo, Monica Ianniello, Marika Casillo,
Frontiers in Medicine.2023;[Epub] CrossRef
The relationship between the CUN-BAE body fatness index and incident diabetes: a longitudinal retrospective study
Qing Peng, Zihao Feng, Zhuojian Cai, Dixing Liu, Jiana Zhong, Hejia Zhao, Xiuwei Zhang, Weikun Chen
Lipids in Health and Disease.2023;[Epub] CrossRef
Association of four lipid-derived indicators with the risk of developing type 2 diabetes: a Chinese population-based cohort study
Linfeng He, Wenbin Zheng, Zeyu Li, Wen Kong, Tianshu Zeng
Lipids in Health and Disease.2023;[Epub] CrossRef
Screening for Coronary Artery Disease in Cancer Survivors
Ragani Velusamy, Mark Nolan, Andrew Murphy, Paaladinesh Thavendiranathan, Thomas H. Marwick
JACC: CardioOncology.2023; 5(1): 22. CrossRef
Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and in vitro validation
Yejun Tan, Jin Kang, Hongli Li, Aifang Zhong, Yaqiong Liu, Zheyu Zhang, Roujie Huang, Xin Cheng, Weijun Peng
Frontiers in Immunology.2023;[Epub] CrossRef
Increased Breast and Colorectal Cancer Risk in Type 2 Diabetes: Awareness Among Adults With and Without Diabetes and Information Provision on Diabetes Websites
Laura Ashley, Kathryn A Robb, Daryl B O’Connor, Rebecca Platt, Mollie Price, Olivia Robinson, Elizabeth Travis, Lorraine Lipscombe, Ramzi Ajjan, Rebecca Birch
Annals of Behavioral Medicine.2023; 57(5): 386. CrossRef
Primary peritoneal serous psammocarcinoma, rare variant: A case report
Srujan Kancharla, Anne Alaniz, Pulin Kothari, Stacy Norton
Gynecologic Oncology Reports.2023; 47: 101176. CrossRef
Association between the Finnish Diabetes Risk Score and cancer in middle-aged and older adults: Involvement of inflammation
Yu Peng, Peng Wang, Jianxiao Gong, Fubin Liu, Yating Qiao, Changyu Si, Xixuan Wang, Huijun Zhou, Fangfang Song
Metabolism.2023; 144: 155586. CrossRef
Interlinking of diabetes mellitus and cancer: An overview
Iftikhar Ahmad, Mohd Suhail, Ausaf Ahmad, Mahmoud Alhosin, Shams Tabrez
Cell Biochemistry and Function.2023; 41(5): 506. CrossRef
High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist
Bingwei Ma, Xingchun Wang, Hui Ren, Yingying Li, Haijiao Zhang, Muqing Yang, Jiyu Li
BMC Cancer.2023;[Epub] CrossRef
Diabetes mellitus and the female reproductive system tumors
K. I. Sharafutdinova, V. S. Shlyapina, A. I. Baeva, A. A. Timurshin, I. E. Sabanaeva, A. G. Nakieva, M. F. Kalashnikova, M. N. Khabibov
Problems of Endocrinology.2023; 69(3): 103. CrossRef
Global estimates of rehabilitation needs and disease burden in tracheal, bronchus, and lung cancer from 1990 to 2019 and projections to 2045 based on the global burden of disease study 2019
Xigui Lai, Conghui Li, Yao Yang, Mingyuan Niu, Yujie Yang, Shanshan Gu, Weiqian Hou, Lili Chen, Yi Zhu
Frontiers in Oncology.2023;[Epub] CrossRef
Social and racial inequalities in diabetes and cancer in the United States
Nour Massouh, Ayad A. Jaffa, Hani Tamim, Miran A. Jaffa
Frontiers in Public Health.2023;[Epub] CrossRef
Lactate in exhaled breath condensate and its correlation to cancer: challenges, promises and a call for data
Veronika Ruzsányi, Miklós Péter Kalapos
Journal of Breath Research.2023; 17(4): 044001. CrossRef
The impact of diabetes status on total and site-specific cancer risk in the elderly population: A nationwide cohort study
Kyuho Kim, Bongseong Kim, Hyunho Kim, Hyung Soon Park, Yu-Bae Ahn, Seung-Hyun Ko, Kyungdo Han, Jae-Seung Yun
Diabetes Research and Clinical Practice.2023; 203: 110866. CrossRef
Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
Current Diabetes Reports.2023; 23(10): 253. CrossRef
PECAM-1 drives β-catenin-mediated EndMT via internalization in colon cancer with diabetes mellitus
Qing Wu, Xingxing Du, Jianing Cheng, Xiuying Qi, Huan Liu, Xiaohong Lv, Xieyang Gong, Changxin Shao, Muhong Wang, Luxiao Yue, Xin Yang, Shiyu Li, Yafang Zhang, Xuemei Li, Huike Yang
Cell Communication and Signaling.2023;[Epub] CrossRef
Saxagliptin, a selective dipeptidyl peptidase-4 inhibitor, alleviates somatic cell aneugenicity and clastogenicity in diabetic mice
Sabry M. Attia, Sheikh F. Ahmad, Ahmed Nadeem, Mohamed S.M. Attia, Mushtaq A. Ansari, Abdelkader E. Ashour, Norah A. Albekairi, Mohammed A. Al-Hamamah, Ali A. Alshamrani, Saleh A. Bakheet
Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2023; 892: 503707. CrossRef
Analysis of differential membrane proteins related to matrix stiffness-mediated metformin resistance in hepatocellular carcinoma cells
Xiangyu Gao, Jiali Qian, Yang Zhang, Heming Wang, Jiefeng Cui, Yehong Yang
Proteome Science.2023;[Epub] CrossRef
Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study
Mia Scholten, Anders Halling, Kathleen Bennett
PLOS ONE.2023; 18(10): e0292853. CrossRef
The interplay between antidiabetic medications and cancer risk
Duaa Durrani, Muhammad Hassan, Aimen Zulfikar
International Journal of Scientific Reports.2023; 9(11): 384. CrossRef
Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study
Hui Gao, Shuhao Zheng, Xin Yuan, Jiarong Xie, Lei Xu
BMC Medicine.2023;[Epub] CrossRef
Association between diabetes at different diagnostic ages and risk of cancer incidence and mortality: a cohort study
Yu Peng, Fubin Liu, Peng Wang, Yating Qiao, Changyu Si, Xixuan Wang, Jianxiao Gong, Huijun Zhou, Fengju Song, Fangfang Song
Frontiers in Endocrinology.2023;[Epub] CrossRef
The Characteristics and Risk of Mortality in the Elderly Korean Population
Sunghwan Suh
Endocrinology and Metabolism.2023; 38(5): 522. CrossRef
Clinical potentials of metformin in cancer therapy
Nidhi Sharma, Richa Dhingra
Journal of Diabetology.2023; 14(4): 186. CrossRef
High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus
Charupong Saengboonmee, Marutpong Detarya, Sakkarn Sangkhamanon, Kanlayanee Sawanyawisuth, Wunchana Seubwai, Sopit Wongkham
Nutrition and Cancer.2022; 74(5): 1734. CrossRef
Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries
Christoph Roderburg, Sven H. Loosen, Laura Hoyer, Tom Luedde, Karel Kostev
Journal of Cancer Research and Clinical Oncology.2022; 148(5): 1057. CrossRef
Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
Lara S. Lemon, Brian Orr, Francesmary Modugno, Ronald J. Buckanovich, Lan Coffman, Robert P. Edwards, Sarah Taylor
Gynecologic Oncology.2022; 165(1): 60. CrossRef
The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms
Bing Zhu, Shen Qu
Frontiers in Endocrinology.2022;[Epub] CrossRef
The impact of diabetes mellitus on levels of sex hormones and their receptors in tumor tissues in female rats with Guerin’s carcinoma
E. M. Frantsiyants, V. A. Bandovkina, I. V. Kaplieva, E. I. Surikova, Yu. A. Pogorelova, N. D. Cheryarina, I. M. Kotieva, M. I. Morozova, A. I. Shikhlyarova
Research and Practical Medicine Journal.2022; 9(1): 23. CrossRef
Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study
Oh. Hyeong Lee, Yong-Moon Park, Seung-Hyun Ko, Kyuna Lee, Yeonji Kim, Kyungdo Han, Jung-Hae Cho
BMC Cancer.2022;[Epub] CrossRef
Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study
Jing Ding, Xudong Li, Jun Ge, Yuanqian Gong, Ya Zhou, Juan Xiao, Qin Yang, Jing Chen, Mian Mao
Cancer Management and Research.2022; Volume 14: 1313. CrossRef
The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients
Xi-yu Liu
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1113. CrossRef
Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz
Christian Jenssen, Cristine Pietsch
Die Diabetologie.2022; 18(4): 379. CrossRef
Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
Guotai Sheng, Dingyang Liu, Maobin Kuang, Yanjia Zhong, Shuhua Zhang, Yang Zou
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1677. CrossRef
The Association of Dietary Fiber Intake in Three Meals with All-Cause and Disease-Specific Mortality among Adults: The U.S. National Health and Nutrition Examination Survey, 2003–2014
Jiayue Qi, Jian Gao, Yuntao Zhang, Wanying Hou, Tianshu Han, Changhao Sun
Nutrients.2022; 14(12): 2521. CrossRef
A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
Lin-Lin Cao, Yi Han, Lin Pei, Zhi-Hong Yue, Bo-Yu Liu, Jing-Wen Cui, Mei Jia, Hui Wang
Metabolites.2022; 12(7): 610. CrossRef
Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
Eun-Jung Rhee
Endocrinology and Metabolism.2022; 37(3): 415. CrossRef
Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
Endocrinology and Metabolism.2022; 37(3): 466. CrossRef
Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract
Piero Portincasa, Leonilde Bonfrate, David Q.‐H. Wang, Gema Frühbeck, Gabriella Garruti, Agostino Di Ciaula
European Journal of Clinical Investigation.2022;[Epub] CrossRef
Editorial: The relationship between diabetes and cancers and its underlying mechanisms
Qiang Huo, Jing Wang, Nannan Zhang, Long Xie, Heshan Yu, Tao Li
Frontiers in Endocrinology.2022;[Epub] CrossRef
Oxidatively Damaged Nucleic Acid: Linking Diabetes and Cancer
Xiujuan Hong, Yiqiu Hu, Zhijun Yuan, Zhihao Fang, Xiaoxiao Zhang, Ying Yuan, Cheng Guo
Antioxidants & Redox Signaling.2022; 37(16-18): 1153. CrossRef
Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links
Ya Wang, Xinling Zeng, Jie Tan, Yi Xu, Cunjian Yi
Medicine.2022; 101(34): e30299. CrossRef
The Good, the Bad and the New about Uric Acid in Cancer
Simone Allegrini, Mercedes Garcia-Gil, Rossana Pesi, Marcella Camici, Maria Grazia Tozzi
Cancers.2022; 14(19): 4959. CrossRef
Family cancer history and smoking habit associated with sarcoma in a Japanese population study
Yoshihiro Araki, Norio Yamamoto, Yoshikazu Tanzawa, Takahiro Higashi, Aya Kuchiba, Katsuhiro Hayashi, Akihiko Takeuchi, Shinji Miwa, Kentaro Igarashi, Makoto Endo, Eisuke Kobayashi, Hiroyuki Tsuchiya, Akira Kawai
Scientific Reports.2022;[Epub] CrossRef
Decreased IGF-1 level is associated with restrained amino acid metabolism in NSCLC with diabetes mellitus
Hehe Lv, Fan Zhang, Can Liang, Xuekui Liu, Yamei Ma, Jiayi Li, Yan Ye, Shanwen Si, Yaran Liu, Hao Heng, Houfa Geng
Frontiers in Endocrinology.2022;[Epub] CrossRef
Acute Pancreatitis Increases the Risk of Gastrointestinal Cancer in Type 2 Diabetic Patients: A Korean Nationwide Cohort Study
Jin Ho Choi, Woo Hyun Paik, Dong Kee Jang, Min Kyu Kim, Ji Kon Ryu, Yong-Tae Kim, Kyungdo Han, Sang Hyub Lee
Cancers.2022; 14(22): 5696. CrossRef
Targets for the prevention of comorbidity of cardiovascular and cancer diseases
M. N. Mamedov, K. K. Badeinikova, A. K. Karimov
Russian Journal of Cardiology.2022; 27(11): 5235. CrossRef
Prevalence and potential risk factors of self-reported diabetes among elderly people in China: A national cross-sectional study of 224,142 adults
Xing Hu, Lingbing Meng, Zhimin Wei, Hongxuan Xu, Jianyi Li, Yingying Li, Na Jia, Hui Li, Xin Qi, Xuezhai Zeng, Qiuxia Zhang, Juan Li, Deping Liu
Frontiers in Public Health.2022;[Epub] CrossRef
Urinary Exosomal Tissue TIMP and Angiopoietin-1 Are Preoperative Novel Biomarkers of Well-Differentiated Thyroid Cancer
Chih-Yuan Wang, Shyang-Rong Shih, Kuen-Yuan Chen, Pei-Jie Huang
Biomedicines.2022; 11(1): 24. CrossRef
Acquired and modifiable cardiovascular risk factors in patients treated for cancer
Gary S. Beasley, Jeffrey A. Towbin
Journal of Thrombosis and Thrombolysis.2021; 51(4): 846. CrossRef
Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products
Wamidh H. Talib, Asma Ismail Mahmod, Sara Feras. Abuarab, Eliza Hasen, Amer A. Munaim, Shatha Khaled Haif, Amani Marwan Ayyash, Samar Khater, Intisar Hadi AL-Yasari, Lina T. Al Kury
Molecules.2021; 26(8): 2179. CrossRef
Epidemiological link between obesity, type 2 diabetes mellitus and cancer
Cornelius J Fernandez, Annu Susan George, Nikhila A Subrahmanyan, Joseph M Pappachan
World Journal of Methodology.2021; 11(3): 23. CrossRef
Evaluation of the Efficacy of the Hospital Glycemic Management System for Patients with Malignant Tumors and Hyperglycemia
Juan Jiang, Danlan Pu, Renzhi Hu, Mingyang Hu, Qinan Wu
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2717. CrossRef
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Aldona Kasprzak
International Journal of Molecular Sciences.2021; 22(12): 6434. CrossRef
TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
Desh Deepak Singh, Dharmendra Kumar Yadav
Biomedicines.2021; 9(8): 876. CrossRef
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Xin Zhao, Minghe Wang, Zhitong Wen, Zhihong Lu, Lijuan Cui, Chao Fu, Huan Xue, Yunfeng Liu, Yi Zhang
Frontiers in Endocrinology.2021;[Epub] CrossRef
The Aneugenicity of Ketone Bodies in Colon Epithelial Cells Is Mediated by Microtubule Hyperacetylation and Is Blocked by Resveratrol
Haruka Sudo, Akira Kubo
International Journal of Molecular Sciences.2021; 22(17): 9397. CrossRef
EFFECT OF DIABETES MELLITUS ON THE LEVEL OF GROWTH FACTORS IN GUERIN CARCINOMA IN RATS OF BOTH SEXES
E.M. Frantsiyants, V.A. Bandovkina, I.V. Kaplieva, E.I. Surikova, I.V. Neskubina, L.K. Trepitaki, N.D. Cheryarina, Yu.A. Pogorelova, L.A. Nemashkalova, A.I. Shikhlyarova, I.M. Kotieva, M.I. Morozova
Ulyanovsk Medico-biological Journal.2021; : 129. CrossRef
Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS
Miao Liu, Yu Liu, Hua Feng, Yixin Jing, Shuang Zhao, Shujia Yang, Nan Zhang, Shi Jin, Yafei Li, Mingjiao Weng, Xinzhu Xue, Fuya Wang, Yongheng Yang, Xiaoming Jin, Dan Kong
Frontiers in Pharmacology.2021;[Epub] CrossRef
Diabetes mellitus and cancer: a system of insulin-like growth factors
E. M. Frantsiyants, E. I. Surikova, I. V. Kaplieva, V. A. Bandovkina, I. V. Neskubina, E. A. Sheiko, M. I. Morozova, I. M. Kotieva
Problems of Endocrinology.2021; 67(5): 34. CrossRef
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
Rabia K. Shahid, Shahid Ahmed, Duc Le, Sunil Yadav
Cancers.2021; 13(22): 5735. CrossRef
Obesity, Diabetes, and Increased Cancer Progression
Dae-Seok Kim, Philipp E. Scherer
Diabetes & Metabolism Journal.2021; 45(6): 799. CrossRef
Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
Monika Kapszewicz, Ewa Małecka-Wojciesko
Journal of Clinical Medicine.2021; 10(22): 5463. CrossRef
Chronic non-communicable diseases, risk factors, and quality of life in patients with malignancies of various localizations
M.N. Mamedov, V.I. Potievskaya, E.K. Saribekyan, O.V. Pikin, D.V. Sidorov, Z.M. Salimov, V.A. Kutsenko, O.M. Drapkina
Profilakticheskaya meditsina.2021; 24(11): 45. CrossRef
Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Esa Läärä
Acta Oncologica.2020; 59(9): 1110. CrossRef
Transcriptional Profiling and Biological Pathway(s) Analysis of Type 2 Diabetes Mellitus in a Pakistani Population
Zarish Noreen, Christopher A. Loffredo, Attya Bhatti, Jyothirmai J. Simhadri, Gail Nunlee-Bland, Thomas Nnanabu, Peter John, Jahangir S. Khan, Somiranjan Ghosh
International Journal of Environmental Research and Public Health.2020; 17(16): 5866. CrossRef
Screening Strategy of Pancreatic Cancer in Patients with Diabetes Mellitus
Suguru Mizuno, Yousuke Nakai, Kazunaga Ishigaki, Kei Saito, Hiroki Oyama, Tsuyoshi Hamada, Yukari Suzuki, Akiyuki Inokuma, Sachiko Kanai, Kensaku Noguchi, Tatsuya Sato, Ryunosuke Hakuta, Tomotaka Saito, Naminatsu Takahara, Hirofumi Kogure, Hiroyuki Isayam
Diagnostics.2020; 10(8): 572. CrossRef
Changes in mortality rates and ratios in people with pharmacologically treated type 2 diabetes mellitus between 2001 and 2016 in Hungary
György Jermendy, Zoltán Kiss, György Rokszin, Ibolya Fábián, István Wittmann, Péter Kempler
Diabetes Research and Clinical Practice.2020; 163: 108134. CrossRef
Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target

Lin Tang, Meng Xu, Long Zhang, Lin Qu, Xiaoyan Liu
OncoTargets and Therapy.2020; Volume 13: 7411. CrossRef
Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study
Jeong Mi Kim, Sang Soo Kim, In Joo Kim, Jong Ho Kim, Bo Hyun Kim, Mi Kyung Kim, Soon Hee Lee, Chang Won Lee, Min Chul Kim, Jun Hyeob Ahn, Jinmi Kim
Cardiovascular Diabetology.2020;[Epub] CrossRef
An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
Kyle J. Gu, Guojun Li
Journal of Cancer Prevention.2020; 25(3): 127. CrossRef
Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2
Xueyan Zhou, Yinxue Xu, Di Yin, Feng Zhao, Zhixiang Hao, Ya’nan Zhong, Jingbo Zhang, Bei Zhang, Xiaoxing Yin
Biomedicine & Pharmacotherapy.2020; 131: 110764. CrossRef
Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case–control studies
Lihai Wang, Lei Zhong, Bin Xu, Min Chen, Hongxiao Huang
BMJ Open.2020; 10(12): e040137. CrossRef

Original Articles

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes: Hyun Hee Chung, Jun Sung Moon, Ji Sung Yoon, Hyoung Woo Lee, Kyu Chang Won; Diabetes Metab J. 2013;37(2):125-131. Published online April 16, 2013; DOI: https://doi.org/10.4093/dmj.2013.37.2.125

6,664 View
33 Download
14 Crossref

Abstract PDF PubReader ePub

Background

Recently, several studies reported that the cancer incidence in type 2 diabetes patients is higher than in the general population. Although a number of risks are shared between cancer and diabetes patients, there have been few studies of its correlation. We evaluated the influences of several factors including low density lipoprotein cholesterol (LDL-C), albuminuria and use of metformin on the risk of cancer in patients with type 2 diabetes.

Methods

We enrolled 1,320 patients with at least 5 years of follow-up and 73 patients were diagnosed with cancer during this period. The associations of the risk factors with cancer incidence were evaluated by multiple regression analysis. The subjects were placed into two subgroups based on metformin dosage (<1,000 mg/day, ≥1,000 mg/day) and we compared cancer incidence using analysis of covariance.

Results

LDL-C and albuminuria were not significantly correlated with cancer risk. In contrast, metformin showed a reverse correlation with cancer risk (P=0.006; relative risk, 0.574). In the metformin nonadministration group, smoking, male gender, and high triglyceride levels tended to be contributing factors without statistical significance. Cancer occurence was lower in the low dose metformin group (less than 1,000 mg/day) (P=0.00).

Conclusion

These results suggest that the administration of low dose metformin in patients with type 2 diabetes may be associated with a reduced risk of cancer.

Citations

Citations to this article as recorded by

Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model
Sudhir Manickavel, Yolanda Hartman, Andrew Burns, Manuel A. Lora Gonzalez, Jason Warram, Erika Walsh, Jacob B. Hunter, Daniel E. Killeen
Otology & Neurotology.2023; 44(9): 941. CrossRef
Metformin induces TPC-1 cell apoptosis through endoplasmic reticulum stress-associated pathways in vitro and in vivo
Jianwen Ye, Lei Qi, Kunlun Chen, Renfeng Li, Shengping Song, Chuang Zhou, Wenlong Zhai
International Journal of Oncology.2019;[Epub] CrossRef
Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells
Deok-Bae Park
Diabetes & Metabolism Journal.2015; 39(6): 518. CrossRef
Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia
Hsin-Hung Chen, Ming-Chia Lin, Chih-Hsin Muo, Su-Yin Yeh, Fung-Chang Sung, Chia-Hung Kao
Medicine.2015; 94(24): e1013. CrossRef
mitoNEET as a novel drug target for mitochondrial dysfunction
Werner J. Geldenhuys, Thomas C. Leeper, Richard T. Carroll
Drug Discovery Today.2014; 19(10): 1601. CrossRef
Diabetes - Increased Risk for Cancers through Chromosomal Aberrations?
Sudhaa Anand, Badari Nath, Radha Saraswathy
Asian Pacific Journal of Cancer Prevention.2014; 15(11): 4571. CrossRef
Oleanolic Acid Induces Metabolic Adaptation in Cancer Cells by Activating the AMP-Activated Protein Kinase Pathway
Jia Liu, Lanhong Zheng, Ning Wu, Leina Ma, Jiateng Zhong, Ge Liu, Xiukun Lin
Journal of Agricultural and Food Chemistry.2014; 62(24): 5528. CrossRef
Association of Vitamin B12Deficiency and Metformin Use in Patients with Type 2 Diabetes
Sun-Hye Ko, Sun-Hee Ko, Yu-Bae Ahn, Ki-Ho Song, Kyung-Do Han, Yong-Moon Park, Seung-Hyun Ko, Hye-Soo Kim
Journal of Korean Medical Science.2014; 29(7): 965. CrossRef
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini, Matteo Puntoni, Brandy M. Heckman-Stoddard, Barbara K. Dunn, Leslie Ford, Andrea DeCensi, Eva Szabo
Cancer Prevention Research.2014; 7(9): 867. CrossRef
Complications of Diabetes Therapy
Sarah D. Corathers, Shawn Peavie, Marzieh Salehi
Clinics Collections.2014; 1: 37. CrossRef
Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
Yanfei Zhang, Meiping Guan, Zongji Zheng, Qian Zhang, Fang Gao, Yaoming Xue, Chunming Liu
PLoS ONE.2013; 8(11): e81264. CrossRef
AACE Comprehensive Diabetes Management Algorithm 2013 Endocrine Practice
Héctor Eloy Tamez-Pérez, Stephanie Lissette Proskauer-Peña, Mayra Ivonne Hernández-Coria
Endocrine Practice.2013; 19(4): 736. CrossRef
Complications of Diabetes Therapy
Sarah D. Corathers, Shawn Peavie, Marzieh Salehi
Endocrinology and Metabolism Clinics of North America.2013; 42(4): 947. CrossRef
Metformin and Cancer in Type 2 Diabetes
Hyeong Kyu Park
Diabetes & Metabolism Journal.2013; 37(2): 113. CrossRef

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone: Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee; Diabetes Metab J. 2012;36(5):371-378. Published online October 18, 2012; DOI: https://doi.org/10.4093/dmj.2012.36.5.371

7,558 View
39 Download
31 Crossref

Abstract PDF PubReader ePub

Background

There is growing concern regarding the increased incidence of bladder cancer in diabetic patients using pioglitazone. This study aimed to investigate the association between bladder cancer and the use of pioglitazone in Korean diabetics.

Methods

This retrospective, matched case-control study included a case group (n=329) of diabetic patients with bladder cancer who presented at the Severance Hospital from November 2005 to June 2011. The control group consisted of patients without bladder cancer (1:2 ratio matching for sex and age, n=658) who were listed on the Severance Hospital diabetes registry.

Results

The percentage of subjects who had ever used pioglitazone was significantly lower in the case group than in the control group (6.4% vs. 15.0%, P<0.001). Multivariate conditional logistic analysis revealed that independent factors affecting bladder cancer were smoking (odds ratio [OR], 11.64; 95% confidence interval [CI], 6.56 to 20.66; P<0.001), coexisting cancer (OR, 6.11; 95% CI, 2.25 to 16.63; P<0.001), and hemoglobin levels (OR, 0.78; 95% CI, 0.69 to 0.88; P<0.001). The OR of the history of pioglitazone use was 2.09 and was not significantly different between the two groups (95% CI, 0.26 to 16.81; P=0.488).

Conclusion

A relationship between pioglitazone use and incidence of bladder cancer was not observed in Korean diabetic patients. This suggests that the risk for bladder cancer in Korean diabetic subjects treated with pioglitazone might be different from that of Caucasian populations. Large-scale, well-designed and multi-center studies are needed to further evaluate this relationship.

Citations

Citations to this article as recorded by

Reassessment of pioglitazone and bladder cancer based on FAERS database
Hai-Yan Chen, Hui Zhao, Jun-Jie Yang, Qian Zhang, Ming-Ming Yan, Xiao-Yan Qiu
Expert Opinion on Drug Safety.2025; 24(9): 1113. CrossRef
Cancer biology in diabetes update: Focusing on antidiabetic drugs
Emi Kawakita, Keizo Kanasaki
Journal of Diabetes Investigation.2024; 15(5): 525. CrossRef
Pioglitazone, Bladder Cancer, and the Presumption of Innocence
Georgios S. Papaetis
Current Drug Safety.2022; 17(4): 294. CrossRef
A systematic review of observational studies of the association between pioglitazone use and bladder cancer
E. Ripamonti, L. Azoulay, M. Abrahamowicz, R.W. Platt, S. Suissa
Diabetic Medicine.2019; 36(1): 22. CrossRef
Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes
Elizabeth M. Garry, John B. Buse, Mugdha Gokhale, Jennifer L. Lund, Matthew E. Nielsen, Virginia Pate, Til Stürmer
Diabetes, Obesity and Metabolism.2019; 21(9): 2096. CrossRef
Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies
Juha Mehtälä, Houssem Khanfir, Dimitri Bennett, Yizhou Ye, Pasi Korhonen, Fabian Hoti
Diabetology International.2019; 10(1): 24. CrossRef
Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay, Daniel Krewski
Critical Reviews in Toxicology.2018; 48(1): 52. CrossRef
An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug’s effect on cardiovascular disease and non-alcoholic steatohepatitis
Mayer B. Davidson, Deyu Pan
Diabetes Research and Clinical Practice.2018; 135: 102. CrossRef
Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world data
Mohammad Adil, Rashid Ali Khan, Pinaki Ghosh, Shiva Kumar Venkata, Amit Dattatraya Kandhare, Manju Sharma
Clinical Epidemiology and Global Health.2018; 6(2): 61. CrossRef
Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
Huilin Tang, Weilong Shi, Shuangshuang Fu, Tiansheng Wang, Suodi Zhai, Yiqing Song, Jiali Han
Cancer Medicine.2018; 7(4): 1070. CrossRef
Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
Hua Qu, Yi Zheng, Yuren Wang, Rui Zhang, Xiongzhong Ruan, Gangyi Yang, Zhenqi Liu, Hongting Zheng
Scientific Reports.2017;[Epub] CrossRef
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
Elena Filipova, Katya Uzunova, Krassimir Kalinov, Toni Vekov
Diabetes Therapy.2017; 8(4): 705. CrossRef
Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
YOUHONG DONG, ANPING WANG
Oncology Letters.2016; 12(1): 89. CrossRef
Ten‐year observational follow‐up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
E. Erdmann, S. Harding, H. Lam, A. Perez
Diabetes, Obesity and Metabolism.2016; 18(3): 266. CrossRef
Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence
Mayer B. Davidson
Journal of Diabetes and its Complications.2016; 30(6): 981. CrossRef
The current role of thiazolidinediones in diabetes management
Christos V. Rizos, Anastazia Kei, Moses S. Elisaf
Archives of Toxicology.2016; 90(8): 1861. CrossRef
Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review
Saarwaani Vallabhajosyula, Shashaank Vallabhajosyula, Saraschandra Vallabhajosyula, Suma Nair, Asha Kamath, Karthik N. Rao
Medical Journal Armed Forces India.2016; 72(3): 253. CrossRef
Baseline glycemic status and mortality in 241,499 Korean metropolitan subjects: A Kangbuk Samsung Health Study
Eun-Jung Rhee, Se Eun Park, Yoosoo Chang, Seungho Ryu, Won-Young Lee
Metabolism.2016; 65(2): 68. CrossRef
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
Eugene Han, Suk-Yong Jang, Gyuri Kim, Yong-ho Lee, Eun Yeong Choe, Chung Mo Nam, Eun Seok Kang
Medicine.2016; 95(6): e2786. CrossRef
Polemics of pioglitazone: an appraisal in 2015
Awadhesh Kumar Singh
Expert Review of Endocrinology & Metabolism.2015; 10(4): 447. CrossRef
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
Daniel Levin, Samira Bell, Reijo Sund, Sirpa A. Hartikainen, Jaakko Tuomilehto, Eero Pukkala, Ilmo Keskimäki, Ellena Badrick, Andrew G. Renehan, Iain E. Buchan, Samantha L. Bowker, Jasjeet K. Minhas-Sandhu, Zafar Zafari, Carlo Marra, Jeffrey A. Johnson, B
Diabetologia.2015; 58(3): 493. CrossRef
Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta‐analysis
Richard M. Turner, Chun S. Kwok, Chen Chen‐Turner, Chinedu A. Maduakor, Sonal Singh, Yoon K. Loke
British Journal of Clinical Pharmacology.2014; 78(2): 258. CrossRef
A Review on Thiazolidinediones and Bladder Cancer in Human Studies
Chin-Hsiao Tseng
Journal of Environmental Science and Health, Part C.2014; 32(1): 1. CrossRef
Physiological Functions of Peroxisome Proliferator-Activated Receptor β
Jaap G. Neels, Paul A. Grimaldi
Physiological Reviews.2014; 94(3): 795. CrossRef
Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
Sang-Man Jin, Sun Ok Song, Chang Hee Jung, Jin-Sun Chang, Sunghwan Suh, Seung Min Kang, Inkyung Jung, Cheol-Young Park, Jae Hyeon Kim, Jae Hyoung Cho, Byung-Wan Lee
Journal of Korean Medical Science.2014; 29(2): 238. CrossRef
Pioglitazone
SS Jadhav, VK Shivane, AR Lila, TR Bandgar, NS Shah
Journal of Postgraduate Medicine.2014; 60(3): 293. CrossRef
Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes
Hannah Seok, Bong Soo Cha
Diabetes & Metabolism Journal.2013; 37(5): 326. CrossRef
Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report
Hirofumi Suzuki, Masaya Sakamoto, Takeshi Hayashi, Hiroyuki Iuchi, Kennosuke Ohashi, Tsuyoshi Isaka, Noriko Sakamoto, Yosuke Kayama, Katsuyoshi Tojo, Michihiro Yoshimura, Kazunori Utsunomiya
Cardiovascular Diabetology.2013;[Epub] CrossRef
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Hanford Yau, Kathya Rivera, Romina Lomonaco, Kenneth Cusi
Current Diabetes Reports.2013; 13(3): 329. CrossRef
Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J2012;36:371-8)
Sheyu Li, Haoming Tian
Diabetes & Metabolism Journal.2013; 37(1): 81. CrossRef
Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m2: A Surgeon’s Perspective
Ricardo Cohen, Pedro Paulo Caravatto, Tarissa Petry
Obesity Surgery.2013; 23(6): 809. CrossRef

First
Prev
Page of 1
Next
Last

Search